Dictyostelium Mutants

Phenotypes for Dictyostelium mutants

View other mutant types: All mutant strains - Null - Overexpression - Multiple - Other - Developmental

To view more details, including parent strains and references, click on the corresponding dictyBase ID.

Systematic Name	Strain Descriptor	Associated gene(s)	Phenotypes
DBS0350195	[act15]: acbA(Y72A)	acbA	decreased lipid binding
DBS0350657	[csaA]: csaA	csaA	aberrant aggregation \| increased calcium-independent cell-cell adhesion
DBS0350059	mcln-	mcln	aberrant cellular response to fluid shear stress \| increased growth rate \| aberrant post-lysosomal vacuole exocytosis
DBS0351382	myoB-/ [act15]: GFP: myoB(1-921,1057-1111)	myoB	abolished protein localization to actin wave
DBS0350826	pinA-	pinA	decreased growth rate \| decreased mound size \| decreased sporulation
DBS0235412	1C7	gp130	decreased cell-substrate adhesion \| delayed development \| increased growth rate
DBS0238601	5NT-	5nt	delayed development of tipped mound \| increased number of mound tips \| increased number of early culminant tips
DBS0351520	AK1334	DDB_G0271574 \| nip7	decreased response to Gram-negative bacterium
DBS0235584	CF45-1-	cf45-1	increased mound size \| increased glucose level \| decreased mound size \| decreased cell motility \| increased cell-cell adhesion
DBS0235585	CF50-	cf50-1 \| cf50-2	decreased response to Gram-negative bacterium \| decreased response to Gram-positive bacterium \| increased mound size \| increased cell-cell adhesion \| increased prespore gene expression \| increased protein level \| decreased protein secretion
DBS0235594	CHE10	cbpC	decreased slug migration \| precocious aggregation \| decreased mound size \| decreased fruiting body size \| delayed culmination
DBS0235595	CHI2	cbpC	increased slug migration
DBS0235596	ChLim-	ChLim	increased growth rate \| increased phagocytosis
DBS0351197	D2B-	D2B	aberrant chemotaxis to cAMP
DBS0235659	DD3-3-	DD3-3	decreased gene expression \| precocious aggregation
DBS0236049	DDB_G0268012-	DDB_G0268012	wild type
DBS0236046	DDB_G0268158-	DDB_G0268158	wild type
DBS0236039	DDB_G0268678-	DDB_G0268678	wild type
DG1007	DDB_G0269232-	DDB_G0269232	abolished culmination
DBS0236025	DDB_G0270366-	DDB_G0270366	wild type
DBS0236026	DDB_G0270368-	DDB_G0270368	wild type
DBS0236036	DDB_G0270744-	DDB_G0270744	wild type
DBS0351081	DDB_G0272538-	DDB_G0272538	delayed aggregation \| increased cell-substrate adhesion
LAS29	DDB_G0273201-	DDB_G0273201	decreased socially cooperative development
LAS8	DDB_G0273809-	zplC-1 \| zplC-2	decreased socially cooperative development
LAS43	DDB_G0274429-	DDB_G0274429	decreased socially cooperative development
DBS0351079	DDB_G0274679-	DDB_G0274679	delayed aggregation \| increased cell-substrate adhesion \| decreased cell motility
DBS0236043	DDB_G0276221-	fam21	wild type
DBS0236042	DDB_G0276689-	DDB_G0276689	wild type
DBS0236041	DDB_G0277179-	DDB_G0277179	wild type
LAS26	DDB_G0277239-	DDB_G0277239	decreased socially cooperative development
DBS0236045	DDB_G0277575-	DDB_G0277575	wild type
DBS0236044	DDB_G0278315-	DDB_G0278315	wild type
LAS34	DDB_G0278585-	DDB_G0278585	decreased socially cooperative development
DBS0236038	DDB_G0279005-	cnot11	wild type
DBS0236032	DDB_G0279163-	DDB_G0279163	wild type
DBS0236033	DDB_G0279163-	DDB_G0279163	wild type
LAS70	DDB_G0279405-	DDB_G0279405	decreased socially cooperative development
DBS0236028	DDB_G0279609-	DDB_G0279609	wild type
DBS0236029	DDB_G0279609-	DDB_G0279609	wild type
LAS103	DDB_G0280089-	DDB_G0280089	decreased socially cooperative development
LAS54	DDB_G0280299-	DDB_G0280299	decreased socially cooperative development
DBS0236035	DDB_G0280481-	DDB_G0280481	wild type
DBS0351082	DDB_G0281485-	DDB_G0281485	delayed aggregation \| increased cell-substrate adhesion \| decreased cell motility
DBS0351080	DDB_G0281497-	DDB_G0281497	delayed aggregation \| increased cell-substrate adhesion \| decreased cell motility
DBS0236019	DDB_G0281735-	DDB_G0281735	wild type
DBS0236020	DDB_G0281735-	DDB_G0281735	wild type
DBS0351620	DDB_G0281735-/ DDB_G0281737-	DDB_G0281735 \| DDB_G0281737	decreased response to Gram-negative bacterium \| aberrant vegetative growth
LAS92	DDB_G0283373-	DDB_G0283373	decreased socially cooperative development
LAS106	DDB_G0283595-	DDB_G0283595	decreased socially cooperative development
DBS0351085	DDB_G0284955-	DDB_G0284955	delayed aggregation \| increased cell-substrate adhesion \| decreased cell motility
LAS3	DDB_G0287153-	DDB_G0287153	decreased socially cooperative development
LAS10	DDB_G0288547-	DDB_G0288547	decreased socially cooperative development
LAS9	DDB_G0289789-	DDB_G0289789	decreased socially cooperative development
DBS0236027	DDB_G0290225-	DDB_G0290225	wild type
DBS0351086	DDB_G0290519-	DDB_G0290519	delayed aggregation \| increased cell-substrate adhesion \| decreased cell motility
LAS7	DDB_G0290685-	DDB_G0290685	decreased socially cooperative development
DG1003	DDB_G0291992-	DDB_G0291992	aberrant late culminant morphology
LAS39	DDB_G0292148-	DDB_G0292148	decreased socially cooperative development
DBS0236037	DDB_G0292186-	DDB_G0292186	wild type
DBS0350073	DDB_G0293074-	DDB_G0293074	decreased spore germination \| delayed aggregation
DBS0351083	DDB_G0293098-	DDB_G0293098	delayed aggregation \| increased cell-substrate adhesion \| decreased cell motility
DBS0236023	DDB_G0293116-	DDB_G0293116	wild type
DBS0236024	DDB_G0293116-	DDB_G0293116	wild type
DBS0350516	DDB_G0293356-	DDB_G0293356	decreased defense response to Gram-negative bacterium
DBS0236030	DDB_G0293762-	DDB_G0293762	wild type
DG1039	DG1039-	DDB_G0284037	aberrant fruiting body morphogenesis
DG1040	DG1040-	DDB_G0276029	aberrant fruiting body morphogenesis
DG1041	DG1041-	DDB_G0269126	aberrant fruiting body morphogenesis
DG1054	DG1054-	DDB_G0277719	aberrant fruiting body morphogenesis
DG1060	DG1060-	DDB_G0281953	aberrant fruiting body morphogenesis
DG1062	DG1062-	cdl1A	aberrant fruiting body morphogenesis
DG1074	DG1074-	DDB_G0272108	aberrant fruiting body morphogenesis
DG1080	DG1080-	DDB_G0281559	aberrant fruiting body morphogenesis
DG1091	DG1091-	DG1091	decreased fruiting body size
DG1098	DG1098-	DG1098	decreased fruiting body size
DG1104	DG1104-	DDB_G0283535	abolished aggregation
DG1106	DG1106-	keaA	abolished aggregation
DG1110	DG1110-	DDB_G0269128	aberrant fruiting body morphogenesis
DG1112	DG1112-	DG1112	decreased stalk width
DG1113	DG1113-	DG1113	increased stalk length
DG1122	DG1122-	DG1122	aberrant fruiting body morphogenesis
DG1124	DG1124-	DG1124	development arrests at loose mound stage
DG2033	DG2033-	DG2033	development arrests at mound stage
DG2044	DG2044-	DG2044	development arrests at loose mound stage
DBS0266700	Dd5P1-	Dd5P1	increased chemotaxis to cAMP \| decreased phagocytosis
DBS0266705	Dd5P1-/ Dd5P2-	Dd5P1 \| Dd5P2	increased chemotaxis to cAMP
DBS0266704	Dd5P1-/ Dd5P3-	Dd5P1 \| Dd5P3	increased chemotaxis to cAMP
DBS0235660	Dd5P2-	Dd5P2	increased chemotaxis to cAMP \| increased actin filament polymerization
DBS0266703	Dd5P2-/ Dd5P3-	Dd5P2 \| Dd5P3	wild type
DBS0266702	Dd5P3-	Dd5P3	wild type
DBS0266692	Dd5P4-	Dd5P4	increased protein localization \| increased protein phosphorylation \| increased contractile vacuole size \| decreased defense response to Gram-negative bacterium \| increased number of mound tips \| aberrant contractile vacuole discharge \| decreased growth rate \| decreased phagocytosis \| decreased engulfment during phagocytosis \| aberrant endosome morphology \| aberrant vacuole organization \| decreased protein localization \| increased cell motility \| increased activation of GTPase activity
DBS0266693	Dd5P4-/ [act15]: Dd5P4	Dd5P4	wild type
DBS0266719	Dd5P4-/ [act15]: Dd5P4: GFP	Dd5P4	wild type
DBS0266695	Dd5P4-/ [act15]: GAP5P4	Dd5P4	increased number of mound tips \| decreased growth rate
DBS0351414	Dd5P4-/ [act15]: GFP: Dd5P4(D319G)	Dd5P4	increased contractile vacuole size \| aberrant contractile vacuole discharge \| aberrant protein localization to contractile vacuole
DBS0266720	Dd5P4-/ [act15]: Hs-OCRL	Dd5P4	decreased phagocytosis
DBS0266721	Dd5P4-/ [act15]: Hs-OCRL(D422A)	Dd5P4	decreased phagocytosis
DBS0266694	Dd5P4-/ [act15]: cat5P4	Dd5P4	increased number of mound tips \| decreased growth rate
DBS0351050	DidioMp27-	DidioMp27	decreased defense response to Gram-negative bacterium \| decreased gene expression \| decreased growth rate \| aberrant phototaxis
DBS0351049	DidioMp36-	DidioMp36	decreased defense response to Gram-negative bacterium \| decreased gene expression \| decreased growth rate \| aberrant phototaxis
CW0391	FLAG-VwkA	vwkA	increased myosin II assembly \| decreased growth rate \| aberrant cytokinesis \| development arrests at mound stage \| aberrant hypotonic response \| increased protein level
DBS0236015	GEG04K11 (tmcB- in KAX3)	tmcB	decreased macrocyst size \| aberrant macrocyst formation
DBS0236017	GEG10K23 (tmcC- in KAX3)	tmcC	aberrant macrocyst formation
CW0368	GFP-VwkA	vwkA	decreased growth rate \| aberrant cytokinesis
DBS0266872	GFP: pcna	pcna	wild type
DBS0350102	GFP: pcp	pcp	aberrant contractile vacuole morphology \| aberrant hypotonic response
DBS0302615	GFP: phgA(1-274: 283-438)/ phgA-	phgA	aberrant hypotonic response
DBS0302614	GFP: phgA/ phgA-	phgA	wild type
DBS0236084	GP138A-/ GP138B-/ GP138C-/ GP138D-	cfrA \| cfrB \| cfrC \| cfrD	decreased gene expression
DBS0236085	GP138C-	cfrC	wild type
DBS0236128	HB3	H3b	abolished stream development \| abolished response to cAMP
DL118	HL216/ HL261	gnt2	decreased migratory slug size \| decreased calcium-independent cell-cell adhesion \| decreased fruiting body size
HL220	HL220	gnt2	abolished gene expression \| aberrant spore coat morphology \| decreased calcium-independent cell-cell adhesion
HL241	HL241	alg9	aberrant protein modification
HL260	HL260	gnt2	decreased calcium-independent cell-cell adhesion
HMW404	HMW404	manA	abolished gene expression \| abolished catalytic activity \| abolished aggregation
DBS0350714	HMW437	manA	wild type \| abolished catalytic activity
AP1	HSPC300-	hspc300	aberrant cytokinesis
AP2	HSPC300-	hspc300	decreased actin filament polymerization \| decreased cell motility \| decreased vegetative cell size \| decreased phototaxis \| decreased pseudopodium size
DBS0351312	HSPC300-/ [act15]: abpB(129-295)	abpB \| hspc300	aberrant cellular process
HTY506	HTY506	pkaR	aberrant spore morphology \| precocious sporulation \| aberrant fruiting body morphogenesis \| decreased actin phosphorylation \| precocious development \| decreased cAMP level \| decreased sporulation
HTY507	HTY507	rdeA	precocious aggregation \| decreased mound size \| increased cAMP level \| aberrant fruiting body morphogenesis
DBS0236426	I6KA-	I6KA	aberrant cellular homeostasis \| aberrant inositol phosphate metabolic process \| increased growth rate
DBS0236444	JH.D	cbfA	abolished gene expression \| aberrant cellular metabolic process \| decreased gene expression \| increased gene expression \| decreased growth rate \| increased pinocytosis \| increased vegetative cell size \| decreased fruiting body size \| decreased stalk width \| abolished aggregation \| increased phagocytosis
DBS0236532	M2	manA	abolished vegetative growth
DBS0236535	M31	modA	decreased catalytic activity \| decreased secretion of lysosomal enzymes
DBS0236840	R7	nosA	development arrests at mound stage
DBS0266873	RFP: pcna	pcna	wild type
DBS0236917	SA219	dscA-1 \| dscA-2 \| dscC-1 \| dscC-2 \| dscD-1 \| dscD-2 \| dscE	abolished gene expression
SA31	SA31	dscA-1 \| dscA-2 \| dscC-1 \| dscC-2 \| dscD-1 \| dscD-2 \| dscE	abolished gene expression \| abolished stream development \| aberrant microtubule cytoskeleton organization \| decreased establishment of cell polarity
DBS0264065	V00262	dagA	abolished stream development \| abolished slug migration \| abolished oscillatory cAMP signaling \| abolished aggregation \| abolished culmination
DBS0264066	V00347	DDB_G0281917	abolished culmination
DBS0264073	V10108	DDB_G0292162	abolished stream development \| abolished slug migration \| aberrant vegetative growth \| abolished oscillatory cAMP signaling \| abolished aggregation \| abolished culmination
DBS0264075	V10113	yakA	abolished stream development \| abolished slug migration \| aberrant vegetative growth \| abolished oscillatory cAMP signaling \| aberrant oscillatory cAMP signaling \| abolished aggregation \| abolished culmination
DBS0264078	V10116	tipB	aberrant aggregation \| abolished slug migration \| aberrant oscillatory cAMP signaling \| abolished culmination
DBS0264079	V10117	DDB_G0285083	aberrant slug migration \| abolished culmination
DBS0264081	V10119	DDB_G0292194	wild type
DBS0264083	V10121	zntC	wild type
DBS0264087	V10125	DDB_G0293302	aberrant slug migration \| aberrant oscillatory cAMP signaling
DBS0264088	V10126	tipC	aberrant culmination \| aberrant slug migration \| aberrant oscillatory cAMP signaling
DBS0264089	V10127	DG1037	abolished stream development \| abolished slug migration \| abolished oscillatory cAMP signaling \| aberrant oscillatory cAMP signaling \| abolished aggregation \| abolished culmination
DBS0264098	V10136	DDB_G0293590	wild type \| aberrant culmination \| aberrant slug migration \| aberrant oscillatory cAMP signaling
DBS0264099	V10137	yelA	aberrant aggregation \| abolished slug migration \| aberrant culmination \| aberrant oscillatory cAMP signaling
DBS0264100	V10138	tipC	wild type
DBS0264106	V10144	comH	aberrant aggregation \| abolished slug migration \| abolished culmination
DBS0264108	V10146	yakA	abolished stream development \| abolished slug migration \| aberrant vegetative growth \| abolished oscillatory cAMP signaling \| abolished aggregation \| abolished culmination
DBS0264109	V10147	tipA	aberrant aggregation \| abolished slug migration \| aberrant culmination \| aberrant stream morphology \| aberrant slug migration \| aberrant oscillatory cAMP signaling \| abolished culmination
DBS0264112	V10150	swp1	wild type
DBS0264116	V10155	DDB_G0282093	abolished stream development \| aberrant aggregation \| abolished slug migration \| aberrant culmination \| aberrant slug migration \| aberrant stream morphology \| aberrant oscillatory cAMP signaling \| abolished aggregation \| abolished culmination
DBS0264118	V10157	usp12	aberrant culmination \| aberrant slug migration \| aberrant stream morphology \| abolished culmination
DBS0264125	V10164	comE	aberrant vegetative growth \| aberrant culmination \| aberrant slug migration \| abolished culmination
DBS0264126	V10165	comD	aberrant aggregation \| abolished slug migration \| aberrant culmination \| aberrant oscillatory cAMP signaling
DBS0264128	V10167	DG1098	wild type \| aberrant oscillatory cAMP signaling
DBS0264129	V10168	prsC	wild type \| aberrant slug migration
DBS0264131	V10170	DDB_G0283015	aberrant culmination \| aberrant slug migration \| aberrant oscillatory cAMP signaling \| abolished culmination
DBS0264135	V10174	DDB_G0288581	aberrant vegetative growth \| aberrant culmination \| aberrant slug migration \| aberrant stream morphology \| aberrant oscillatory cAMP signaling
DBS0264145	V10185	abcA5	wild type \| aberrant vegetative growth \| aberrant culmination \| aberrant oscillatory cAMP signaling
DBS0264150	V10190	yelA	aberrant aggregation \| abolished slug migration \| aberrant culmination \| aberrant oscillatory cAMP signaling
DBS0264151	V10191	sfbA	aberrant culmination \| aberrant slug migration \| abolished culmination
DBS0264152	V10192	tipD	aberrant aggregation \| abolished slug migration \| aberrant oscillatory cAMP signaling \| abolished culmination
DBS0264154	V10194	modA	aberrant culmination \| aberrant slug migration
DBS0264155	V10195	migA	aberrant culmination \| aberrant stream morphology \| aberrant slug migration \| aberrant oscillatory cAMP signaling
DBS0264157	V10197	yelA	abolished slug migration \| aberrant culmination \| aberrant slug migration
DBS0264158	V10198	splA	aberrant aggregation \| aberrant culmination \| aberrant stream morphology \| aberrant oscillatory cAMP signaling
DBS0264159	V10199	DG1037	abolished slug migration \| aberrant stream morphology \| aberrant oscillatory cAMP signaling \| abolished aggregation \| abolished culmination
DBS0264160	V10200	DDB_G0289377	aberrant culmination \| aberrant slug migration \| aberrant oscillatory cAMP signaling
DBS0264161	V10201	rgaA	aberrant vegetative growth \| aberrant culmination \| aberrant slug migration \| aberrant oscillatory cAMP signaling \| abolished culmination
DBS0264163	V10203	modA	wild type \| aberrant vegetative growth \| aberrant culmination
DBS0264164	V10204	DG1124	aberrant aggregation \| aberrant stream morphology \| aberrant oscillatory cAMP signaling
DBS0264166	V10206	wimA	wild type
DBS0264169	V10209	dcsA	abolished culmination
DBS0264170	V10210	mkpA	abolished stream development \| abolished slug migration \| abolished oscillatory cAMP signaling \| abolished aggregation \| abolished culmination
DBS0264171	V10211	migA	aberrant culmination \| aberrant stream morphology \| aberrant oscillatory cAMP signaling
DBS0264172	V10212	tipC	aberrant aggregation \| abolished slug migration \| aberrant vegetative growth \| aberrant culmination \| aberrant oscillatory cAMP signaling
DBS0264173	V10213	DG1098	aberrant stream morphology \| aberrant oscillatory cAMP signaling
DBS0264175	V10215	cbfB	wild type
DBS0264176	V10216	DDB_G0292884	wild type \| aberrant vegetative growth
DBS0264180	V10220	potA	wild type
DBS0264181	V10221	tipD	aberrant culmination \| aberrant slug migration \| aberrant oscillatory cAMP signaling
DBS0264182	V10222	ctaA	wild type
DBS0264183	V10223	erkA	aberrant stream morphology \| aberrant oscillatory cAMP signaling
DBS0264184	V10224	DG1091	aberrant oscillatory cAMP signaling
DBS0264185	V10225	acrA	aberrant culmination \| aberrant slug migration \| aberrant oscillatory cAMP signaling
DBS0264186	V10226	ggtA	aberrant vegetative growth \| aberrant culmination \| aberrant slug migration \| abolished aggregation \| abolished culmination
DBS0264187	V10227	piaA	abolished stream development \| abolished slug migration \| abolished oscillatory cAMP signaling \| abolished aggregation \| abolished culmination
DBS0264188	V10228	comG	aberrant aggregation \| abolished slug migration \| aberrant vegetative growth \| aberrant culmination \| aberrant stream morphology \| aberrant slug migration \| aberrant oscillatory cAMP signaling \| abolished culmination
DBS0264189	V10229	dcsA	aberrant oscillatory cAMP signaling \| abolished culmination
DBS0264190	V10230	ctrA	aberrant aggregation \| aberrant culmination \| aberrant slug migration
DBS0264193	V10233	piaA	abolished stream development \| abolished slug migration \| abolished oscillatory cAMP signaling \| abolished aggregation \| abolished culmination
DBS0264195	V10235	DDB_G0285985	wild type
DBS0264196	V10236	DDB_G0270872_ps	aberrant stream morphology
DBS0264197	V10237	DDB_G0278621	wild type
DBS0264198	V10238	DDB_G0269128	aberrant culmination \| aberrant slug migration
DBS0264199	V10239	kif12	wild type \| aberrant culmination
DBS0264201	V10241	lvsB	aberrant culmination
DBS0264202	V10242	tagB	aberrant aggregation \| abolished slug migration \| abolished culmination
DBS0264204	V10244	gbfA	aberrant culmination \| aberrant slug migration
DBS0264205	V10245	gefA	abolished stream development \| abolished slug migration \| abolished oscillatory cAMP signaling \| abolished aggregation \| abolished culmination
DBS0264206	V10246	dicB	aberrant stream morphology \| aberrant oscillatory cAMP signaling
DBS0264207	V10247	yelA	aberrant aggregation \| abolished slug migration \| aberrant culmination \| aberrant oscillatory cAMP signaling \| abolished culmination
DBS0264212	V10252	tagB	aberrant aggregation \| abolished slug migration \| abolished culmination
DBS0264216	V10256	DDB_G0293302	abolished slug migration \| aberrant culmination \| aberrant stream morphology \| aberrant oscillatory cAMP signaling
DBS0264218	V10258	rdeA	aberrant aggregation \| abolished slug migration \| aberrant culmination \| aberrant stream morphology \| aberrant oscillatory cAMP signaling \| abolished culmination
DBS0264220	V10260	gacT	aberrant culmination \| aberrant slug migration \| aberrant oscillatory cAMP signaling
DBS0264224	V10264	DDB_G0282787_RTE	aberrant aggregation \| wild type \| abolished slug migration \| aberrant stream morphology \| aberrant oscillatory cAMP signaling \| abolished culmination
DBS0264225	V10265	lvsD	aberrant vegetative growth \| aberrant culmination \| aberrant oscillatory cAMP signaling
DBS0264227	V10267	DDB_G0292260_RTE	aberrant aggregation \| aberrant stream morphology
DBS0264228	V10268	dhkA	aberrant culmination \| aberrant slug migration \| aberrant stream morphology \| aberrant oscillatory cAMP signaling
DBS0264229	V10269	helC	wild type \| aberrant culmination \| aberrant slug migration \| abolished culmination
DBS0264230	V10270	mekA	aberrant vegetative growth \| aberrant culmination \| aberrant stream morphology \| aberrant oscillatory cAMP signaling
DBS0264231	V10271	lvsB	abolished stream development \| abolished slug migration \| aberrant oscillatory cAMP signaling \| abolished aggregation \| abolished culmination
DBS0264232	V10272	modA	abolished stream development \| abolished slug migration \| aberrant oscillatory cAMP signaling \| abolished aggregation \| abolished culmination
DBS0264233	V10273	DDB_G0283535	wild type \| aberrant vegetative growth
DBS0264234	V10274	DG1113	aberrant vegetative growth \| aberrant culmination \| aberrant oscillatory cAMP signaling
DBS0264235	V10275	DG1122	abolished stream development \| wild type \| abolished slug migration \| aberrant vegetative growth \| aberrant stream morphology \| aberrant oscillatory cAMP signaling \| abolished aggregation \| abolished culmination
DBS0264236	V10276	DDB_G0270654	wild type
DBS0264237	V10277	lvsE	aberrant oscillatory cAMP signaling
DBS0264238	V10278	modA	aberrant aggregation \| abolished slug migration \| aberrant culmination \| aberrant stream morphology \| aberrant slug migration \| aberrant oscillatory cAMP signaling \| abolished culmination
DBS0264240	V10280	mekA	aberrant culmination \| aberrant stream morphology \| aberrant slug migration \| aberrant oscillatory cAMP signaling \| abolished culmination
DBS0264241	V10281	DDB_G0268266	aberrant slug migration \| aberrant oscillatory cAMP signaling
DBS0264242	V10282	phdA	abolished slug migration \| aberrant culmination \| aberrant stream morphology
DBS0264245	V10285	scaA	abolished stream development \| abolished slug migration \| aberrant vegetative growth \| aberrant oscillatory cAMP signaling \| abolished aggregation \| abolished culmination
DBS0264246	V10286	amdA	wild type \| aberrant culmination
DBS0264247	V10287	helC	wild type \| aberrant culmination \| aberrant slug migration
DBS0264251	V10300	DDB_G0278333	aberrant culmination \| aberrant slug migration \| aberrant oscillatory cAMP signaling
DBS0264269	V10322	roco5	aberrant culmination \| aberrant slug migration \| aberrant oscillatory cAMP signaling \| abolished culmination
DBS0264272	V10326	DG1113	wild type \| aberrant oscillatory cAMP signaling
DBS0264275	V10330	DDB_G0282121	wild type
DBS0264278	V10342	DDB_G0279727	wild type
DBS0264281	V10356	DDB_G0275747	aberrant slug migration
DBS0264283	V10363	msh5	wild type
DBS0264284	V10367	DDB_G0282463	aberrant vegetative growth \| aberrant culmination \| aberrant slug migration \| aberrant oscillatory cAMP signaling \| abolished culmination
DBS0264287	V10431	kcnma1	wild type \| aberrant culmination \| aberrant slug migration
DBS0264288	V10432	DDB_G0291103	wild type
DBS0264290	V10435	gefL	abolished slug migration \| aberrant culmination \| aberrant slug migration \| aberrant oscillatory cAMP signaling
DBS0264292	V10438	DDB_G0275671	wild type
DBS0264295	V10442	pks3	wild type
DBS0264297	V10445	DDB_G0290835	aberrant slug migration
DBS0264303	V10460	abcC9	aberrant slug migration
DBS0264316	V10483	yod1	aberrant aggregation \| aberrant culmination \| aberrant slug migration \| aberrant oscillatory cAMP signaling \| abolished culmination
DBS0264318	V10490	gefV	aberrant culmination \| aberrant oscillatory cAMP signaling
DBS0264319	V10492	med23	aberrant culmination \| aberrant oscillatory cAMP signaling
DBS0264320	V10495	DDB_G0269128	wild type \| aberrant culmination \| aberrant slug migration
DBS0264324	V10514	adprt3	aberrant stream morphology \| aberrant oscillatory cAMP signaling
DBS0264326	V10519	DDB_G0290575	wild type
DBS0264330	V10529	cyp508B1	aberrant aggregation \| abolished slug migration \| aberrant culmination \| aberrant stream morphology \| aberrant slug migration \| aberrant oscillatory cAMP signaling
DBS0264331	V10530	DDB_G0270344	wild type \| aberrant slug migration \| aberrant oscillatory cAMP signaling
DBS0264334	V10534	DDB_G0291812	wild type \| aberrant culmination
DBS0264335	V10535	DDB_G0277165	aberrant stream morphology \| aberrant oscillatory cAMP signaling
DBS0264337	V10537	gbpC	abolished stream development \| wild type \| aberrant stream morphology \| aberrant oscillatory cAMP signaling
DBS0264347	V10567	dagA	abolished stream development \| abolished slug migration \| abolished oscillatory cAMP signaling \| abolished aggregation \| abolished culmination
DBS0264349	V10570	DDB_G0281115	wild type \| aberrant culmination \| aberrant stream morphology \| aberrant slug migration \| aberrant oscillatory cAMP signaling
DBS0264356	V10588	dhkC	wild type \| aberrant stream morphology \| aberrant oscillatory cAMP signaling
DBS0264373	V10633	gtaG	abolished slug migration \| aberrant culmination \| aberrant slug migration \| abolished culmination
DBS0264377	V10642	fscD	wild type
DBS0264384	V10670	taf2	wild type
DBS0264390	V10682	clcD	abolished stream development \| abolished slug migration \| abolished oscillatory cAMP signaling \| aberrant oscillatory cAMP signaling \| abolished aggregation \| abolished culmination
DBS0264425	V11033	nfaA	aberrant aggregation \| wild type \| aberrant stream morphology \| aberrant oscillatory cAMP signaling
DBS0264432	V11040	DDB_G0274177	abolished stream development \| abolished slug migration \| abolished oscillatory cAMP signaling \| abolished aggregation \| abolished culmination
DBS0264438	V11047	DDB_G0269296	wild type
DBS0264439	V11048	xrcc4	wild type
DBS0264444	V11053	dscA-1 \| dscA-2	wild type \| aberrant vegetative growth
DBS0264446	V11055	ku80	aberrant vegetative growth \| aberrant culmination
DBS0264464	V11075	cinC	wild type \| aberrant culmination
DBS0264480	V11092	cnrO	wild type
DBS0264489	V11105	DDB_G0270350_ps	wild type \| aberrant stream morphology \| aberrant oscillatory cAMP signaling
DBS0264512	V11128	DDB_G0278945	aberrant vegetative growth \| aberrant stream morphology \| aberrant oscillatory cAMP signaling
DBS0264575	V30069	DDB_G0284619	aberrant stream morphology \| aberrant oscillatory cAMP signaling
DBS0264607	V30110	alg9	wild type \| aberrant vegetative growth \| aberrant oscillatory cAMP signaling
DBS0264630	V30133	DDB_G0272953	wild type \| aberrant stream morphology \| aberrant oscillatory cAMP signaling
DBS0264634	V30137	DDB_G0289529	wild type
DBS0264662	V30165	alg9	wild type \| aberrant culmination \| aberrant stream morphology \| aberrant oscillatory cAMP signaling
DBS0264668	V30171	DDB_G0285261	wild type \| aberrant vegetative growth \| aberrant stream morphology \| aberrant oscillatory cAMP signaling
DBS0264677	V30180	gpaF	wild type \| aberrant stream morphology \| aberrant oscillatory cAMP signaling
DBS0264684	V30188	DDB_G0287723	wild type \| aberrant stream morphology \| aberrant oscillatory cAMP signaling
DBS0264687	V30191	DDB_G0288219	wild type \| aberrant vegetative growth
DBS0264700	V30213	act9	wild type \| aberrant culmination
DBS0264715	V30229	dhx35	wild type \| aberrant oscillatory cAMP signaling
DBS0264716	V30230	regA	aberrant aggregation \| abolished slug migration \| aberrant stream morphology \| aberrant oscillatory cAMP signaling \| abolished culmination
DBS0264731	V30245	DDB_G0279461	wild type \| aberrant culmination
DBS0264749	V30264	DDB_G0273651	wild type
DBS0264752	V30267	DDB_G0283759	wild type
DBS0264756	V30271	ncapGa	wild type
DBS0264763	V30278	tnlA	wild type
DBS0264765	V30280	ppt1	wild type
DBS0264768	V30283	DDB_G0270872_ps	wild type
DBS0264770	V30285	DDB_G0293762	wild type \| aberrant vegetative growth
DBS0264773	V30288	DDB_G0293300	wild type \| aberrant stream morphology \| aberrant oscillatory cAMP signaling
DBS0264777	V30292	glpD	wild type
DBS0264781	V30296	DDB_G0270212	wild type
DBS0264785	V30303	pakE	aberrant oscillatory cAMP signaling
DBS0264823	V30341	frmB	wild type \| aberrant culmination \| aberrant stream morphology
DBS0264832	V30350	DDB_G0284059	wild type
DBS0264835	V30353	DDB_G0282471	wild type
DBS0264853	V30371	abpC	aberrant aggregation \| abolished slug migration \| aberrant culmination \| abolished culmination
DBS0264905	V30427	DDB_G0291926	aberrant culmination \| aberrant slug migration \| aberrant stream morphology \| aberrant oscillatory cAMP signaling
DBS0264910	V30432	malA	wild type
DBS0264922	V30446	DDB_G0269430	wild type
DBS0264924	V30448	DDB_G0269680	wild type \| aberrant oscillatory cAMP signaling
DBS0264941	V30466	dtfA	wild type \| aberrant oscillatory cAMP signaling
DBS0264992	V30522	DDB_G0288007	wild type \| aberrant stream morphology \| aberrant oscillatory cAMP signaling
DBS0264994	V30524	prmt5	aberrant culmination \| aberrant stream morphology \| aberrant slug migration \| aberrant oscillatory cAMP signaling \| abolished culmination
DBS0265002	V30532	lvsA	wild type \| abolished slug migration \| aberrant oscillatory cAMP signaling \| abolished aggregation \| abolished culmination
DBS0265017	V30547	DDB_G0279105	wild type \| aberrant vegetative growth \| aberrant culmination \| aberrant stream morphology \| aberrant oscillatory cAMP signaling
DBS0265029	V30561	DDB_G0277355	wild type \| aberrant culmination
DBS0265045	V30578	DDB_G0277165	aberrant culmination \| aberrant slug migration \| aberrant oscillatory cAMP signaling
DBS0265049	V30582	DDB_G0291722	wild type
DBS0265064	V30604	DDB_G0279461	abolished slug migration \| aberrant culmination \| aberrant slug migration \| aberrant stream morphology \| aberrant oscillatory cAMP signaling
DBS0265066	V30606	adkB	wild type
DBS0265099	V30642	tipC	aberrant aggregation \| abolished slug migration \| aberrant oscillatory cAMP signaling \| abolished culmination
DBS0265126	V30673	dicB	aberrant aggregation \| abolished slug migration \| aberrant culmination \| aberrant oscillatory cAMP signaling
DBS0265140	V30688	DDB_G0279727	wild type \| aberrant culmination
DBS0265170	V30724	cnrK	wild type
DBS0265206	V30766	rhgA	wild type
DBS0265226	V30789	itpa	wild type
DBS0265231	V30794	tpsA	wild type
DBS0265247	V30814	adprt1B	wild type
DBS0265279	V30846	DDB_G0286091	wild type
DBS0265286	V30853	DDB_G0292058	wild type
DBS0265296	V30863	DDB_G0269128	wild type
DBS0265302	V30869	DDB_G0292454	wild type \| aberrant vegetative growth
DBS0265303	V30870	gxcJJ	wild type \| aberrant oscillatory cAMP signaling
DBS0265309	V30876	DDB_G0268248	wild type \| aberrant stream morphology \| aberrant oscillatory cAMP signaling
DBS0265311	V30879	exoc2	wild type \| aberrant stream morphology \| aberrant oscillatory cAMP signaling
DBS0265319	V30887	adcC	wild type
DBS0265339	V30912	DDB_G0283821	wild type \| aberrant oscillatory cAMP signaling
DBS0265348	V30921	snpC	wild type \| aberrant culmination
DBS0265422	V30995	DDB_G0282959	wild type
DBS0265466	V31043	DDB_G0275917	aberrant aggregation \| wild type \| aberrant vegetative growth \| aberrant slug migration \| abolished culmination
DBS0265497	V31075	DDB_G0282985	wild type \| abolished slug migration \| aberrant culmination \| aberrant stream morphology \| aberrant oscillatory cAMP signaling \| abolished aggregation
DBS0265520	V31102	DDB_G0287865	wild type
DBS0265529	V31111	vps13E	wild type \| aberrant culmination \| aberrant stream morphology \| aberrant oscillatory cAMP signaling
DBS0265539	V31121	DDB_G0270912	wild type \| aberrant vegetative growth \| aberrant oscillatory cAMP signaling
DBS0265567	V31151	DDB_G0275539	wild type \| aberrant vegetative growth \| abolished culmination
DBS0265573	V31157	act9	wild type
DBS0265588	V31173	ggtA	aberrant vegetative growth \| aberrant culmination \| aberrant stream morphology \| aberrant oscillatory cAMP signaling
DBS0265662	V31255	psiN	wild type \| aberrant culmination \| aberrant stream morphology \| aberrant oscillatory cAMP signaling
DBS0265688	V31281	DDB_G0286417	wild type \| aberrant culmination \| aberrant stream morphology \| aberrant oscillatory cAMP signaling
DBS0265701	V31294	DDB_G0268424	wild type
DBS0265873	V31480	DDB_G0284177	aberrant culmination
DBS0265890	V31501	DDB_G0282985	wild type \| aberrant culmination \| aberrant oscillatory cAMP signaling
DBS0265908	V31523	tmem184C	wild type \| aberrant culmination
DBS0265911	V31528	DDB_G0279945	aberrant culmination
DBS0265938	V31568	rsc12	aberrant culmination
DBS0265947	V31583	DDB_G0282943	wild type
DBS0265992	V31640	DDB_G0274343	wild type
DBS0266000	V31649	DDB_G0290383	wild type \| aberrant culmination
DBS0266021	V31670	DDB_G0281269	wild type
DBS0266022	V31671	dhkA	aberrant culmination \| aberrant slug migration
DBS0266036	V31685	tipC	aberrant aggregation \| wild type \| abolished slug migration \| aberrant culmination \| aberrant stream morphology \| aberrant oscillatory cAMP signaling
DBS0266084	V31738	dcsA	wild type \| aberrant culmination \| abolished culmination
DBS0266088	V31742	dstA	aberrant culmination \| aberrant slug migration \| abolished culmination
DBS0266089	V31743	DDB_G0273459	aberrant aggregation \| aberrant culmination \| aberrant stream morphology \| aberrant slug migration \| aberrant oscillatory cAMP signaling
DBS0266098	V31752	oplah	wild type \| aberrant oscillatory cAMP signaling
DBS0266149	V31807	gpt1	wild type \| aberrant vegetative growth \| abolished vegetative growth
DBS0266153	V31811	gpt1	wild type \| aberrant vegetative growth \| aberrant culmination \| aberrant oscillatory cAMP signaling
DBS0266190	V31853	chlA	aberrant aggregation \| aberrant culmination \| aberrant slug migration \| aberrant oscillatory cAMP signaling
DBS0266195	V31858	DDB_G0286341	wild type \| aberrant stream morphology \| aberrant oscillatory cAMP signaling
DBS0266246	V31916	psiF	wild type \| aberrant vegetative growth \| aberrant culmination \| aberrant oscillatory cAMP signaling
DBS0266249	V31919	DDB_G0276251	aberrant culmination \| aberrant stream morphology \| aberrant slug migration \| aberrant oscillatory cAMP signaling
DBS0266253	V31923	DDB_G0268314	wild type \| aberrant culmination
DBS0266258	V31928	DDB_G0268314	wild type
DBS0266271	V31941	manA	aberrant aggregation \| aberrant culmination \| aberrant stream morphology \| aberrant slug migration \| aberrant oscillatory cAMP signaling
DBS0266299	V31970	DDB_G0280581	wild type \| aberrant stream morphology \| aberrant oscillatory cAMP signaling
DBS0266309	V31982	DDB_G0286341	abolished stream development \| wild type \| aberrant stream morphology \| aberrant oscillatory cAMP signaling
DBS0266316	V31989	DDB_G0270342	abolished stream development \| wild type \| abolished slug migration \| aberrant culmination \| aberrant oscillatory cAMP signaling
DBS0237041	VatMpr	vatM	increased protein localization to cytoplasm \| decreased phagocytosis \| decreased growth rate \| aberrant regulation of intracellular pH
DBS0237044	VatMpr/ [act15]: vatM	vatM	wild type
DBS0237042	VatMpr/ [act15]: vatM: GFP	vatM	decreased growth rate
DBS0237236	[AS]: [tet]: trrA	trrA	decreased growth rate \| delayed development \| abolished aggregation
DBS0350570	[AS]PARP	DDB_G0286613 \| DDB_G0289141 \| adprt1A \| adprt1B \| adprt2 \| adprt3 \| adprt4 \| pARTf \| pARTg	decreased cell death \| aberrant positive regulation of mitochondrial membrane potential
DBS0350559	[AS]act15: adprt1A	adprt1A	development arrests at loose mound stage \| decreased gene expression \| decreased ATP level \| increased mitochondrial fission
DBS0351092	[AS]aif	aif	aberrant cellular homeostasis \| aberrant regulation of mitochondrial membrane potential \| aberrant mitochondrion morphology \| decreased ATP level \| increased gene expression \| decreased gene expression \| decreased growth rate \| aberrant cell cycle \| increased necrotic cell death \| delayed development \| aberrant response to oxidative stress \| aberrant cell morphology \| increased mitochondrial fission \| aberrant mitochondrion organization
DBS0304456	[AS]alrA/ gcsA-	alrA \| gcsA	aberrant cellular metabolic process \| increased gene expression \| decreased growth rate \| mitotic G1 phase arrest
DBS0237273	[AS]calA	calA	abolished cytokinesis
DBS0350897	[AS]carA	carA-1 \| carA-2	abolished aggregation
DBS0237222	[AS]cf60	cf60	increased mound size \| decreased number of mounds
DBS0237228	[AS]cfrA/ [AS]cfrB	cfrA \| cfrB	decreased sexual fusion
DBS0237223	[AS]chcA	chcA	decreased pinocytosis \| delayed hypotonic response \| decreased number of vacuoles \| decreased vegetative cell size \| aberrant vacuole organization \| abolished aggregation
DBS0237224	[AS]cmfA	cmfA	abolished aggregation
DBS0236982	[AS]csbA/ csbB	csbA \| csbB	decreased cell-cell adhesion
DBS0237225	[AS]cupB	cupB	abolished aggregation
DBS0350979	[AS]deeJ	deeJ	decreased pinocytosis \| decreased phagocytosis \| aberrant fruiting body morphogenesis
DBS0237226	[AS]dia1	dia1	decreased gene expression \| precocious aggregation
DBS0351176	[AS]dscA	dscA-1 \| dscA-2	abolished stream development
DBS0238235	[AS]dutA	dutA	wild type
DBS0350560	[AS]ecmB: adprt1A	adprt1A	development arrests at slug stage
DBS0350676	[AS]erkA	erkA	aberrant vegetative growth
DBS0237229	[AS]gpaA	gpaA	wild type
DBS0351057	[AS]gshB	gshB	increased slug migration
HPF414	[AS]hspA	hspA	decreased growth rate \| aberrant fruiting body morphogenesis \| decreased defense response to bacterium
DBS0351041	[AS]hspA/ [AS]ndkC-1	hspA \| ndkC-1 \| ndkC-2	wild type
DBS0238749	[AS]hspA/ snfA	hspA \| snfA	wild type
DBS0252819	[AS]hssA	hssA	wild type
DBS0351171	[AS]htrA	htrA	decreased growth rate \| aberrant fruiting body morphogenesis
DBS0237230	[AS]ino1	ino1	abolished vegetative growth
DBS0304425	[AS]mppA1	mppA1	delayed development
DBS0304424	[AS]mppB	mppB	increased gene expression
DBS0236725	[AS]patA	patA	decreased growth rate
DBS0237504	[AS]pikE	pikE	aberrant stalk morphogenesis \| decreased growth rate
DBS0237231	[AS]ppiA	ppiA	increased stalk length
DBS0237232	[AS]proA	proA	wild type
DBS0350355	[AS]proA-/ proB-/ lmpA-	lmpA \| proA \| proB	abolished sporulation \| wild type
DBS0351311	[AS]proA/ abpB(129-295)	abpB \| proA	aberrant cellular process
DBS0236827	[AS]proA/ proB-	proA \| proB	decreased exocytosis \| decreased pinocytosis \| aberrant exocytosis \| increased actin filament polymerization \| development arrests at slug stage \| aberrant cytokinesis \| decreased cell motility \| abolished vegetative growth \| decreased secretion of lysosomal enzymes \| increased phagocytosis
DBS0238036	[AS]proA/ proB-/ [act15]: proA	proA \| proB	wild type
DBS0238037	[AS]proA/ proB-/ [act15]: proB	proA \| proB	wild type
DBS0238035	[AS]proA/ proB-/ [unk]: FLAG: proC	proA \| proB \| proC	wild type
DBS0350334	[AS]proA/ proB-/ scrA-	proA \| proB \| scrA	decreased exocytosis \| decreased pinocytosis \| decreased secretion of lysosomal enzymes
DBS0350117	[AS]ptcB	ptcB	decreased growth rate
DBS0236851	[AS]rapA	rapA	decreased pinocytosis \| aberrant osmosensory signaling pathway \| decreased phagocytosis \| abolished vegetative growth \| increased actin phosphorylation \| aberrant hyperosmotic response
DBS0351303	[AS]rheb	rheb	decreased growth rate \| increased macropinocytosis \| increased phagocytosis
DBS0350574	[AS]rps4	rps4	decreased spore germination \| aberrant actin cytoskeleton organization \| aberrant vegetative growth \| decreased mound size \| decreased spore size \| aberrant fruiting body morphogenesis \| decreased sporulation
DBS0236904	[AS]rps4	mrps4	delayed aggregation \| aberrant fruiting body morphogenesis
DBS0237234	[AS]smlA	smlA	decreased fruiting body size
DBS0238748	[AS]snfA	snfA	decreased number of mitochondria \| decreased ATP level \| increased growth rate \| decreased fruiting body size \| aberrant mitochondrion organization
DBS0304498	[AS]sslA1	sslA1	decreased fruiting body size
DBS0237235	[AS]tcp1	tcp1	decreased growth rate \| development arrests at mound stage \| aberrant fruiting body morphogenesis
DBS0351302	[AS]tpp1	tpp1	aberrant cellular process \| decreased growth rate \| aberrant sorocarp development \| increased macropinocytosis \| increased phagocytosis
DBS0351218	[AS]twm1	twm1	decreased growth rate
DBS0350649	[AS]vatB	vatB	delayed aggregation \| aberrant slug migration \| aberrant response to chemical
DBS0306101	[AS]vatP	vatP	decreased calcium ion import \| decreased growth rate
DBS0306102	[AS]vatP	vatP	decreased calcium ion import \| decreased growth rate \| delayed development
DBS0237276	[OE]: GFP: gxcA	gxcA	abolished aggregation
DBS0237279	[OE]: HA: rab21(Q66L)	rab21	increased phagocytosis \| aberrant cytoskeleton organization
DBS0237280	[OE]: HA: rab21(T21N)	rab21	decreased phagocytosis \| aberrant actin filament organization
DBS0237274	[OE]: chlim	ChLim	increased actin filament polymerization \| decreased phagocytosis \| decreased growth rate
DBS0350519	[OE]: egeA	egeA	decreased protein level \| abolished aggregation
DBS0237275	[OE]: gbfA	gbfA	precocious prespore gene expression
JH182	[OE]: gpaD	gpaD	aberrant fruiting body morphogenesis \| decreased sporulation
JH258	[OE]: gpaE	gpaE	precocious prestalk gene expression \| precocious prespore gene expression \| precocious development of tipped mound
DBS0348921	[OE]: ipkA1	ipkA1	aberrant inositol phosphate metabolic process \| decreased response to lithium \| aberrant gene expression
DBS0348922	[OE]: itpk1	itpk1	aberrant inositol phosphate metabolic process \| decreased response to lithium \| aberrant gene expression
DBS0237281	[OE]: limF	limF	increased actin filament polymerization \| increased phagocytosis
DBS0237282	[OE]: pakC	pakC	decreased cell motility
DBS0236962	[OE]: pdiA	pdiA	delayed aggregation
DBS0237015	[OE]: pdiA	pdiA	aberrant development of tipped mound \| abolished culmination \| abolished slug development
DBS0237283	[OE]: rasB(G12T)	rasB	aberrant cytokinesis
DBS0302685	[OE]: sgcA(1-2000)(N1106A): GFP/ gca-/ sgcA-	gcA \| sgcA	decreased chemotaxis rate
DBS0302683	[OE]: sgcA(878-2843)(N1106A): GFP/ gca-/ sgcA-	gcA \| sgcA	decreased chemotaxis rate
DBS0302681	[OE]: sgcA(878-2843): GFP/ sgcA-	gcA \| sgcA	aberrant chemotaxis to cAMP \| decreased chemotaxis rate
DBS0302682	[OE]: sgcA(N1106A): GFP/ gca-/ sgcA-	gcA \| sgcA	increased lateral pseudopodium formation \| aberrant chemotaxis to cAMP \| aberrant stream morphology \| decreased chemotaxis rate
DBS0302684	[OE]: sgcA: GFP/ gca-/ sgcA-	gcA \| sgcA	increased lateral pseudopodium formation \| decreased chemotaxis rate
DBS0237284	[OE]GFP: gxcA(1-750: 764-1217)	gxcA	development arrests at loose mound stage
DBS0237285	[OE]GFP: gxcA(1-750: 764-984)	gxcA	development arrests at loose mound stage
DBS0266621	[OE]mipp1	mipp1	aberrant inositol phosphate metabolic process \| aberrant gene expression \| increased response to lithium
DBS0237299	[RNAi]DDB_G0270366	DDB_G0270366	wild type
DBS0237300	[RNAi]DDB_G0270368	DDB_G0270368	wild type
DBS0237301	[RNAi]DDB_G0271700	DDB_G0271700	wild type
DBS0237304	[RNAi]DDB_G0273449	DDB_G0273449 \| DDB_G0273577	wild type
DBS0237303	[RNAi]DDB_G0279609	DDB_G0279609	wild type
DBS0237306	[RNAi]DDB_G0290063	DDB_G0290063	wild type
DBS0237302	[RNAi]DDB_G0290225	DDB_G0290225	wild type
DBS0237298	[RNAi]DDB_G0293116	DDB_G0293116	wild type
DBS0237305	[RNAi]DDB_G0293762	DDB_G0293762	wild type
DBS0237294	[RNAi]DidioMp05	DidioMp05	wild type
DBS0350172	[RNAi]allC	allC	development arrests at loose mound stage \| decreased protein level \| decreased gene expression \| decreased vegetative cell size \| increased growth rate
DBS0350070	[RNAi]canA	canA	aberrant sorus morphology \| aberrant response to cation stress \| increased defense response to Gram-negative bacterium \| decreased fruiting body size \| decreased stalk length
DBS0350727	[RNAi]cepE	cepE	increased number of centrosomes \| aberrant cell separation during cytokinesis \| aberrant mitotic sister chromatid segregation
DBS0235409	[RNAi]cnbA	cnbA	aberrant sorus morphology \| decreased gene expression \| aberrant response to cation stress \| increased defense response to Gram-negative bacterium \| aberrant stalk cell differentiation \| decreased stalk length
DBS0349787	[RNAi]ctnnA	ctnnA	abolished epithelium-like organization \| abolished stalk development \| aberrant protein secretion \| abolished establishment of cell polarity \| aberrant Golgi localization \| aberrant centrosome localization \| abolished culmination \| aberrant protein localization
DBS0349923	[RNAi]ctnnA/ [act15]: GFP-mhcA	ctnnA	aberrant stalk morphogenesis \| decreased epithelium-like organization \| aberrant protein localization
DBS0237537	[RNAi]enlA	enlA	decreased substrate adhesion-dependent cell spreading \| decreased cell-substrate adhesion \| aberrant cytokinesis
DBS0237295	[RNAi]fimA	fimA	wild type
DBS0349944	[RNAi]fttB	fttB	increased number of mound tips \| aberrant cytokinesis \| decreased growth rate \| delayed development \| decreased chemotaxis to cAMP \| aberrant cytoskeleton organization
DBS0237308	[RNAi]gmsA	gmsA	decreased sexual fusion
DBS0237309	[RNAi]gsr	gsr	precocious culmination \| decreased cell migration to prestalk region \| precocious gene expression
DBS0252820	[RNAi]hssA	hssA	wild type
DBS0237307	[RNAi]kctd9	kctd9	wild type
DBS0350940	[RNAi]kif6	kif6	aberrant mitotic spindle organization
DBS0237310	[RNAi]lipA	lipA	wild type
DBS0349871	[RNAi]lkb1	lkb1	abolished prespore cell differentiation \| delayed aggregation \| aberrant slug development \| aberrant sorocarp development \| aberrant response to osmotic stress \| aberrant response to oxidative stress \| aberrant regulation of protein kinase activity \| increased prestalk cell differentiation \| decreased sporulation
DBS0350643	[RNAi]nse1	nse1	aberrant response to UV \| aberrant stream morphology \| decreased fruiting body size
DBS0350644	[RNAi]nse4	nse4	decreased gene expression \| aberrant response to UV \| aberrant stream morphology \| decreased fruiting body size
DBS0237296	[RNAi]pks16	pks16	wild type
DBS0237297	[RNAi]psiM	psiM	wild type
DBS0237311	[RNAi]racF2	racF2	abolished vegetative growth
DBS0237312	[RNAi]rasZ	rasZ	wild type
DBS0350488	[RNAi]rmd1	rmd1	aberrant cell separation during cytokinesis
DBS0238734	[RNAi]sdhA	sdhA	abolished aggregation \| decreased phototaxis
DBS0351295	[RNAi]sir2D	sir2D	decreased gene expression \| delayed development
DBS0351599	[RNAi]srtA	srtA	increased pre-miRNA processing
DBS0304564	[RNAi]sun1	sun1	aberrant nucleus morphology \| increased vegetative cell size
DBS0349929	[RNAi]tacA	tacA	aberrant response to cation stress \| increased gene expression \| delayed development \| aberrant fruiting body morphogenesis
DBS0350046	[RNAi]tacc	tacc	aberrant response to abiotic stimulus \| decreased protein level \| decreased size of astral microtubules
YLD53	[RNAi]thg1	thg1	decreased growth rate
DBS0350794	[RNAi]tlp3	tlp3	decreased growth rate
DBS0350795	[RNAi]tlp4	tlp4	decreased growth rate
DBS0237313	[RNAi]tmcB	tmcB	aberrant macrocyst formation
DBS0237314	[RNAi]tmcC	tmcC	aberrant macrocyst formation
DBS0237315	[RNAi]trap1	trap1	decreased gene expression \| delayed development
DBS0237818	[RNAi]wipA	wipA	decreased actin filament polymerization at leading edge \| delayed pseudopodium formation \| decreased chemotaxis to cAMP \| decreased filopodium formation
DBS0350924	[TRE-Pmin]: 6xHis: GFP: dhcA(1384-4725(K1975T))	dhcA	aberrant molecular function
DBS0350052	[TRE-Pmin]: arfA(Q71L): GFP	arfA	aberrant filopodium formation \| aberrant cytokinesis
DBS0350053	[TRE-Pmin]: arfA(T31N): GFP	arfA	wild type \| increased defense response to Gram-negative bacterium
DBS0351202	[act15]: 6xHis: amd1: eYFP	amd1	decreased gene expression \| increased gene expression \| aberrant vegetative growth \| aberrant fruiting body morphogenesis \| delayed development \| mitotic G1 phase arrest
DBS0351167	[act15]: 6xHis: ei24: eYFP	ei24	aberrant aggregation \| increased chemotaxis to cAMP \| aberrant cell cycle \| increased cAMP level \| increased sporulation
DBS0350674	[act15]: 6xHis: erkA	erkA	aberrant slug development
DBS0351253	[act15]: 6xHis: sesn: eYFP	sesn	aberrant aggregation \| decreased protein level \| increased gene expression \| decreased growth rate \| aberrant response to oxidative stress
DBS0349845	[act15]: 7xHis: myoK: Ty1	myoK	aberrant cortical actin cytoskeleton organization \| aberrant engulfment during phagocytosis \| aberrant cell morphology
DBS0237100	[act15]: CFP: racC(G15V)	racC	increased actin filament polymerization
DBS0237101	[act15]: CFP: racC(T20N)	racC	decreased actin filament polymerization \| aberrant cytokinesis \| abolished positive chemotaxis
DBS0350908	[act15]: DD: GFP: rab8A(N128I)	rab8A	increased contractile vacuole size \| increased number of contractile vacuoles \| abolished protein localization to contractile vacuole
DBS0350909	[act15]: DD: GFP: rab8A(Q74L)	rab8A	aberrant contractile vacuole localization \| increased number of contractile vacuoles \| decreased contractile vacuole size
DBS0266512	[act15]: DDB_G0272656	sigN4	wild type
DBS0350566	[act15]: FLAG: Rab14(Q67L)	rab14	increased lysosome size \| increased post-lysosomal vacuole size \| aberrant phagosome maturation \| increased endosomal vesicle fusion
DBS0350049	[act15]: FLAG: cycC	cycC	precocious development of tipped mound
DBS0350321	[act15]: FLAG: hbx4	hbx4	aberrant aggregation \| abolished gene expression \| abolished slug migration \| decreased growth rate \| aberrant cytokinesis
DBS0350322	[act15]: FLAG: hbx4/ [act15]: cadA	cadA \| hbx4	wild type
DBS0350325	[act15]: FLAG: hbx4/ [ecmAO]: lacZ	hbx4	decreased spore germination \| increased prestalk gene expression \| abolished prespore gene expression \| increased prestalk cell differentiation
DBS0351294	[act15]: FLAG: mybB	mybB	increased gene expression \| precocious development
DBS0238107	[act15]: FLAG: ppp4C	ppp4c	wild type
DBS0238108	[act15]: FLAG: ppp4C(H113Q)	ppp4c	development arrests at mound stage \| delayed development
DBS0351488	[act15]: FLAG: rasC(Q62L)	rasC	abolished protein localization to plasma membrane \| increased actin filament polymerization \| decreased chemotaxis to cAMP
DBS0351292	[act15]: FLAG: sir2A	sir2A	delayed development
DBS0351293	[act15]: FLAG: sir2C	sir2C	delayed development
DBS0351291	[act15]: FLAG: sir2D	sir2D	increased gene expression \| precocious development
DBS0237110	[act15]: GFP(S65T)-racG	racG	increased filopodium formation \| decreased actin filament polymerization \| decreased cell motility \| increased phagocytosis
DBS0304572	[act15]: GFP: abpD(1441-1736)	abpD	abolished protein localization to nuclear envelope
DBS0304571	[act15]: GFP: abpD(1441-1738)	abpD	abolished protein localization to nuclear envelope
DBS0304573	[act15]: GFP: abpD(1441-1738,1737P/ A)	abpD	abolished protein localization to nuclear envelope
DBS0237114	[act15]: GFP: abpE(413-481)	abpE-1 \| abpE-2	increased lateral pseudopodium formation
DBS0237116	[act15]: GFP: act15	act15	abolished cytokinesis \| decreased cell motility \| aberrant cell morphology
DBS0351483	[act15]: GFP: aqpB(1-208,219-294)	aqpB	decreased hypotonic response
DBS0351097	[act15]: GFP: cbpG	cbpG	increased cell-substrate adhesion \| increased vegetative cell size \| decreased chemotaxis to cAMP \| abolished aggregation
DBS0350593	[act15]: GFP: cepL	cepL	decreased growth rate \| decreased phagocytosis \| increased vegetative cell size \| increased cell-substrate adhesion \| aberrant centrosome localization \| decreased establishment of cell polarity
DBS0350594	[act15]: GFP: cepL(1-1114)	cepL	increased number of centrosomes \| decreased growth rate \| aberrant vegetative growth \| increased fruiting body size \| decreased phagocytosis \| increased cell-substrate adhesion \| decreased chemotaxis rate \| aberrant phototaxis
DBS0350595	[act15]: GFP: cepL(1-763)	cepL	increased number of centrosomes \| decreased growth rate \| aberrant vegetative growth \| increased fruiting body size \| decreased phagocytosis \| increased cell-substrate adhesion \| decreased chemotaxis rate \| aberrant phototaxis
DBS0350596	[act15]: GFP: cepL(763-1114)	cepL	development arrests at loose mound stage \| abolished establishment of cell polarity \| delayed aggregation \| decreased vegetative cell size \| increased cell-substrate adhesion \| decreased chemotaxis rate \| increased growth rate \| aberrant phototaxis \| delayed gene expression
DBS0350460	[act15]: GFP: docD	docD	increased actin filament polymerization \| increased cell motility \| increased pseudopodium formation
DBS0350288	[act15]: GFP: forF(1-1087)	forF	decreased pinocytosis \| decreased phagocytosis \| decreased growth rate
DBS0235662	[act15]: GFP: forH(1-425)	forH	abolished protein localization to pseudopodium
DBS0350984	[act15]: GFP: frmB	frmB	decreased spore size \| aberrant stalk development
DBS0304973	[act15]: GFP: gefQ(173-651,818-1298)	gefQ	increased guanyl-nucleotide exchange factor activity
DBS0304971	[act15]: GFP: gefQ(683-833)	gefQ	decreased guanyl-nucleotide exchange factor activity
DBS0304972	[act15]: GFP: gefQ(910-1298)	gefQ	aberrant cytokinesis \| aberrant phototaxis
DBS0351254	[act15]: GFP: gflB	gflB	decreased substrate adhesion-dependent cell spreading \| decreased actin filament polymerization \| increased cell motility
DBS0350422	[act15]: GFP: gpbB	gpbB	aberrant vegetative growth \| delayed development
DBS0350349	[act15]: GFP: gtaC(1-467: 497-587)	gtaC	abolished protein localization to nucleus
DBS0350351	[act15]: GFP: gtaC(229-587)	gtaC	abolished protein localization to cytoplasm
DBS0350359	[act15]: GFP: gtaC(281-467: 497-587)	gtaC	aberrant protein localization to cytoplasm
DBS0350352	[act15]: GFP: gtaC(281-587)	gtaC	abolished protein localization to cytoplasm
DBS0350360	[act15]: GFP: gtaC(346-467: 497-587)	gtaC	aberrant protein localization to cytoplasm \| aberrant protein localization to nucleus
DBS0350353	[act15]: GFP: gtaC(346-587)	gtaC	abolished protein localization to cytoplasm
DBS0350350	[act15]: GFP: gtaC(K469,470,494,496A/ R468,471A)	gtaC	abolished protein localization to nucleus
DBS0236070	[act15]: GFP: hcpA	hcpA	decreased growth rate \| aberrant mitotic anaphase
DBS0236071	[act15]: GFP: hcpB	hcpB	decreased growth rate
DBS0351562	[act15]: GFP: impA1	impa1	decreased response to lithium
DBS0237117	[act15]: GFP: krsA	krsA	decreased slug migration
DBS0237118	[act15]: GFP: limE	limE	aberrant cytokinesis
DBS0351530	[act15]: GFP: lis1	lis1	decreased phagocytosis \| decreased chemotaxis to folate
DBS0349983	[act15]: GFP: lmnB	lmnB	aberrant chromatin assembly
DBS0350490	[act15]: GFP: mhcA(T1823D/ T1833D/ T2029D)/ AX3	mhcA	decreased growth rate \| aberrant localization
DBS0237120	[act15]: GFP: nek2	nek2	aberrant nucleus morphology \| increased number of microtubule organizing center
DBS0350852	[act15]: GFP: nkaP	nkaP	aberrant aggregation \| decreased gene expression \| increased gene expression \| aberrant vegetative growth \| increased chemotaxis rate
DBS0237121	[act15]: GFP: numA(1-117: 168-340)	numA	aberrant cytokinesis
DBS0350338	[act15]: GFP: pakA	pakA	increased phagocytosis
DBS0350337	[act15]: GFP: pakA(797-1197)	pakA	decreased phagocytosis \| decreased cell motility
DBS0237122	[act15]: GFP: pats1(2087-2351)	pats1	aberrant cytokinesis
DBS0237123	[act15]: GFP: phg2(1-245)	phg2	decreased phagocytosis
DBS0235442	[act15]: GFP: pldB	pldB	abolished aggregation
DBS0237702	[act15]: GFP: rac1A	rac1A	increased filopodium formation \| increased membrane ruffling \| increased macropinocytosis \| increased growth rate \| increased cell motility
DBS0351073	[act15]: GFP: rac1A(G12V)	rac1A	decreased growth rate \| decreased phagocytosis \| aberrant cytokinesis \| decreased macropinocytosis \| decreased cell motility \| delayed development \| aberrant actin filament organization \| abolished filopodium formation
DBS0351075	[act15]: GFP: rac1A(T17N)	rac1A	aberrant filopodium formation
DBS0237703	[act15]: GFP: rac1B	rac1B	increased filopodium formation \| increased membrane ruffling
DBS0237704	[act15]: GFP: rac1C	rac1C	increased filopodium formation \| increased membrane ruffling \| increased growth rate \| increased cell motility
DBS0351074	[act15]: GFP: rac1C(G12V)	rac1C	decreased growth rate \| decreased phagocytosis \| aberrant cytokinesis \| decreased macropinocytosis \| decreased cell motility \| delayed development \| aberrant actin filament organization \| abolished filopodium formation
DBS0351076	[act15]: GFP: rac1C(T17N)	rac1C	aberrant filopodium formation
DBS0237125	[act15]: GFP: racG(1-168): racH(164-200)	racG \| racH	increased filopodium formation \| decreased actin filament polymerization \| decreased phagocytosis
DBS0237127	[act15]: GFP: racH	racH	decreased pinocytosis \| wild type \| decreased phagocytosis \| decreased growth rate \| aberrant cytokinesis \| aberrant cell morphology
DBS0237128	[act15]: GFP: racH(1-163): racG(167-201)	racG \| racH	decreased actin filament polymerization
DBS0237130	[act15]: GFP: racH(M13V)	racH	increased actin filament polymerization \| aberrant cytokinesis \| aberrant cell morphology
DBS0237132	[act15]: GFP: racH(T18N)	racH	aberrant cytokinesis \| aberrant cell morphology
DBS0237133	[act15]: GFP: racH: gemA(630-658)	gemA \| racH	delayed cytokinesis
DBS0238392	[act15]: GFP: rapA	rapA	increased cell-substrate adhesion
DBS0238393	[act15]: GFP: rapA(G12V)	rapA	increased cell-substrate adhesion
DBS0238394	[act15]: GFP: rapA(S17N)	rapA	decreased cell-substrate adhesion
DBS0350112	[act15]: GFP: rheb(D60I)	rheb	increased phagocytosis
DBS0350111	[act15]: GFP: rheb(Q64L)	rheb	decreased phagocytosis
DBS0237134	[act15]: GFP: sbds	sbds	wild type
DBS0237135	[act15]: GFP: sbds	sbds	wild type
DBS0351177	[act15]: GFP: sey1	sey1	decreased defense response to Gram-negative bacterium \| aberrant vacuole organization
DBS0351178	[act15]: GFP: sey1(K154A)	sey1	increased defense response to Gram-negative bacterium \| aberrant catalytic activity \| decreased protein localization \| aberrant endoplasmic reticulum organization
DBS0350715	[act15]: GFP: src1(2-646)	src1	aberrant nuclear envelope morphology
DBS0304563	[act15]: GFP: sun1(283-905)	sun1	increased number of centrosomes \| decreased protein localization to nuclear envelope \| aberrant nuclear membrane organization \| aberrant nucleus morphology \| increased vegetative cell size \| aberrant centrosome localization \| aberrant mitotic sister chromatid segregation
DBS0350441	[act15]: GFP: talA/ mhcA-/ talA-	mhcA \| talA	aberrant protein localization
DBS0350648	[act15]: HA: Rab14(N121I)	rab14	decreased pinocytosis \| decreased hypotonic response \| aberrant contractile vacuole morphology
DBS0350899	[act15]: HA: rab11(N126I)	rab11A	aberrant contractile vacuole organization \| aberrant contractile vacuole morphology \| increased phagocytosis
DBS0350812	[act15]: HA: rab7A(Q67L)	rab7A	increased exocytosis
DBS0350813	[act15]: HA: rab7A(T22N)	rab7A	decreased pinocytosis \| increased secretion of lysosomal enzymes \| decreased exocytosis \| decreased phagocytosis \| aberrant phagosome maturation \| abolished macropinocytosis \| abolished protein localization to phagocytic vesicle
DBS0238111	[act15]: HA: smkA	smkA	delayed development \| decreased fruiting body size \| decreased establishment of cell polarity \| decreased chemotaxis to cAMP
DBS0350429	[act15]: RFP: abpE	abpE-1 \| abpE-2	delayed aggregation
DBS0350867	[act15]: RFP: mtpn	mtpn	increased filopodium formation \| decreased protein localization to cell cortex \| aberrant actin filament organization \| decreased pseudopodium size
DBS0351228	[act15]: T7: rasG(G12T)	rasG	increased protein phosphorylation \| decreased growth rate \| decreased phagocytosis \| increased cell-substrate adhesion \| decreased filopodium formation
DBS0351226	[act15]: YFP: iqgC	iqgC	decreased phagocytosis \| decreased macropinocytosis
DBS0350986	[act15]: YFP: myoC(G395A)	myoC	decreased pinocytosis \| aberrant mitotic spindle organization \| decreased phagocytosis
DBS0237201	[act15]: YFP: myoE	myoE	decreased pinocytosis \| increased phagocytosis
DBS0237817	[act15]: YFP: wipA	wipA	increased filopodium formation \| increased actin filament polymerization at leading edge
DBS0237819	[act15]: YFP: wipA(K36A)	wipA	increased filopodium formation \| increased actin filament polymerization at leading edge
DBS0237821	[act15]: YFP: wipA(K93A/ S95A)	wipA	increased filopodium formation \| increased actin filament polymerization at leading edge
DBS0237227	[act15]: [AS]dia2	dia2	aberrant extracellular cAMP signaling pathway \| abolished aggregation \| decreased cAMP level
DBS0350673	[act15]: abpC: GFP	abpC	decreased cell motility
DBS0304574	[act15]: abpD	abpD	abolished protein localization to nuclear envelope
DBS0237096	[act15]: abpE	abpE-1 \| abpE-2	aberrant aggregation \| increased lateral pseudopodium formation \| decreased cell motility \| delayed development \| decreased fruiting body size
DBS0349940	[act15]: acrA(1-731): YFP	acrA	aberrant spore coat morphology \| decreased adenylate cyclase activity
DBS0350292	[act15]: act15(Y144W)	act15	aberrant binding
DBS0350800	[act15]: adprt1A	adprt1A	increased gene expression \| decreased gene expression \| decreased ATP level \| delayed aggregation \| aberrant cell cycle \| decreased growth rate \| aberrant response to oxidative stress \| increased mitochondrial fission \| decreased cAMP level
DBS0238086	[act15]: atg1	atg1	wild type
DBS0238091	[act15]: atg1(1-628)	atg1	wild type
DBS0238088	[act15]: atg1(K36A)	atg1	abolished macroautophagy \| increased number of autophagosomes \| aberrant cellular response to nitrogen starvation \| abolished aggregation
DBS0238090	[act15]: atg1(K36A/ 1-628)	atg1	wild type
DBS0350008	[act15]: bzpN: GFP	bzpN	decreased growth rate \| abolished negative regulation of vegetative growth
DBS0237097	[act15]: cak1: myc	cak1-1 \| cak1-2	aberrant DNA repair
JK1	[act15]: carA	carA-1 \| carA-2	delayed aggregation
DBS0252737	[act15]: carA(I104A)	carA-1 \| carA-2	decreased cAMP binding
DBS0252732	[act15]: carA(I104C)	carA-1 \| carA-2	decreased protein kinase activation
DBS0252740	[act15]: carA(I104D)	carA-1 \| carA-2	increased cAMP binding \| delayed aggregation \| aberrant oscillatory cAMP signaling \| decreased protein kinase activation
DBS0252744	[act15]: carA(I104E)	carA-1 \| carA-2	increased cAMP binding \| delayed aggregation \| aberrant oscillatory cAMP signaling
DBS0252741	[act15]: carA(I104F)	carA-1 \| carA-2	increased cAMP binding \| decreased protein kinase activation
DBS0252738	[act15]: carA(I104G)	carA-1 \| carA-2	increased cAMP binding \| decreased protein kinase activation
DBS0252747	[act15]: carA(I104H)	carA-1 \| carA-2	development arrests at loose mound stage \| increased cAMP binding \| abolished oscillatory cAMP signaling \| decreased protein kinase activation
DBS0252749	[act15]: carA(I104K)	carA-1 \| carA-2	increased cAMP binding \| abolished oscillatory cAMP signaling \| decreased protein kinase activation \| abolished aggregation
DBS0252739	[act15]: carA(I104L)	carA-1 \| carA-2	wild type
DBS0252742	[act15]: carA(I104M)	carA-1 \| carA-2	increased cAMP binding
DBS0252746	[act15]: carA(I104N)	carA-1 \| carA-2	development arrests at loose mound stage \| increased cAMP binding \| abolished oscillatory cAMP signaling \| decreased protein kinase activation
DBS0252734	[act15]: carA(I104P)	carA-1 \| carA-2	decreased protein kinase activation
DBS0252745	[act15]: carA(I104Q)	carA-1 \| carA-2	development arrests at loose mound stage \| increased cAMP binding \| abolished oscillatory cAMP signaling \| decreased protein kinase activation
DBS0252750	[act15]: carA(I104R)	carA-1 \| carA-2	development arrests at loose mound stage \| increased cAMP binding \| abolished oscillatory cAMP signaling \| decreased protein kinase activation
DBS0252743	[act15]: carA(I104S)	carA-1 \| carA-2	increased cAMP binding \| aberrant oscillatory cAMP signaling \| decreased protein kinase activation
DBS0252735	[act15]: carA(I104T)	carA-1 \| carA-2	increased cAMP binding \| aberrant oscillatory cAMP signaling
DBS0252736	[act15]: carA(I104V)	carA-1 \| carA-2	wild type
DBS0252733	[act15]: carA(I104W)	carA-1 \| carA-2	increased cAMP binding
DBS0252748	[act15]: carA(I104Y)	carA-1 \| carA-2	development arrests at loose mound stage \| increased cAMP binding \| aberrant oscillatory cAMP signaling \| decreased protein kinase activation
DBS0351055	[act15]: catA	catA	decreased slug migration \| decreased fruiting body size \| decreased superoxide generation \| decreased sporulation
DBS0351588	[act15]: cdcD(E219K): RFP	cdcD	abolished catalytic activity
DBS0350533	[act15]: cdcD(R154C): RFP	cdcD	decreased catalytic activity \| aberrant protein modification \| decreased phototaxis
DBS0350532	[act15]: cdcD: RFP	cdcD	decreased protein level \| increased catalytic activity \| decreased growth rate
DBS0237098	[act15]: cdk5(D144N)	cdk5	decreased pinocytosis \| increased mound size \| aberrant protein level \| delayed aggregation \| decreased phagocytosis \| decreased growth rate \| decreased sporulation \| decreased protein secretion
DBS0237099	[act15]: cf60	cf60	increased number of mounds \| aberrant mound size
DBS0302445	[act15]: cfaD	cfaD	decreased growth rate \| aberrant fruiting body morphogenesis
DBS0350333	[act15]: cnrF: GFP	cnrF	aberrant regulation of GTPase activity
DBS0302658	[act15]: cnrN: myc/ smlA-	cnrN \| smlA	decreased fruiting body size
DBS0237102	[act15]: cofA	cofA	increased actin bundle formation \| increased membrane ruffling \| increased cell motility
DBS0350583	[act15]: csaA	csaA	decreased cell-substrate adhesion \| precocious aggregation \| increased calcium-independent cell-cell adhesion
DBS0350684	[act15]: csaA(1-488): gppA(469-544)	csaA \| gppA	aberrant protein localization to cell surface
DBS0350642	[act15]: cynA: GFP	cynA	aberrant cell motility \| precocious aggregation \| aberrant establishment or maintenance of cell polarity
DBS0349864	[act15]: cyrA: GFP	cyrA	increased chemotaxis to cAMP
DBS0237104	[act15]: dagA	dagA	wild type
DBS0350978	[act15]: deeJ	deeJ	increased pinocytosis \| increased growth rate \| increased phagocytosis
DBS0237105	[act15]: dgkA	dgkA	development arrests at loose mound stage \| decreased chemotaxis rate \| decreased myosin II assembly
DBS0350946	[act15]: dhcA(1384-4725)	dhcA	aberrant microtubule cytoskeleton organization
DBS0237106	[act15]: dhkC(394-661)	dhkC	development arrests at slug stage \| increased slug migration
DBS0235716	[act15]: dhkK	dhkK	precocious aggregation \| development arrests at mound stage
DBS0235705	[act15]: dhkK(D1125N)	dhkK	aberrant extracellular cAMP signaling pathway \| delayed development
DBS0235707	[act15]: dhkK(H825Q)	dhkK	precocious development \| decreased fruiting body size
DBS0235709	[act15]: dhkK(H825Q/ D1125N)	dhkK	aberrant slug migration \| delayed culmination
DBS0237107	[act15]: dng1	dng1	aberrant extracellular cAMP signaling pathway \| decreased growth rate \| precocious aggregation
DBS0351565	[act15]: eIF6	eIF6	aberrant cellular process
DBS0350396	[act15]: eif2s1(S53A)	eif2s1	aberrant spore morphology \| decreased spore germination \| decreased protein level
DBS0350424	[act15]: eif2s1(S53A)/ [bzpR]: lacZ	eif2s1	abolished translation
DBS0237562	[act15]: enlA(92-497)	enlA	decreased cell-substrate adhesion
DBS0237108	[act15]: fbxA: FLAG	fbxA	decreased prespore cell differentiation
DBS0350365	[act15]: fip(1163-2038)	fip-1 \| fip-2	aberrant prestalk O cell differentiation
DBS0237109	[act15]: fps	fps	increased resistance to alendronic acid
DBS0350012	[act15]: fps: GFP	fps	increased resistance to alendronic acid
DBS0235979	[act15]: fszA: GFP	fszA	aberrant mitochondrion morphology
DBS0351485	[act15]: fszB: GFP	fszB	decreased mitochondrial fusion \| decreased mitochondrial fission
DBS0349956	[act15]: fttB(K49E): GFP	fttB	aberrant cytoskeleton organization
DBS0237601	[act15]: gbpD	gbpD	aberrant aggregation \| decreased cell-cell adhesion \| increased guanyl-nucleotide exchange factor activity \| increased cell-substrate adhesion \| decreased chemotaxis to cAMP \| aberrant cell morphology \| increased pseudopodium formation
DBS0351056	[act15]: gcsA	gcsA	increased catalytic activity \| decreased slug migration \| aberrant gene expression \| decreased fruiting body size \| decreased superoxide generation \| decreased sporulation
DBS0237136	[act15]: gpaA	gpaA	increased stalk length \| aberrant cytokinesis \| aberrant fruiting body morphogenesis
DBS0351058	[act15]: gpaB	gpaB	aberrant aggregation \| abolished sporulation \| development arrests at mound stage \| increased cAMP level \| aberrant actin filament polymerization \| decreased establishment of cell polarity \| aberrant protein localization to plasma membrane \| increased prestalk cell differentiation
DBS0350680	[act15]: gpaE	gpaE	abolished vegetative growth \| decreased chemotaxis to folate
DBS0237145	[act15]: gpaG	gpaG	aberrant fruiting body morphogenesis
DBS0237146	[act15]: gpaH	gpaH	wild type
DBS0350971	[act15]: gpaH/ AX2	gpaH	aberrant cytokinesis \| decreased growth rate \| aberrant spore germination \| aberrant sorocarp development \| increased cell-substrate adhesion \| increased cell-cell adhesion
DBS0237147	[act15]: gpaI(G38V): FLAG	gpaI	increased mound size \| delayed aggregation \| decreased number of mounds \| aberrant fruiting body morphogenesis
DBS0237148	[act15]: gpaI(Q196L): FLAG	gpaI	increased oscillatory cAMP signaling \| decreased protein localization to plasma membrane \| increased mound size \| aberrant activation of adenylate cyclase activity \| increased chemotaxis to cAMP \| increased lateral pseudopodium formation \| delayed aggregation \| decreased number of mounds \| increased actin filament polymerization \| aberrant adaptation of signaling pathway \| aberrant fruiting body morphogenesis \| decreased establishment of cell polarity \| decreased cGMP biosynthesis
DBS0350079	[act15]: grlB	grlB	delayed aggregation
DBS0237149	[act15]: grxA	grxA	decreased prespore gene expression \| delayed culmination
DBS0237151	[act15]: grxA(C21S)	grxA	wild type
DBS0237152	[act15]: grxA/ [act15]: lacZ	grxA	increased cell migration to prestalk region
DBS0351054	[act15]: gshB	gshB	aberrant aggregation \| abolished sporulation \| increased gene expression \| development arrests at mound stage \| increased cAMP level \| aberrant actin filament polymerization \| decreased establishment of cell polarity
DBS0351059	[act15]: gshB/ [AS]gpaB	gpaB \| gshB	aberrant stream morphology \| decreased establishment of cell polarity \| decreased sporulation
DBS0237153	[act15]: gsr	gsr	increased cell migration to prestalk region \| delayed culmination
DBS0350989	[act15]: gst4	gst4	increased fruiting body size
DBS0236152	[act15]: hcpA(1-161: 218-225): GFP	hcpA	decreased growth rate
DBS0236159	[act15]: hcpB(1-197: 237-244): GFP	hcpB	decreased growth rate
DBS0351607	[act15]: hsp101(K213A)	hsp101	decreased cellular thermotolerance
DBS0351608	[act15]: hsp101(K613A)	hsp101	decreased cellular thermotolerance
DBS0252821	[act15]: hssA	hssA	wild type
DBS0351173	[act15]: htrA(S300A)	htrA	decreased growth rate \| aberrant fruiting body morphogenesis
DBS0351282	[act15]: htt: eYFP	htt	decreased gene expression \| increased gene expression
DBS0350397	[act15]: ifkA(881-1514(K1258G,F1320L))	ifkA	decreased growth rate \| increased protein level
DBS0350037	[act15]: mekA(299-360)	mekA	decreased mound size
DBS0350034	[act15]: mekA(K321A)	mekA	decreased mound size
DBS0350033	[act15]: mekA(S444A/ T448A)	mekA	decreased mound size
DBS0237203	[act15]: mhkB: FLAG	mhkB	aberrant cytokinesis \| decreased myosin II assembly
DBS0350026	[act15]: mip1/ [act15]: mekA: FLAG	mekA \| mip1-1 \| mip1-2	aberrant protein localization to nucleus
DBS0237157	[act15]: mkkA	mkkA	development arrests at mound stage \| delayed development
DBS0237158	[act15]: mkkA(K199A)	mkkA	precocious development \| decreased sporulation
DBS0237159	[act15]: mkkA{deltaWD40}	mkkA	development arrests at mound stage \| aberrant fruiting body morphogenesis \| delayed development
DBS0350331	[act15]: mkpA: GFP: TAP	mkpA	increased resistance to cisplatin
DBS0350332	[act15]: mkpB(C294V)	mkpB-1 \| mkpB-2	decreased migratory slug size \| delayed prestalk gene expression \| delayed prespore gene expression \| aberrant sorocarp development \| decreased resistance to cisplatin
DBS0350330	[act15]: mkpB: GFP: TAP	mkpB-1 \| mkpB-2	increased resistance to cisplatin
DBS0237160	[act15]: mtaA(1-813)/ [dscB]tubA: GFP	cepJ	aberrant microtubule cytoskeleton organization
DBS0237162	[act15]: myc-cdk8	cdk8	increased number of tip-organizers \| precocious development of tipped mound
DBS0350050	[act15]: myc: cdk8/ [act15]: FLAG: cycC	cdk8 \| cycC	precocious development of tipped mound
DBS0266837	[act15]: myc: ptpC	ptpC	abolished protein localization to nucleus \| aberrant hyperosmotic response \| aberrant signal transduction
DBS0350417	[act15]: myc: ptpC	ptpC	aberrant protein phosphorylation
DBS0266839	[act15]: myc: ptpCΔ(C649S)	ptpC	aberrant protein localization to nucleus \| increased protein tyrosine phosphorylation
DBS0266838	[act15]: myc: ptpC(C649S)	ptpC	aberrant protein localization to nucleus \| increased protein tyrosine phosphorylation
DBS0238398	[act15]: myc: rapA	rapA	increased cell-substrate adhesion \| decreased cell motility \| aberrant cell morphology
DBS0238396	[act15]: myc: rapA(G12V)	rapA	increased protein localization to cell cortex \| delayed aggregation \| increased cell-substrate adhesion \| decreased cell motility \| increased protein kinase activation
DBS0238397	[act15]: myc: rapA(S17N)	rapA	decreased cell-substrate adhesion
DBS0237167	[act15]: myc: rckA	rckA	delayed development
DBS0237163	[act15]: myc: rckA(C551A)	rckA	delayed slug development \| decreased chemotaxis rate
DBS0237164	[act15]: myc: rckA(E510G)	rckA	delayed slug development \| decreased chemotaxis rate
DBS0237165	[act15]: myc: rckA(E510G/ N511A)	rckA	delayed slug development \| decreased chemotaxis rate
DBS0237166	[act15]: myc: rckA(K867A)	rckA	precocious aggregation \| delayed slug development \| decreased chemotaxis rate
DBS0350132	[act15]: myc: splB	splB	increased protein localization to nucleus \| increased protein tyrosine phosphorylation
DBS0351051	[act15]: myc: talA(2255-2492)/ puf118(677-1036)	puf118 \| talA	aberrant chemotaxis to cAMP \| abolished protein localization to leading edge
DBS0351359	[act15]: myoB	myoB	decreased pinocytosis \| increased protein localization to cell cortex \| delayed aggregation \| decreased growth rate \| decreased cell motility \| delayed development \| decreased fruiting body size \| aberrant actin filament organization
DBS0351037	[act15]: myoE(1-1005)	myoE	abolished phosphatidylinositol binding
DBS0351036	[act15]: myoE(K859A/ K863A/ R868A/ R869A): GFP	myoE	abolished phosphatidylinositol binding \| abolished protein localization to plasma membrane
DBS0349847	[act15]: myoK: Myc	myoK	decreased phagocytosis
DBS0237175	[act15]: myoM	myoM	aberrant stream morphology \| delayed development \| increased pseudopodium size
DBS0237178	[act15]: myoM-Mtail	myoM	decreased growth rate \| aberrant hypotonic response \| aberrant stream morphology \| aberrant hyperosmotic response \| delayed development \| increased pseudopodium size
DBS0237179	[act15]: myr: rckA	rckA	delayed development \| decreased chemotaxis rate
DBS0349860	[act15]: ndkC	ndkC-1 \| ndkC-2	decreased exocytosis \| decreased pinocytosis \| decreased phagocytosis \| decreased growth rate \| increased growth rate
DBS0237180	[act15]: nramp1: GFP	nramp1	increased defense response to Gram-negative bacterium \| increased iron ion transport
DBS0350858	[act15]: odc	odc	aberrant cellular metabolic process \| aberrant cell cycle
DBS0351201	[act15]: odc: eYFP	odc	decreased growth rate \| delayed development
DBS0237182	[act15]: pakA	pakA	wild type
DBS0237183	[act15]: pakA(K394A)	pakA	development arrests at mound stage \| delayed development
DBS0237184	[act15]: pakA[CA]	pakA	abolished aggregation
DBS0237185	[act15]: pakA[G+K]	pakA	wild type
DBS0349855	[act15]: pakB(1-337: 563-852)	pakB	decreased phagocytosis
DBS0350901	[act15]: pdeE: YFP	pdeE	development arrests at loose mound stage \| decreased oscillatory cAMP signaling
DBS0351186	[act15]: phr2ab: GFP	phr2aB	aberrant cytokinesis \| aberrant centrosome organization
DBS0349903	[act15]: pisA	pisA	aberrant development of tipped mound \| decreased slug migration \| delayed aggregation \| decreased fruiting body size
DBS0349902	[act15]: pisA: GFP	pisA	decreased slug migration \| increased gene expression \| decreased gene expression \| delayed aggregation \| delayed development \| decreased phototaxis
DBS0350693	[act15]: pkaC	pkaC	precocious development
DBS0237188	[act15]: pkaC(1-497)	pkaC	precocious development \| decreased fruiting body size \| decreased cAMP level
DBS0235418	[act15]: pkaR	pkaR	aberrant response to abiotic stimulus
DBS0237189	[act15]: pkaR(G135E/ G261A)	pkaR	decreased protein tyrosine phosphorylation \| decreased protein kinase activity \| abolished cAMP binding \| abolished oscillatory cAMP signaling \| abolished aggregation
DBS0350701	[act15]: pkaR(G135E/ G261A)/ AX3	pkaR	decreased gene expression \| abolished oscillatory cAMP signaling
DBS0350609	[act15]: pkaR(S133T,G135E)	pkaR	decreased cAMP binding \| decreased protein kinase activity \| abolished oscillatory cAMP signaling \| abolished aggregation
DBS0350920	[act15]: pkcA	pkcA	increased catalytic activity \| abolished aggregation
DBS0235538	[act15]: pldB	pldB	increased catalytic activity \| increased exocytosis \| decreased actin filament polymerization \| aberrant chemotaxis to cAMP \| abolished aggregation \| decreased sporulation
DBS0349874	[act15]: psaA: GFP	psaA	aberrant sporulation
DBS0351577	[act15]: psiA	psiA	decreased prespore gene expression \| decreased stalk cell differentiation
DBS0351579	[act15]: psiA/ [cudA]: lacZ	psiA	aberrant prespore gene expression
DBS0351580	[act15]: psiA/ [ecmB]: lacZ	psiA	delayed prestalk gene expression
DBS0350751	[act15]: pten(16-515): GFP	pten	abolished catalytic activity
DBS0350750	[act15]: pten(186-515): GFP	pten	abolished catalytic activity
DBS0350752	[act15]: pten(C124S): GFP	pten	abolished catalytic activity
DBS0350753	[act15]: pten(G129E): GFP	pten	abolished catalytic activity
DBS0350318	[act15]: rab11A: RFP	rab11A	aberrant contractile vacuole organization \| decreased contractile vacuole size \| abolished hypotonic response
DBS0350951	[act15]: rac1B(Q61L)	rac1B	increased lateral pseudopodium formation \| decreased chemotaxis to cAMP \| aberrant actin filament organization
DBS0350952	[act15]: rac1B(T17N)	rac1B	abolished establishment of cell polarity \| delayed aggregation \| aberrant actin filament organization \| abolished chemotaxis to cAMP
DBS0350469	[act15]: racE(G20V): GFP	racE	decreased actin filament polymerization \| aberrant cytokinesis \| decreased growth rate
DBS0350584	[act15]: rapA(G12V)	rapA	abolished protein localization to nucleus \| increased protein localization to cell cortex \| aberrant nucleus morphology \| decreased growth rate \| aberrant cytokinesis \| increased cell-substrate adhesion \| abolished protein localization to centrosome \| increased number of microtubule organizing center
DBS0351497	[act15]: rasD(Q61L)	rasD	decreased protein kinase activation
DBS0351496	[act15]: rasD(S17N)	rasD	increased protein kinase activation
DBS0351212	[act15]: rasG(S17N)	rasG	aberrant activation of GTPase activity \| decreased chemotaxis to cAMP
DBS0350262	[act15]: rbg3	rbg3	increased lysosome size \| decreased growth rate \| delayed development
DBS0237192	[act15]: rblA	rblA	delayed mitotic cell cycle
DBS0350671	[act15]: regA(126-316): myc	regA	precocious sporulation
DBS0349938	[act15]: rgaA	rgaA	decreased actin filament polymerization \| aberrant cytokinesis \| decreased cell motility
DBS0351529	[act15]: rgbA(751-1072,1080-1284,1517-1846)	rgbA	aberrant macropinocytosis \| abolished protein localization to macropinosome
DBS0351528	[act15]: rgbA(751-1072,1121-1317,1505-1834)	rgbA	aberrant macropinocytosis \| abolished protein localization to macropinosome
DBS0351304	[act15]: rheb	rheb	decreased phagocytosis \| decreased macropinocytosis \| increased growth rate
DBS0350294	[act15]: rheb: YFP	rheb	increased vegetative cell size
DBS0350890	[act15]: rnp1A	rnp1A	increased resistance to nocodazole
DBS0350575	[act15]: rps4	rps4	decreased spore germination \| aberrant actin cytoskeleton organization \| aberrant vegetative growth \| decreased mound size \| decreased spore size \| aberrant fruiting body morphogenesis \| decreased sporulation
DBS0236915	[act15]: rzpA	rzpA	increased prestalk gene expression \| decreased prespore gene expression \| delayed culmination
DBS0349793	[act15]: sadA(921-952)	sadA	decreased cell-substrate adhesion
SA604	[act15]: sgkA: FLAG	sgkA	aberrant response to abiotic stimulus \| increased resistance to cisplatin \| aberrant cytokinesis \| increased resistance to carboplatin
DBS0304461	[act15]: sir2E	sir2E	increased growth rate
HPF437	[act15]: snfA(1-379): GFP	snfA	increased stalk width \| increased ATP level \| decreased growth rate \| increased number of mitochondria \| decreased defense response to bacterium \| decreased phototaxis \| decreased stalk length \| aberrant mitochondrion organization
DBS0351040	[act15]: snfA(1-379): GFP/ [AS]ndkC-1	ndkC-1 \| ndkC-2 \| snfA	wild type
DBS0350976	[act15]: snfA: YFP	snfA	decreased growth rate \| aberrant fruiting body morphogenesis
DBS0351053	[act15]: sod2	sod2	decreased slug migration \| decreased fruiting body size \| decreased superoxide generation \| decreased sporulation
DBS0304457	[act15]: sodA/ gcsA-	gcsA \| sodA	wild type
DBS0237194	[act15]: sodA: myc	sodA	aberrant response to abiotic stimulus \| decreased gene expression \| abolished aggregation
DBS0237195	[act15]: spkA: FLAG	spkA-1 \| spkA-2	aberrant aggregation \| decreased chemotaxis rate \| aberrant actin filament organization \| decreased establishment of cell polarity
AK1209	[act15]: tagA(1-890)	tagA	increased number of mound tips
DBS0350962	[act15]: tor(212-2380): YFP	tor	decreased growth rate \| aberrant sorocarp development
DBS0237198	[act15]: torA	torA	abolished vegetative growth
DBS0350862	[act15]: tpt1: YFP	tpt1	decreased gene expression \| decreased growth rate \| decreased number of mounds \| delayed development \| aberrant fruiting body morphogenesis
DBS0237199	[act15]: trrA	trrA	aberrant aggregation \| decreased growth rate \| decreased phagocytosis \| delayed culmination
DBS0351572	[act15]: vacA: GFP	vacA	decreased phagocytosis
DBS0351573	[act15]: vacB: GFP	vacB	decreased phagocytosis
DBS0351574	[act15]: vacC: GFP	vacC	decreased phagocytosis
DBS0237200	[act15]: vasP	vasP	increased filopodium formation \| increased actin filament polymerization
DBS0351184	[act15]: washc5(N457D): GFP	washc5	aberrant cytokinesis
DBS0351183	[act15]: washc5: GFP	washc5	aberrant cytokinesis
DBS0350911	[act6]: GFP: cepA/ cepA(183-346)	cepA	increased number of centrosomes
DBS0237209	[act6]: GFP: cepJ	cepJ	decreased resistance to nocodazole \| aberrant cytokinesis \| decreased size of astral microtubules \| decreased number of astral microtubules \| increased number of microtubule organizing center
DBS0351235	[act6]: GFP: cepL	cepL	increased number of microtubule organizing center
DBS0351586	[act6]: GFP: gefQ(S431A)	gefQ	increased number of mound tips \| delayed development
DBS0349984	[act6]: GFP: lmnB(1-712)	lmnB	aberrant cellular response to fluid shear stress \| aberrant intermediate filament organization \| abolished vegetative growth
DBS0351551	[act6]: GFP: lmnB(1-712)/ S122A	lmnB	aberrant intermediate filament bundle assembly
DBS0350497	[act6]: GFP: rab2A	rab2A	decreased pinocytosis \| decreased phagocytosis \| aberrant hypotonic response \| increased growth rate
DBS0350498	[act6]: GFP: rab2A(N118I)	rab2A	aberrant cell-cell adhesion \| aberrant hypotonic response \| increased growth rate \| precocious development
DBS0350499	[act6]: GFP: rab2A(Q64L)	rab2A	decreased autophagic cell death \| aberrant cell-cell adhesion \| aberrant sorocarp development \| aberrant hypotonic response \| increased growth rate \| increased phagocytosis
DBS0306243	[act6]: GFP: sun1	sun1	increased number of centrosomes \| aberrant nucleus morphology \| aberrant mitotic sister chromatid segregation \| aberrant centromere complex assembly \| aberrant centrosome organization
DBS0306244	[act6]: GFP: sun1(1-722)	sun1	increased number of centrosomes \| aberrant nucleus morphology \| aberrant mitotic sister chromatid segregation \| aberrant centromere complex assembly \| aberrant centrosome organization
DBS0235563	[act6]: abpD(33-262)	abpB	decreased growth rate \| delayed development
DBS0237204	[act6]: canA	canA	wild type
DBS0350685	[act6]: csaA	csaA	increased migratory slug size \| increased calcium-independent cell-cell adhesion
DBS0237205	[act6]: dia1	dia1	delayed aggregation
DBS0236905	[act6]: mrps4	mrps4	precocious aggregation
DBS0235444	[act6]: myc: eppA(S250A)	eppA	decreased growth rate \| delayed development \| decreased cAMP level
DBS0235445	[act6]: myc: eppA(S325A)	eppA	decreased growth rate
DBS0266836	[act6]: ptpB	ptpB	delayed aggregation \| decreased fruiting body size
DBS0237218	[act6]: ptpC	ptpC	increased mound size \| decreased growth rate
DBS0237219	[act6]: ptpC(C649S)	ptpC	increased mound size \| decreased growth rate
DBS0350807	[act6]: rabS(N137I): GFP	rabS	increased secretion of lysosomal enzymes \| aberrant contractile vacuole organization \| increased endocytic recycling
DBS0350806	[act6]: rabS: GFP	rabS	decreased cell-cell adhesion \| increased secretion of lysosomal enzymes \| increased cell death \| increased pinocytosis \| aberrant sorocarp development \| aberrant hyperosmotic response \| decreased chemotaxis to cAMP \| increased growth rate \| increased phagocytosis
DBS0350982	[act6]: rps6	rps6	aberrant cytokinesis \| delayed development
DBS0304410	[act6]: srsA	srsA	increased migratory slug size \| increased mound size \| decreased gene expression \| delayed aggregation \| aberrant fruiting body morphogenesis \| decreased sporulation
DBS0237220	[act6]: trap1	trap1	development arrests at loose mound stage \| aberrant aggregation \| abolished pinocytosis \| increased gene expression \| decreased gene expression \| decreased growth rate
DBS0350695	[act6]: yakA	yakA	increased gene expression \| abolished vegetative growth
DBS0350069	[act6]: zizB: GFP	zizB	aberrant cell separation during cytokinesis \| increased filopodium formation
DBS0304460	[act]: alrA/ gcsA-	alrA \| gcsA	wild type
DBS0349955	[ampA]: RFP: ampA	ampA	development arrests at mound stage
DBS0237221	[arkA]: arkA: myc2	arkA	aberrant aggregation
HM2191	[arpB]: arpB: GFP	arpB	decreased actin filament polymerization \| decreased cell-substrate adhesion \| decreased growth rate \| decreased cell motility \| decreased chemotaxis rate \| increased bleb assembly
DBS0235407	[carA]: carA(1-317)	carA-1 \| carA-2	delayed development
DBS0351495	[cotB]: FLAG: fbxD	fbxD	delayed culmination
HW358	[cotB]: fpaB: myc	fpaB-1 \| fpaB-2	increased response to hypoxia
DBS0350705	[cotC]: pkaC	pkaC	aberrant sorocarp development \| aberrant fruiting body morphogenesis \| precocious development
DBS0350706	[cotC]: pkaC/ [spiA]: lacZ	pkaC \| spiA	precocious gene expression
DBS0350048	[cycC]: cycC: TAP	cycC	decreased protein level
DBS0350942	[disc]: HA: rab14(N121I)	rab14	decreased endosomal vesicle fusion \| decreased phagocytosis
DBS0350941	[disc]: HA: rab14(Q67L)	rab14	increased lysosome size \| increased endosomal vesicle fusion \| increased phagocytosis
DBS0351493	[dscA]: His: agtA	agtA	decreased sporulation
DBS0351492	[dscA]: His: agtA(D132A)	agtA	aberrant stalk morphogenesis \| abolished sporulation
DBS0237238	[dscB]: GFP: rab8A	rab8A	wild type
DBS0237239	[dscB]: GFP: rab8A(N128I)	rab8A	increased mound size \| increased cell-cell adhesion \| decreased fruiting body size
DBS0237240	[dscB]: GFP: rab8A(Q74L)	rab8A	abolished aggregation \| aberrant cytoskeleton organization
DBS0237241	[dscB]: GFP: rab8B	rab8B	increased mound size
DBS0237242	[dscB]: GFP: rab8B(Q74L)	rab8B	increased mound size
DBS0305081	[dscB]: GFP: vamp7A(L35A)	vamp7A	increased protein localization to plasma membrane
DBS0351106	[dscB]: HA: racC	racC	decreased exocytosis \| decreased pinocytosis \| decreased macropinocytosis \| aberrant actin filament organization \| increased phagocytosis
DBS0350903	[dscB]: HA: rapB(G12V)	racB	decreased exocytosis \| decreased phagocytosis \| aberrant cytokinesis \| decreased growth rate \| decreased macropinocytosis \| aberrant actin filament organization \| aberrant cell morphology
DBS0350433	[dscB]: abpB(E60K): GFP	abpB	abolished actin filament polymerization
DBS0350820	[dscB]: cafA	cafA	increased gene expression \| precocious development
DBS0237237	[dscB]: cycB(106-436)	cycB	mitotic M phase arrest
DBS0350922	[dscB]: dicA(1-278)	dicA	increased cell death \| abolished protein binding \| aberrant microtubule cytoskeleton organization \| aberrant Golgi localization \| aberrant mitotic sister chromatid segregation \| aberrant centrosome organization
DBS0350923	[dscB]: dicA(48-654)	dicA	aberrant microtubule cytoskeleton organization \| aberrant Golgi localization \| decreased protein binding \| aberrant mitotic sister chromatid segregation \| aberrant centrosome organization
DBS0237243	[dscB]: myc: rac1B	rac1B	increased rate of endocytosis \| aberrant cytokinesis \| decreased growth rate \| delayed development
DBS0237244	[dscB]: myc: rac1B(G12V)	rac1B	decreased rate of endocytosis \| decreased growth rate \| abolished aggregation \| aberrant cell morphology
DBS0237245	[dscB]: myc: rac1B(Q61L)	rac1B	decreased rate of endocytosis \| decreased growth rate \| abolished aggregation \| aberrant cell morphology
DBS0237246	[dscB]: myc: rac1B(T17N)	rac1B	decreased rate of endocytosis \| decreased growth rate \| abolished aggregation
DBS0351510	[dscB]: rac1B(G12V): myc	rac1B	decreased pinocytosis \| decreased growth rate \| aberrant cytokinesis \| delayed development \| aberrant actin filament organization \| aberrant cell morphology
DBS0351511	[dscB]: rac1B(Q61L): myc	rac1B	decreased growth rate \| aberrant cytokinesis \| delayed development \| aberrant actin filament organization \| aberrant cell morphology
DBS0351512	[dscB]: rac1B(T17N): myc	rac1B	decreased pinocytosis \| decreased growth rate \| aberrant cytokinesis \| decreased chemotaxis to folate \| delayed development \| aberrant actin filament polymerization \| aberrant cell morphology
DBS0350589	[dscB]: rapA	rapA	decreased pinocytosis \| aberrant actin filament organization \| aberrant cell morphology \| increased phagocytosis
DBS0350586	[dscB]: rapA(D40E)	rapA	aberrant actin filament organization \| aberrant cell morphology
DBS0350588	[dscB]: rapA(F160L)	rapA	aberrant actin filament organization \| aberrant cell morphology
DBS0350590	[dscB]: rapA(G12T)	rapA	decreased pinocytosis \| increased phagocytosis
DBS0237247	[dscB]: rapA(G12V)	rapA	aberrant osmosensory signaling pathway \| aberrant actin filament organization \| aberrant cell morphology
DBS0350585	[dscB]: rapA(S19N)	rapA	decreased phagocytosis \| aberrant cell morphology
DBS0350587	[dscB]: rapA(T63Q)	rapA	aberrant cell morphology
DBS0237248	[dscB]: rasG(G12T)	rasG	decreased gene expression \| decreased growth rate \| increased cell-cell adhesion \| decreased cell motility \| decreased protein kinase activation \| decreased fruiting body size \| abolished aggregation \| aberrant cell morphology \| decreased sporulation
DBS0351227	[dscB]: rasG(G12T/ T45Q)	rasG	wild type \| aberrant cell morphology
DBS0350933	[dscC]: kif2	kif2	aberrant cell cycle
DBS0351230	[ecmAO]: rasG(G12T)	rasG	aberrant prestalk gene expression \| aberrant culmination
DBS0350703	[ecmA]: pkaC	pkaC	development arrests at mound stage \| abolished development of tipped mound
DBS0350659	[ecmA]: pkaC(9-648)	pkaC	development arrests at tipped mound stage
DBS0350699	[ecmA]: pkaR(G135E/ G261A)	pkaR	decreased migratory slug size \| delayed development of tipped mound \| aberrant culmination \| aberrant slug migration \| decreased prestalk gene expression \| increased slug migration \| aberrant prestalk cell differentiation
DBS0350700	[ecmA]: pkaR(G135E/ G261A)/ [ecmB-frag]: lacZ	pkaR	abolished stalk cell differentiation
DBS0350704	[ecmB]: pkaC	pkaC	development arrests at mound stage \| abolished development of tipped mound
DBS0350639	[ecmF]: expl3: myc	expl3	aberrant stalk morphogenesis \| delayed slug development
DBS0304865	[expl7]: expl7: GFP	expl7	aberrant late culminant morphology
DBS0237252	[gpaA]: gpaA(G45V)	gpaA	delayed development
DBS0237253	[gpaA]: gpaA(Q206L)	gpaA	increased basal disc size
DBS0237254	[gpaB]: gpaB(Q208L)	gpaB	aberrant protein localization to plasma membrane
DBS0237255	[hairpin]dct	dct	aberrant cytokinesis \| aberrant pseudopodium formation
DBS0238412	[inviable]arcB-	arcB	abolished vegetative growth
DBS0238407	[inviable]arpB-	arpB	abolished vegetative growth
DBS0237257	[inviable]cofA-	cofA	abolished vegetative growth
DBS0349945	[inviable]fttB	fttB	abolished vegetative growth
DBS0349872	[inviable]lkb1-	lkb1	abolished vegetative growth
DBS0237265	[inviable]phlp2-	phlp2	abolished vegetative growth
DBS0349948	[ndm]: ndm: RFP	ndm	development arrests at mound stage
DBS0236086	[pdsA-agg]: pdsA	pdsA	precocious development
DBS0236111	[pdsA-ldev]: pdsA	pdsA	development arrests at mound stage
DBS0236484	[pkaC]: pkaC	pkaC	increased gene expression \| precocious prespore gene expression \| decreased spore cell differentiation \| aberrant fruiting body morphogenesis \| precocious development \| precocious gene expression \| decreased cAMP level
DBS0350709	[pkaC]: pkaC/ [dscC]: lacZ	dscC-1 \| dscC-2 \| pkaC	aberrant gene expression
DBS0350196	[pkaC]: pkaC/ nsfA(A1854T,T1984A,C2131A,A2398T,T2574A)	nsfA \| pkaC	decreased spore cell differentiation
DBS0350696	[pkaC]: pkaC/ srfA-	pkaC \| srfA	aberrant spore coat morphology \| aberrant gene expression
DBS0237289	[psmC1]: psmC1	psmC1	delayed development of tipped mound \| aberrant cytokinesis \| delayed gene expression
DBS0349928	[pspA]: lacZ	pspA	aberrant prespore gene expression
DBS0350658	[pspA]: pkaC(9-648)	pkaC	precocious sporulation \| aberrant fruiting body morphogenesis
DBS0350697	[pspA]: pkaR(G135E/ G261A)	pkaR	abolished gene expression \| decreased prespore gene expression \| aberrant sorus color
DBS0351229	[pspA]: rasG(G12T)	rasG	increased number of mound tips \| increased prestalk gene expression \| decreased prespore gene expression \| abolished phototaxis \| increased prestalk cell differentiation
DBS0237290	[ptpA1]: ptpA1	ptpA1-1 \| ptpA1-2	delayed aggregation \| decreased growth rate \| aberrant fruiting body morphogenesis
DBS0237291	[ptpB]ptpB	ptpB	decreased growth rate \| development arrests at mound stage
DBS0351231	[rasD]: rasG(G12T)	rasG	development arrests at loose mound stage \| increased number of mound tips
DBS0236867	[rasG]: rasG(G12T)	rasG	aberrant aggregation
SA601	[sglA-myc]neo^R-1	sglA	decreased resistance to carboplatin \| decreased growth rate \| aberrant cytokinesis \| decreased resistance to cisplatin
DBS0237316	[tet]: GFP(S65T): racG(G12V)	racG	increased filopodium formation \| decreased positive regulation of GTPase activity \| decreased actin filament polymerization \| increased phagocytosis \| abolished chemotaxis to cAMP
DBS0237317	[tet]: GFP(S65T): racG(T17N)	racG	abolished actin filament polymerization \| abolished chemotaxis to cAMP
DBS0350110	[tet]: RNAi: raptor	raptor	decreased growth rate
DBS0238351	[tet]: [RNAi]cinC	cinC	decreased translation \| precocious aggregation \| decreased growth rate
DBS0237318	[tet]: pten	pten	decreased cell motility \| decreased protein kinase activation
DBS0237622	[tet]: rapA(S17N)/ [act15]: gbpD	gbpD \| rapA	increased establishment of cell polarity \| increased cell-substrate adhesion \| aberrant cell morphology
DBS0351461	[tet]rasD(G12T)	rasD	increased gene expression \| increased prestalk cell differentiation
DBS0351463	[tet]rasD(G12T)/ rigA-	rasD \| rigA	wild type
DBS0350494	[tgrB1]: [RNAi]abcB3/ [tgrC1]: GFP	abcB3	delayed development \| decreased cAMP level
DBS0351290	[tre]: drkA: myc	drkA	decreased growth rate \| increased protein tyrosine phosphorylation
DBS0304911	[tre]: paxB	paxB	abolished sporulation \| aberrant endocytosis \| decreased cell-substrate adhesion \| aberrant chemotaxis to folate \| development arrests at mound stage \| decreased cell motility \| increased cell-cell adhesion
DBS0350267	[tre]: secG	secG	increased filopodium formation \| abolished establishment of cell polarity \| development arrests at mound stage \| aberrant actin cytoskeleton organization \| aberrant actin filament polymerization \| abolished chemotaxis to cAMP \| delayed gene expression
DBS0351555	[unk]: FLAG: rab1A(Q67L)	rab1A	aberrant actin filament polymerization \| aberrant pseudopodium formation
DBS0351556	[unk]: FLAG: rab1A(S22N)	rab1A	decreased actin filament polymerization \| decreased chemotaxis to cAMP
DBS0351442	[unk]: GFP: RasG	rasG	increased macropinocytosis
DBS0351443	[unk]: GFP: RasG(G12T)	rasG	increased macropinocytosis
DBS0351444	[unk]: GFP: RasS	rasS	increased macropinocytosis
DBS0351445	[unk]: GFP: RasS(G12V)	rasS	increased macropinocytosis
DBS0350726	[unk]: GFP: cepE	cepE	increased number of centrosomes \| aberrant cytokinesis
DBS0351454	[unk]: GFP: piaA(G963E)	piaA	delayed aggregation \| decreased protein binding
DBS0351507	[unk]: GFP: wasA(I173A/ F179A)	wasA	abolished protein binding
DBS0350447	[unk]: PTEN(H385G/ N389A/ H390A)	pten	decreased protein localization to plasma membrane \| decreased fruiting body size
DBS0351270	[unk]: gpgA(1-65)	gpgA	decreased protein localization to plasma membrane \| abolished aggregation \| aberrant actin filament organization \| abolished chemotaxis to cAMP
DBS0350576	[unk]: mhkC(1-498)	mhkC	abolished protein localization to cell cortex \| abolished protein phosphorylation
DBS0350405	[unk]: myc: rgaA(K273E/ K282E)	rgaA	aberrant binding
DBS0350716	[unk]: pdsA	pdsA	aberrant sorocarp development
DBS0350259	[unk]: pikA(1-492(S7A/ S11A/ S109A/ S113A/ S177A/ S181A))	pikA	increased protein localization to plasma membrane
DBS0350558	[unk]: pikI(T262E)	pikI	increased catalytic activity
DBS0350258	[unk]: rapA(G12V)	rapA	increased activation of GTPase activity
DBS0236859	[unk]: rasD(G12T)	rasD	increased myo-inositol level \| decreased gene expression \| increased prestalk gene expression \| decreased prespore gene expression \| development arrests at tipped mound stage \| increased protein kinase activation
DBS0350837	[unk]: rasD(G12T)/ [rasD]: rapA	rapA \| rasD	increased number of mound tips \| aberrant culmination \| decreased prespore cell differentiation \| aberrant gene expression \| decreased stalk cell differentiation
DBS0304636	[unk]: rasG(Q61L)/ rasG-	rasG	aberrant extracellular cAMP signaling pathway \| increased protein modification
DBS0350597	[unk]: roco4(1018-1292;F1107L,F1161L)	roco4	decreased small molecule binding
DBS0238439	[unk]: scrA(97-443): GFP	scrA	aberrant cytokinesis \| increased vegetative cell size \| decreased chemotaxis to cAMP \| aberrant cytoskeleton organization
DBS0351430	[unk]: tps9(N236A)	tps9	decreased catalytic activity
DBS0350056	[unk]: tubA: GFP/ RNAi]cepG	cepG \| tubA	aberrant cytokinesis \| aberrant microtubule cytoskeleton organization \| aberrant protein localization to nuclear envelope \| aberrant centromere complex assembly
DBS0350913	[unk]: tubA: GFP/ [RNAi]cepD	cepD	increased number of centrosomes \| aberrant mitotic spindle organization \| decreased protein localization to microtubule organizing center
DBS0351237	[unk]: tubA: GFP/ [RNAi]cepL	cepL \| tubA	decreased growth rate \| aberrant cytokinesis \| aberrant microtubule cytoskeleton organization \| aberrant centromere complex assembly
DBS0351561	[unk]: vacA: myc: vasP	vacA \| vasP	decreased phagocytosis \| decreased growth rate \| aberrant cytokinesis \| increased protein level \| aberrant cell morphology
DBS0350464	[unk]: vasP(1-197: 221-261: 285-380)	vasP	abolished actin filament polymerization
DBS0350463	[unk]: vasP(1-261: 285-380)	vasP	aberrant actin filament organization
DBS0350465	[unk]: vasP(1-340: 376-380)	vasP	decreased actin filament polymerization \| aberrant actin filament organization
DBS0237288	[unk]skp1	fpaA \| fpaB-1	aberrant fruiting body morphogenesis
HAD186	aarA-	aarA	aberrant stalk morphogenesis \| aberrant Golgi localization \| aberrant epithelium-like organization \| decreased prespore gene expression \| aberrant centrosome localization \| aberrant stalk development \| aberrant establishment or maintenance of cell polarity \| decreased sporulation
DBS0349920	aarA-/ [act15]: GFP-mhcA	aarA	aberrant stalk morphogenesis \| aberrant protein localization
DBS0350143	abcA10-	abcA10	aberrant sorocarp development \| decreased sporulation
DBS0350135	abcA3-	abcA3	aberrant sorocarp development \| aberrant fruiting body morphogenesis \| decreased sporulation
DBS0350138	abcA4-	abcA4	aberrant fruiting body morphogenesis
DBS0350139	abcA5-	abcA5	aberrant sorocarp development \| decreased sporulation
DBS0350140	abcA6-	abcA6	decreased fruiting body size
DBS0350141	abcA7-	abcA7	aberrant sorocarp development
DBS0350142	abcA9-	abcA9	aberrant fruiting body morphogenesis \| decreased sporulation
DBS0350145	abcB1-	abcB1	delayed culmination
DBS0350146	abcB4-	abcB4	decreased sporulation
DBS0350147	abcB5-	abcB5	decreased growth rate \| delayed culmination
DBS0350153	abcC13-	abcC13	aberrant sorocarp development \| delayed culmination \| decreased sporulation
DBS0350154	abcC14-	abcC14	aberrant sorocarp development \| decreased fruiting body size \| decreased sporulation
DBS0350148	abcC2-	abcC2	aberrant sorocarp development \| delayed culmination
DBS0350149	abcC3-	abcC3	delayed culmination
DBS0350150	abcC6-	abcC6	aberrant sorocarp development \| delayed culmination
DBS0350151	abcC8-	abcC8	decreased growth rate \| increased number of early culminant tips \| decreased sporulation
DBS0350155	abcD2-	abcD2	decreased fruiting body size
DBS0350156	abcF1-	abcF1	aberrant sorocarp development \| delayed culmination \| decreased sporulation
DBS0350157	abcF2-	abcF2	delayed development of tipped mound \| decreased sporulation
DBS0350158	abcF4-	abcF4	aberrant sorocarp development \| aberrant fruiting body morphogenesis
DBS0350164	abcG10-	abcG10	delayed development of tipped mound \| decreased fruiting body size \| decreased sporulation
DBS0350165	abcG15-	abcG15	aberrant sorocarp development \| decreased sporulation
DBS0350166	abcG16-	abcG16	delayed culmination
DBS0350167	abcG17-	abcG17-1 \| abcG17-2	decreased fruiting body size \| decreased sporulation
DBS0350168	abcG18-	abcG18	decreased sporulation
DBS0350169	abcG19-	abcG19	delayed aggregation \| decreased fruiting body size
DBS0350160	abcG2-	abcG2	delayed development of tipped mound \| decreased fruiting body size
DBS0236539	abcG2-/ abcG18-	abcG18 \| abcG2	decreased rate of endocytosis \| decreased growth rate \| abolished vegetative growth
DBS0236540	abcG2-/ abcG18-/ rtoA-	abcG18 \| abcG2 \| rtoA	decreased growth rate \| abolished vegetative growth
DBS0350170	abcG22-	abcG22	delayed development of tipped mound \| aberrant sorocarp development
DBS0350171	abcG24-	abcG24	decreased sporulation \| delayed culmination
DBS0350161	abcG5-	abcG5	delayed culmination
DBS0350162	abcG6-	abcG6	decreased sporulation
DBS0351078	abcG6-	abcG6	delayed aggregation \| increased cell-substrate adhesion \| decreased cell motility
DBS0350163	abcG7-	abcG7	delayed development of tipped mound \| decreased fruiting body size \| decreased sporulation
DBS0350159	abcH2-	abcH2	decreased sporulation
DBS0266687	abiA-	abiA	abolished protein localization to pseudopodium \| decreased protein level \| aberrant cytokinesis \| decreased growth rate \| decreased chemotaxis to folate
DBS0266688	abiA-	abiA	abolished protein localization to pseudopodium
DBS0351531	abiA-/ AX2	abiA	abolished protein localization to pseudopodium \| decreased migratory slug size \| aberrant filopodium formation \| aberrant macropinocytosis \| decreased cell motility \| aberrant pseudopodium formation \| decreased fruiting body size
DBS0350386	abiA-/ abiA(45-136)	abiA	decreased protein level \| aberrant cytokinesis
DBS0350384	abiA-/ abiA(45-332)	abiA	aberrant cytokinesis
DBS0351535	abiA-/ pirA-/ AX2	abiA \| pirA	aberrant macropinocytosis \| decreased cell motility \| aberrant cell morphology
DBS0266689	abiA-/ scrA-	abiA \| scrA	decreased cell motility \| decreased vegetative cell size
LAS53	abkD-	abkD	aberrant socially cooperative development
DBS0351065	abnC-	abnC	delayed aggregation \| increased cell-substrate adhesion \| decreased cell motility
DBS0235459	abpA-	abpA	aberrant hyperosmotic response
DBS0235456	abpA-/ abpC-	abpA \| abpC	decreased pinocytosis \| decreased phagocytosis \| decreased growth rate \| decreased cell motility \| aberrant sorocarp development \| aberrant cell-cell adhesion \| aberrant hyperosmotic response
DBS0305672	abpB-	abpB	increased filopodium formation
DBS0351087	abpB-/ abpA-	abpA \| abpB	decreased pinocytosis \| decreased growth rate \| increased cell-cell adhesion \| decreased vegetative cell size \| aberrant fruiting body morphogenesis \| aberrant hyperosmotic response \| precocious gene expression \| decreased chemotaxis to cAMP
DBS0351088	abpB-/ abpC-	abpB \| abpC	decreased prespore gene expression \| decreased prestalk gene expression \| aberrant fruiting body morphogenesis \| aberrant hyperosmotic response \| decreased chemotaxis to cAMP
DBS0235425	abpB-/ fimA-	abpB \| fimA	decreased vegetative cell size \| decreased fruiting body size \| decreased sporulation
HG1264	abpC-	abpC	aberrant actin cytoskeleton organization
DBS0350936	abpC-	abpC	aberrant cortical actin cytoskeleton organization \| decreased phagocytosis \| decreased cell motility \| decreased chemotaxis to cAMP \| aberrant pseudopodium formation \| decreased establishment of cell polarity
DBS0236077	abpC-	abpC	decreased response to Gram-negative bacterium \| aberrant thermotaxis \| aberrant cortical actin cytoskeleton organization \| decreased cell motility \| aberrant phototaxis \| decreased establishment of cell polarity \| aberrant actin filament polymerization
HG1270	abpC-	abpC	aberrant phototaxis
DBS0237938	abpC-/ [act15]: GFP: abpC(9-148)	abpC	aberrant phototaxis
DBS0235426	abpC-/ [act15]: abpC	abpC	wild type
DBS0350938	abpC-/ [act15]: abpC	abpC	wild type
DBS0237945	abpC-/ [act15]: abpC(1-348: 449-857): GFP	abpC	aberrant phototaxis \| aberrant actin filament organization
DBS0237946	abpC-/ [act15]: abpC(1-556: 644-857): GFP	abpC	aberrant phototaxis \| aberrant actin filament organization
DBS0237941	abpC-/ [act15]: abpC(1-739): GFP	abpC	aberrant phototaxis
DBS0351553	abpC-/ [act15]: qkgA(425-1553)	abpC \| qkgA-1 \| qkgA-2	aberrant actin filament polymerization
DBS0237949	abpC-/ [cotB]: abpC: GFP	abpC	aberrant phototaxis
DBS0237948	abpC-/ [ecmA]: abpC: GFP	abpC	wild type
DBS0235427	abpD-	abpD	decreased cell-cell adhesion \| decreased spore germination \| aberrant sorocarp development \| delayed development
DBS0235428	abpE-	abpE-1 \| abpE-2	increased lateral pseudopodium formation
DBS0349851	abpE-	abpE-1 \| abpE-2	aberrant phagosome maturation \| precocious phagosome acidification \| increased phagocytosis
DBS0349852	abpE-/ [act15]: abpE	abpE-1 \| abpE-2	decreased phagocytosis
DBS0350529	abpG-	abpG	increased actin filament polymerization \| decreased chemotaxis to cAMP \| decreased fruiting body size
DBS0235562	acaA-	acaA	abolished stream development \| abolished gene expression \| abolished establishment of cell polarity \| decreased gene expression \| increased cellular thermotolerance \| abolished aggregation \| decreased adenylate cyclase activity \| decreased cAMP level
GP6	acaA-	acaA	increased lateral pseudopodium formation \| decreased chemotaxis rate \| aberrant actin filament organization \| aberrant cell morphology \| increased protein kinase activation
DBS0235429	acaA-	acaA	decreased gene expression \| abolished oscillatory cAMP signaling
DBS0350720	acaA-/ [acaA-agg]: acaA: myc	acaA	decreased gene expression \| decreased fruiting body size
DBS0350721	acaA-/ [acaA-psp]: acaA: myc	acaA	decreased gene expression \| decreased mound size \| decreased fruiting body size
DBS0350722	acaA-/ [acaA-pst]: acaA: myc	acaA	wild type
DBS0350702	acaA-/ [act15]: HA: pkaC	acaA \| pkaC	wild type \| delayed development \| decreased cAMP level
DBS0350725	acaA-/ [act15]: HA: pkaC/ acrA-	acaA \| acrA \| pkaC	decreased gene expression \| abolished adenylate cyclase activity \| development arrests at tipped mound stage
DBS0350737	acaA-/ [act15]: acaA	acaA	aberrant slug development
DBS0350738	acaA-/ [act15]: acaA(1-390;398-1407)	acaA	abolished aggregation
DBS0350739	acaA-/ [act15]: acaA(L394T/ K482N)	acaA	wild type
DBS0350603	acaA-/ [act15]: cap: GFP	acaA \| cap	development arrests at loose mound stage \| increased calcium-dependent cell-cell adhesion \| wild type
DBS0350735	acaA-/ [act15]: pkaR(G135E/ G261A)	acaA \| pkaR	increased cAMP level
DBS0350736	acaA-/ [unk]: acaA(F306L/ S498G,K504E,E593V,I649T)	acaA	decreased gene expression \| abolished oscillatory cAMP signaling \| decreased cAMP level
DBS0350734	acaA-/ [unk]: acaA(N333D,G633S)	acaA	abolished adenylate cyclase activity
DBS0350733	acaA-/ [unk]: acaA(V427I,S642F)	acaA	abolished activation of adenylate cyclase activity
DBS0350711	acaA-/ [unk]: acgA	acaA \| acgA	aberrant sorocarp development
DBS0306125	acapA-	acapA	wild type
DBS0350051	acapA-	acapA	aberrant exocytosis \| aberrant filopodium formation \| increased defense response to Gram-negative bacterium \| aberrant endocytosis \| aberrant cytokinesis \| aberrant stream morphology \| decreased cell motility \| delayed development \| aberrant lysosome organization
DBS0350055	acapA-/ [act15]: acapA(R633Q): GFP	acapA	aberrant filopodium formation \| aberrant lysosome organization
DBS0350054	acapA-/ [act15]: acapA: GFP	acapA	increased filopodium formation
DBS0306126	acapA-/ acapB-	acapA \| acapB	decreased sporulation
DBS0306127	acapB-	acapB	wild type
TL177	acbA-	acbA	decreased response to Gram-negative bacterium \| abolished cell migration to prestalk region \| abolished spore cell differentiation \| decreased sporulation \| decreased resistance to cisplatin
DBS0350194	acbA-/ [act15]: acbA(Y72A)	acbA	abolished spore cell differentiation
AK1211	acbA-/ tagA-	acbA \| tagA	increased prestalk B cell differentiation
DBS0235440	acgA-	acgA	abolished polyketide metabolic process \| decreased spore germination \| decreased spore cell differentiation \| precocious spore germination \| abolished response to biotic stimulus
DBS0237788	acgA-	acgA	decreased prespore cell differentiation \| decreased prespore gene expression
DBS0237790	acgA-/ [acrA]: lacZ	acgA \| acrA	aberrant prestalk gene expression
DG1100	acrA-	acrA	decreased gene expression \| increased stalk length \| decreased prespore gene expression \| decreased sporulation
DBS0349939	acrA-	acrA	aberrant spore coat morphology \| decreased stalk width
DBS0350723	acrA-/ [act15]: acaA(L394S)	acaA \| acrA	precocious spore germination
DBS0237786	acrA-/ [act15]: acgA(1-401)	acgA \| acrA	decreased prespore gene expression \| decreased prespore cell differentiation \| decreased sporulation
DBS0349970	acrA-/ [act15]: acrA(D1010A)	acrA	decreased adenylate cyclase activity
DBS0349971	acrA-/ [act15]: acrA(D1174A)	acrA	increased adenylate cyclase activity
DBS0349969	acrA-/ [act15]: acrA(N796D/ D854A/ G856A)	acrA	wild type
DBS0350724	acrA-/ [pkaC]: pkaC	acrA \| pkaC	decreased spore germination \| decreased fruiting body size \| precocious development \| decreased sporulation
DBS0351249	act5-/ [act5]: RFP/ NC4	act5	increased chemotaxis to folate \| increased fruiting body size \| increased growth rate
DBS0350443	adcB-	adcB	wild type
DBS0350444	adcC-	adcC	wild type
DBS0351190	adcC-/ [act15]: adcC(1-485)	adcC	decreased protein localization to plasma membrane
DBS0351189	adcC-/ [act15]: adcC(101-654): GFP	adcC	abolished protein localization to plasma membrane
DBS0350445	adcC-/ adcB-	adcB \| adcC	increased oscillatory cAMP signaling \| aberrant endocytosis \| delayed aggregation \| aberrant regulation of protein kinase activity
DBS0350538	adprt1A-	adprt1A	decreased resistance to phleomycin \| decreased double-strand break repair via nonhomologous end joining
DBS0351248	adprt1A-	adprt1A	decreased gene expression \| increased gene expression \| decreased ATP level \| delayed mitotic cell cycle \| decreased growth rate \| delayed aggregation \| increased prestalk gene expression \| decreased mound size \| aberrant response to oxidative stress \| decreased fruiting body size \| increased mitochondrial fission \| decreased cAMP level \| abolished chemotaxis to cAMP
DBS0350541	adprt1A-/ adprt2-	adprt1A \| adprt2	decreased resistance to phleomycin \| decreased double-strand break repair via nonhomologous end joining \| decreased resistance to cisplatin
DBS0264268	adprt1B-	adprt1B	wild type \| decreased single-strand break repair \| aberrant oscillatory cAMP signaling
DBS0350539	adprt2-	adprt2	decreased single-strand break repair \| decreased double-strand break repair \| decreased resistance to cisplatin
DBS0238203	adrm1-	adrm1-1	decreased catalytic activity \| precocious gene expression \| aberrant response to nutrient \| precocious development
DBS0351596	agnA-	agnA	increased pre-miRNA processing \| aberrant production of siRNA involved in RNA interference \| increased gene expression \| abolished transitive RNA interference
DBS0351603	agnA-/ agnB-	agnA \| agnB	aberrant production of siRNA involved in RNA interference \| increased gene expression
DBS0351602	agnB-	agnB	decreased gene expression
HW420	agtA-	agtA	development arrests at slug stage
HW520	agtA-/ gnt1(1-253/ H104D)	agtA \| gnt1	development arrests at slug stage
DBS0235457	ahhA-	ahhA	aberrant late culminant morphology
DBS0252637	aip1-	aip1	decreased pinocytosis \| delayed cytokinesis \| decreased growth rate \| decreased phagocytosis \| increased actin filament polymerization \| aberrant nucleus morphology \| decreased cell motility
DBS0266759	alp-	alp	wild type
DBS0235513	alrA-	alrA	increased mound size \| decreased cell motility \| decreased glucose level \| decreased protein secretion
DBS0235473	alrA-/ [act15]: alrA	alrA	wild type
DBS0235474	alxA-	alxA	development arrests at loose mound stage \| aberrant standing slug morphology \| decreased growth rate
DBS0235475	alxA-	alxA	abolished sporulation \| aberrant standing slug morphology \| aberrant cellular process \| decreased gene expression \| development arrests at mound stage
DBS0235488	alxA-/ [act15]: FLAG: alxA	alxA	delayed development
DBS0235476	alxA-/ [act15]: alxA(1-596): myc2	alxA	aberrant standing slug morphology
DBS0235477	alxA-/ [act15]: alxA(1-697): myc2	alxA	wild type
DBS0235478	alxA-/ [act15]: alxA(155-697): myc2	alxA	aberrant standing slug morphology
DBS0235479	alxA-/ [act15]: alxA(293-697): myc2	alxA	aberrant standing slug morphology
DBS0235480	alxA-/ [act15]: alxA(460-794): myc2	alxA	aberrant standing slug morphology
DBS0235481	alxA-/ [act15]: alxA(D310A/ N311A)	alxA	wild type
DBS0235482	alxA-/ [act15]: alxA(Q181E/ Q183)	alxA	wild type
DBS0235483	alxA-/ [act15]: alxA(S700A/ S704A/ S708A)	alxA	wild type
DBS0235484	alxA-/ [act15]: alxA(S700D/ S704D/ S708D)	alxA	wild type
DBS0235485	alxA-/ [act15]: alxA(Y315D)	alxA	wild type
DBS0235486	alxA-/ [act15]: alxA(Y315F)	alxA	wild type
DBS0235487	alxA-/ [act15]: alxA: myc2	alxA	wild type
DBS0235489	alyA-	alyA	increased phagocytosis
AK1350	alyL-	alyL	decreased response to Gram-negative bacterium
DG1114	amdA-	amdA	decreased spore germination \| aberrant sorus color \| increased prestalk A cell differentiation
HM1158	amdA-	amdA	decreased fruiting body size \| decreased sporulation \| increased cell differentiation
DBS0235490	amiB-	amiB	abolished aggregation
DBS0235491	amiB-	amiB	aberrant cell motility \| increased gene expression \| decreased gene expression \| decreased oscillatory cAMP signaling \| decreased cGMP-mediated signaling \| abolished aggregation \| decreased chemotaxis to cAMP
DBS0235493	ampA-	ampA	delayed development of tipped mound \| delayed prestalk gene expression \| precocious prespore gene expression \| increased cell-cell adhesion \| increased cell-substrate adhesion \| aberrant gene expression \| delayed development \| decreased prestalk cell differentiation
DBS0349962	ampA-	ampA	wild type \| decreased actin filament polymerization \| aberrant chemotaxis to folate \| increased cell-substrate adhesion \| decreased pseudopodium formation
DBS0349951	ampA-/ lmbd2B-	ampA \| lmbd2B	aberrant chemotaxis
DBS0235496	ampA-/ pspD: lacZ	ampA	aberrant prespore gene expression
DBS0349963	ampA-/ sma-	ampA \| sma	increased chemotaxis to folate \| increased cell-substrate adhesion
DBS0349953	ampA/ [ampA]: TAP	ampA	increased protein secretion \| development arrests at mound stage
DBS0235495	ampA/ [ampA]: ampA	ampA	decreased cell-substrate adhesion \| increased pinocytosis \| increased actin filament polymerization \| aberrant chemotaxis to folate \| increased pseudopodium formation
DBS0349952	ampA/ [ampA]: ampA/ lmbd2B-	ampA \| lmbd2B	aberrant chemotaxis
BS155	amtA-	amtA	decreased slug migration \| decreased mound size \| decreased fruiting body size \| increased growth rate \| decreased ammonia level
DBS0267100	amtA-	amtA	increased number of mounds \| increased glucose level \| decreased mound size \| decreased ammonia level \| decreased stalk length \| aberrant sporulation \| increased intracellular ammonia level
DBS0267101	amtA-/ [OE]: amtA	amtA	wild type
BS165	amtA-/ amtC-	amtA \| amtC	decreased protein localization to nucleus \| aberrant slug migration \| decreased ammonia level \| delayed gene expression
	amtB-	amtB
BS169	amtB-/ amtA-	amtA \| amtB	decreased ammonia level
BS168	amtB-/ amtC-	amtB \| amtC	decreased ammonia level
BS154	amtC-	amtC	abolished protein localization to nucleus \| development arrests at slug stage \| aberrant gene expression \| decreased prestalk gene expression \| aberrant fruiting body morphogenesis \| decreased ammonia level \| delayed culmination
DBS0235501	amtC-/ [act15]: cudA	amtC \| cudA	delayed culmination
DBS0235502	amtC-/ [ecmA]: cudA	amtC \| cudA	delayed culmination
DBS0235503	amtC-/ [pspA]: cudA	amtC \| cudA	development arrests at slug stage
BS163	amtC-/ dhkC-	amtC \| dhkC	aberrant gene expression
DBS0236890	amtC-/ regA-	amtC \| regA	precocious sporulation
DBS0350432	aoxA-	aoxA	decreased resistance to hydrogen peroxide \| aberrant cellular process \| aberrant sorocarp development
DBS0349869	ap1b1-	ap1b1	aberrant aggregation \| aberrant cell separation during cytokinesis \| aberrant contractile vacuole organization \| decreased growth rate \| aberrant hypotonic response \| decreased protein stabilization
DBS0305197	ap2a1-	ap2a1-1 \| ap2a1-2	aberrant cell separation during cytokinesis
DBS0350296	aph1-	aph1	aberrant culmination \| abolished catalytic activity \| decreased prespore cell differentiation
DBS0351357	aph1-	aph1	increased protein modification \| decreased phagocytosis \| decreased macropinocytosis \| aberrant sorocarp development \| decreased protein processing in phagocytic vesicle \| delayed phagosome acidification
DBS0350299	aph1-/ ncstn-	aph1 \| ncstn	decreased phagocytosis \| decreased prespore cell differentiation
DBS0350300	aph1-/ psenA-	aph1 \| psenA	aberrant culmination \| abolished catalytic activity \| decreased prespore cell differentiation
DBS0350805	apl-	apl	aberrant response to cisplatin
DBS0351160	aplD-	aplD	decreased defense response to Gram-negative bacterium \| decreased growth rate
DBS0351161	aplP-	aplD	decreased growth rate
DBS0235505	apm1-	apm1	decreased spore germination \| aberrant contractile vacuole organization \| decreased growth rate \| aberrant endosome morphology \| aberrant hypotonic response \| delayed development \| decreased stalk width
DBS0235506	apm2-	apm2	aberrant cell separation during cytokinesis
DBS0305085	apm2-/ [dscB]: GFP: vamp7A	apm2 \| vamp7A	increased protein localization to plasma membrane
DBS0235507	apm3-	apm3	decreased pinocytosis \| increased exocytosis \| aberrant endosome morphology \| decreased cellular localization \| aberrant secretion \| aberrant lysosome organization
DBS0305083	apm3-/ [dscB]: GFP: vamp7A	apm3 \| vamp7A	increased protein localization to plasma membrane
DBS0235508	apm4-	apm4	wild type
DBS0235509	aprA-	aprA	aberrant cellular homeostasis \| increased mound size \| decreased spore germination \| increased cell death \| aberrant cytokinesis \| aberrant vegetative growth \| aberrant fruiting body morphogenesis \| increased growth rate \| abolished chemorepellant activity \| decreased sporulation
DBS0235510	aprA-/ [act15]: aprA	aprA	decreased growth rate \| aberrant fruiting body morphogenesis
DBS0350009	aprA-/ [act15]: bzpN: GFP	aprA \| bzpN	abolished negative regulation of vegetative growth
DBS0238124	aqpA-	aqpA	decreased spore germination \| decreased sporulation
DBS0351484	aqpB-	aqpB	decreased cell motility
DBS0351067	araA-	araA	delayed aggregation \| increased cell-substrate adhesion \| decreased cell motility \| increased protein kinase activation
HM2245	arcB(I191L/ D197Y/ K206V/ A213V/ F223L/ P224S/ E232G/ I237T/ H245L/ S250S)	arcB	decreased actin filament polymerization \| decreased growth rate \| decreased cell motility \| decreased chemotaxis rate \| decreased pseudopodium formation
DBS0350886	areA-	areA	increased autophagy
DBS0350887	areB-	areB	increased autophagy
DBS0235511	arkA-	arkA	increased gene expression \| aberrant fruiting body morphogenesis
DBS0235512	arkA-/ [arkA]: arkA: myc2	arkA	aberrant aggregation
DBS0350000	arpB+/ aprB-/ [act15]: myc: arpB(T235A/ T236A)	arpB	wild type
DBS0349998	arpB+/ aprB-/ [act15]: myc: arpB(Y200F/ T235A/ T236A)	arpB	decreased actin filament polymerization \| delayed aggregation \| decreased fruiting body size \| decreased establishment of cell polarity \| decreased chemotaxis to cAMP \| delayed gene expression
DJK45	arpB+/ arpB-	arpB	wild type
DMZ10	arpB+/ arpB-/ [act15]: myc: arpB	arpB	wild type
MZ10	arpB-/ [act15]: myc: arpB	arpB	wild type
DBS0350191	arpin-	arpin	increased cell motility
DBS0350206	arpin-/ [act15]: GFP: arpin	arpin	wild type
DBS0350654	ase1A-	ase1A	aberrant mitotic spindle organization \| aberrant cytokinesis \| aberrant microtubule cytoskeleton organization
DBS0350655	ase1B-	ase1B	aberrant cell morphology
DBS0235514	aslA-	aslA-1 \| aslA-2	wild type
DBS0351219	ate1-	ate1	aberrant cell motility \| decreased cell-substrate adhesion \| decreased vegetative cell size \| aberrant actin filament organization
DBS0236305	atg1-	atg1	aberrant macroautophagy \| abolished autophagosome organization
DBS0236304	atg1-	atg1	aberrant macroautophagy \| aberrant mitochondrion morphology \| abolished autophagosome organization
DBS0350450	atg1-	atg1	aberrant autophagy \| decreased defense response to Gram-negative bacterium \| aberrant defense response to bacterium \| aberrant vacuole organization
DBS0350839	atg1-	atg1	decreased catalytic activity \| abolished protein localization to autophagosome
HR131	atg1-	atg1	abolished macroautophagy \| increased number of autophagosomes \| aberrant autophagy \| decreased defense response to Gram-negative bacterium \| aberrant cellular response to nitrogen starvation \| decreased growth rate \| abolished spore cell differentiation \| aberrant vacuole organization \| abolished stalk cell differentiation \| abolished aggregation \| increased defense response to fungus \| decreased defense response to Gram-positive bacterium \| aberrant protein localization
DBS0238085	atg1-/ [act15]: atg1	atg1	wild type
DBS0238092	atg1-/ [act15]: atg1(1-628)	atg1	aberrant cellular response to nitrogen starvation \| abolished aggregation
DBS0238087	atg1-/ [act15]: atg1(K36A)	atg1	aberrant cellular response to nitrogen starvation \| abolished aggregation
DBS0238089	atg1-/ [act15]: atg1(K36A/ 1-628)	atg1	aberrant cellular response to nitrogen starvation \| abolished aggregation
DBS0238093	atg1-/ [act15]: atg1(P138S)	atg1	abolished aggregation
DBS0266655	atg1-/ iplA-	atg1 \| iplA	decreased necrotic cell death
DBS0252632	atg1-/ pcp-	atg1 \| pcp	abolished autophagosome organization
DBS0351613	atg1-/ tsg101-	atg1 \| tsg101	decreased defense response to Gram-positive bacterium
DBS0350838	atg1-/ vmp1-	atg1 \| vmp1	wild type \| abolished protein localization to autophagosome
DBS0350884	atg101-	atg101	increased number of tip-organizers \| decreased autophagy
DBS0351232	atg12-	atg12	decreased pinocytosis \| increased cell death \| decreased spore germination \| decreased catalytic activity \| increased gene expression \| increased number of mound tips \| increased protein modification \| decreased phagocytosis \| aberrant phagosome maturation \| aberrant fruiting body morphogenesis
DBS0351233	atg12-/ tipD-	atg12 \| tipD	decreased pinocytosis \| increased cell death \| decreased spore germination \| increased gene expression \| increased number of mound tips \| increased protein modification \| decreased phagocytosis \| aberrant phagosome maturation \| aberrant fruiting body morphogenesis
DBS0350883	atg13-	atg13	aberrant autophagy \| abolished aggregation
DBS0350885	atg17-	atg17	wild type
HR75	atg5-	atg5	increased number of tip-organizers \| aberrant macroautophagy \| abolished sporulation \| aberrant cellular response to nitrogen starvation \| abolished aggregation \| aberrant protein localization
DBS0351478	atg5-	atg5	abolished sporulation \| decreased gene expression \| delayed development
DBS0351582	atg5-	atg5	increased cell death \| decreased catalytic activity \| decreased growth rate \| aberrant phagocytosis \| increased protein modification \| decreased macropinocytosis \| aberrant fruiting body morphogenesis \| increased growth rate
DBS0351576	atg5-/ abpB-/ [dscB]: abpB(D93A/ D95A/ D97A): GFP	abpB \| atg5	aberrant cellular component organization \| abolished vegetative growth
DBS0351583	atg5-/ atg12-	atg12 \| atg5	increased cell death \| decreased catalytic activity \| decreased growth rate \| decreased phagocytosis \| increased protein modification \| decreased macropinocytosis \| aberrant fruiting body morphogenesis
DBS0351584	atg5-/ atg12-/ tipD-	atg12 \| atg5 \| tipD	increased cell death \| decreased catalytic activity \| decreased growth rate \| aberrant phagocytosis \| increased protein modification \| decreased macropinocytosis \| aberrant fruiting body morphogenesis \| increased growth rate
HR174	atg6-	atg6A	increased number of tip-organizers \| aberrant macroautophagy \| decreased defense response to Gram-negative bacterium \| aberrant cellular response to nitrogen starvation \| decreased spore cell differentiation \| decreased defense response to fungus \| decreased fruiting body size \| decreased stalk length \| decreased sporulation
HR79	atg7-	atg7	increased number of tip-organizers \| aberrant macroautophagy \| abolished sporulation \| decreased defense response to Gram-negative bacterium \| aberrant cellular response to nitrogen starvation \| abolished spore cell differentiation \| aberrant protein localization
DBS0351476	atg7-	atg7	aberrant sorus morphology \| decreased spore germination \| decreased gene expression \| decreased prespore cell differentiation \| delayed development
DBS0351477	atg7-/ [act15]: YFP: atg7(C563A)	atg7	aberrant sorus morphology \| decreased spore germination \| delayed development
DBS0351479	atg7-/ [act15]: pkaC: YFP	atg7 \| pkaC	decreased gene expression \| decreased sporulation
HR141	atg8-	atg8a	increased number of tip-organizers \| aberrant macroautophagy \| aberrant spore morphology \| aberrant cellular response to nitrogen starvation \| decreased spore cell differentiation \| aberrant vacuole organization \| decreased fruiting body size \| decreased defense response to Gram-positive bacterium \| decreased sporulation
DBS0351222	atg8a-	atg8a	increased cell death \| decreased catalytic activity \| increased number of mound tips \| decreased growth rate \| decreased phagocytosis \| increased protein modification \| delayed development \| decreased fruiting body size \| aberrant lysosome organization
DBS0351224	atg8a-/ atg8b-	atg8a \| atg8b	increased cell death \| decreased catalytic activity \| decreased growth rate \| decreased phagocytosis \| increased protein modification \| aberrant sorocarp development \| aberrant lysosome organization
DBS0351223	atg8b-	atg8b	precocious development \| aberrant lysosome organization
DBS0305977	atg9-	atg9	increased stalk width \| decreased pinocytosis \| abolished sporulation \| aberrant sorus morphology \| aberrant autophagy \| decreased protein localization to autophagosome \| increased number of mound tips \| decreased gene expression \| decreased phagocytosis \| decreased growth rate \| abolished catalytic activity \| aberrant slug development \| aberrant slug migration \| aberrant protein modification \| aberrant phagosome maturation \| decreased prespore cell differentiation \| aberrant fruiting body morphogenesis \| delayed development \| abolished phototaxis
DBS0305978	atg9-/ [act15]: GFP: atg9	atg9	wild type
DBS0305979	atg9-/ [act15]: atg9: GFP	atg9	wild type
DBS0350535	atg9-/ [act15]: cdcD(R154C): RFP	atg9 \| cdcD	decreased growth rate \| decreased phototaxis
DBS0351589	atg9-/ [act15]: cdcD(R154C/ E219K): RFP	atg9 \| cdcD	wild type
DBS0350534	atg9-/ [act15]: cdcD: RFP	atg9 \| cdcD	decreased growth rate \| aberrant fruiting body morphogenesis \| abolished phototaxis
DBS0351480	atg9-/ [act15]: pkaC: YFP	atg9 \| pkaC	abolished sporulation
DBS0350731	atg9-/ tipD-	atg9 \| tipD	decreased pinocytosis \| aberrant phagosome maturation \| development arrests at tipped mound stage
DBS0351043	atp1-	atp1	decreased defense response to Gram-negative bacterium \| decreased gene expression \| decreased growth rate \| aberrant phototaxis
DBS0351044	atp6-	atp6	decreased defense response to Gram-negative bacterium \| decreased gene expression \| decreased growth rate \| aberrant phototaxis
HM1591	axeB-	axeB	aberrant macropinocytosis \| increased macropinocytosis \| increased phagocytosis
DBS0351503	bcas3-	bcas3	decreased number of autophagosomes \| aberrant fruiting body morphogenesis \| aberrant phototaxis \| decreased sporulation
DBS0351039	bzpF-	bzpF	decreased spore germination \| decreased gene expression \| aberrant fruiting body morphogenesis \| aberrant sporulation \| decreased sporulation
DBS0349965	bzpN-	bzpN	aberrant cytokinesis \| abolished negative regulation of vegetative growth \| increased growth rate
DBS0349966	bzpN-/ [act15]: bzpN: GFP	bzpN	wild type
DBS0350419	bzpR-	bzpR	increased stalk width \| aberrant sorus morphology \| decreased sporulation
DBS0351486	c2gapB-	c2gapB	increased cell motility \| increased activation of GTPase activity
DBS0351619	cadA-	cadA	aberrant vegetative growth
TL97	cadA-	cadA	increased number of tip-organizers \| decreased calcium-dependent cell-cell adhesion \| decreased protein level \| increased gene expression \| abolished cell migration to prestalk region \| increased chemotaxis to cAMP \| aberrant cytokinesis \| decreased sporulation \| delayed culmination \| increased prestalk cell differentiation
DBS0351372	cadA-	cadA	aberrant defense response to bacterium \| decreased growth rate \| aberrant response to oxidative stress
DBS0235561	cap-	cap	decreased protein level \| aberrant pinocytosis \| aberrant contractile vacuole organization \| aberrant cytokinesis \| decreased cell motility \| delayed development \| aberrant response to osmotic stress
JB4	carA-	carA-1 \| carA-2	abolished aggregation
JS14	carA-	carA-1 \| carA-2	abolished protein tyrosine phosphorylation \| abolished protein localization to nucleus \| aberrant phagocytosis \| increased cell-substrate adhesion \| decreased oscillatory cAMP signaling \| decreased cGMP-mediated signaling \| aberrant regulation of GTPase activity \| abolished aggregation \| aberrant regulation of protein kinase activity \| abolished chemotaxis to cAMP
DBS0351266	carA-/ [act15]: gpbA: YFP	carA-1 \| carA-2 \| gpbA	abolished aggregation
DBS0350431	carA-/ [unk]: carA(261-359;S299A,S302G,S303G,S304G,S308A,S324G,S325A,S331A)(369-392;S383A,S385A): eYFP	carA-1 \| carA-2	aberrant adaptation of signaling pathway \| aberrant protein localization to plasma membrane
RI9	carA-/ carC-	carA-1 \| carA-2 \| carC	decreased gene expression \| abolished protein localization to plasma membrane
RI4	carA-/ carC-	carA-1 \| carA-2 \| carC	decreased actin filament polymerization \| abolished activation of GTPase activity \| abolished aggregation \| abolished cGMP-mediated signaling \| abolished chemotaxis to cAMP
DBS0350568	carA-/ carC-/ [act15]: carA(261-359;S299A,S302G,S303G,S304G,S308A,S324G,S325A,S331A)(369-392;S383A,S385A)	carA-1 \| carA-2 \| carC	abolished stream development \| aberrant activation of adenylate cyclase activity \| aberrant chemotaxis to cAMP \| aberrant oscillatory cAMP signaling \| aberrant actin filament polymerization
DBS0235570	carB-	carB	development arrests at mound stage
DBS0350661	carB-	carB	development arrests at mound stage \| abolished development of tipped mound \| increased prespore gene expression \| decreased prestalk gene expression
JB6	carC-	carC	wild type
DBS0235568	carD-	carD	decreased migratory slug size \| decreased slug migration \| increased prespore gene expression \| decreased prestalk gene expression \| aberrant slug migration \| aberrant fruiting body morphogenesis \| decreased stalk length \| decreased prestalk cell differentiation
DBS0235573	carmil-	carmil	decreased pinocytosis \| decreased actin filament polymerization \| decreased growth rate \| decreased mound size
DBS0266775	catA-	catA	abolished catalase activity
X9	catA-	catA	decreased resistance to hydrogen peroxide \| abolished catalase activity
IR40	catA-	catA	abolished catalase activity
IR41	catA-	catA	abolished catalase activity
IR29	catA-	catA	decreased resistance to hydrogen peroxide
DBS0235574	catB-	catB	decreased spore resistance to hydrogen peroxide \| aberrant gene expression \| delayed development \| delayed gene expression
DBS0350249	cbhA-	cbhA	delayed development
DBS0350250	cbhA-/ [cbhA]: cbhA	cbhA	wild type
DBS0304455	cblA-	cblA-1 \| cblA-2	aberrant slug development \| abolished basal disc formation \| aberrant signal transduction
DBS0351096	cbpG-	cbpG	decreased cell-substrate adhesion \| decreased vegetative cell size
DBS0235575	cbpJ-	cbpJ	wild type
DBS0350238	ccdc53-	ccdc53	abolished exocytosis \| decreased growth rate \| abolished phagosome reneutralization \| abolished actin filament polymerization
DBS0235661	cdk8-	cdk8	decreased gene expression \| aberrant gene expression \| abolished aggregation
DBS0350435	cdk8-	cdk8	decreased spore germination \| decreased gene expression \| aberrant gene expression \| abolished aggregation
DBS0350436	cdk8-/ [act15]: myc: cdk8	cdk8	wild type
DBS0350437	cdk8-/ [act15]: myc: cdk8(D194A)	cdk8	decreased spore germination \| abolished aggregation
DBS0235578	cdk8-/ [cdk8]: cdk8	cdk8	wild type
DBS0306226	cenB-	cenB	increased number of centrosomes \| aberrant cell separation during cytokinesis \| aberrant nuclear envelope morphology \| abolished protein localization to microtubule organizing center \| aberrant nucleus morphology \| aberrant cytokinesis \| decreased microtubule nucleation \| aberrant centrosome organization
DBS0306227	cenB-/ [act15]: RFP: cenB	cenB	wild type
DBS0349926	cepC-	cepC	aberrant mitotic spindle organization \| decreased growth rate \| aberrant Golgi localization \| abolished vegetative growth \| aberrant centrosome organization
DBS0350265	cepK-	cepK	decreased protein level \| decreased protein localization to nuclear envelope \| aberrant chemotaxis to cAMP \| decreased growth rate \| decreased mound size \| decreased vegetative cell size \| decreased fruiting body size
DBS0302444	cfaD-	cfaD	aberrant cellular homeostasis \| increased cell death \| decreased spore germination \| aberrant vegetative growth \| aberrant cytokinesis \| aberrant fruiting body morphogenesis \| increased growth rate \| decreased sporulation
DBS0350010	cfaD-/ [act15]: bzpN: GFP	bzpN \| cfaD	abolished negative regulation of vegetative growth
DBS0302446	cfaD-/ [act15]: cfaD	cfaD	wild type
HO101	chcA-	chcA	decreased pinocytosis \| delayed cell separation during cytokinesis \| aberrant cytokinesis \| decreased growth rate
HO103	chcA-	chcA	abolished sporulation \| abolished cytokinesis \| abolished gene expression \| delayed aggregation \| abolished vegetative growth \| aberrant fruiting body morphogenesis
DBS0350090	chcA-/ [act15]: GFP: ap2a1	ap2a1-1 \| ap2a1-2 \| chcA	increased protein localization
DBS0235588	chcA-/ [act15]: GFP: mhcA	chcA \| mhcA	decreased positive regulation of GTPase activity
DBS0302455	chcA-/ [act15]: epnA: GFP	chcA \| epnA	aberrant protein localization to clathrin-coated pit
DBS0350091	chcA-/ [act15]: gppA: GFP	chcA \| gppA	aberrant protein localization to plasma membrane
DBS0235589	chcA-/ [cotB]: lacZ	chcA	aberrant prestalk gene expression \| aberrant prespore gene expression
DBS0235590	chcA-/ [ecmA]: lacZ	chcA	aberrant prestalk gene expression \| aberrant prespore gene expression
DBS0235591	chcA-/ [ecmB]: lacZ	chcA	aberrant prestalk gene expression \| aberrant prespore gene expression
DBS0235592	chcA-/ [pspA]: lacZ	chcA	aberrant prestalk gene expression \| aberrant prespore gene expression
DBS0350524	chdA-	chdA	aberrant culmination \| aberrant gene expression \| decreased chemotaxis to cAMP
DBS0350525	chdB-	chdB	aberrant gene expression \| delayed development
DBS0350526	chdC-	chdC	decreased growth rate \| development arrests at mound stage \| aberrant gene expression \| aberrant chromatin assembly \| decreased chemotaxis to cAMP
DBS0350528	chdC-/ [ecmA]: lacZ	chdC	decreased prestalk cell differentiation
DBS0350527	chdC-/ [pspA]: lacZ	chdC	decreased prespore cell differentiation
HM1522	chlA-	chlA	abolished DIF-1 biosynthesis \| aberrant slug development \| aberrant fruiting body morphogenesis
LAS1	chtB-	chtB	decreased socially cooperative development \| increased growth rate
CCR2	chtC-	chtC	decreased socially cooperative development \| decreased prestalk A cell differentiation
LAS5	chtC-REMI	chtC	decreased socially cooperative development
DBS0305614	chtC-ins	chtC	decreased socially cooperative development \| decreased prestalk A cell differentiation
DBS0235601	clc-	clc	abolished cytokinesis \| decreased protein localization to plasma membrane \| aberrant hypotonic response \| abolished vegetative growth \| aberrant fruiting body morphogenesis
DBS0235604	clc-/ [act15]: GFP-clc(146-194)	clc	abolished cytokinesis \| wild type \| aberrant fruiting body morphogenesis
DBS0235605	clc-/ [act15]: GFP-clc(85-124)	clc	abolished cytokinesis \| wild type \| aberrant fruiting body morphogenesis
DBS0235607	clc-/ [act15]GFP: clc(1-124)	clc	abolished cytokinesis \| wild type \| aberrant fruiting body morphogenesis
DBS0350408	cldA-	cldA	decreased gene expression
AK1338	clkB-	clkB	decreased response to Gram-negative bacterium
DBS0235608	clmA-	clmA	aberrant contractile vacuole morphology \| aberrant hypotonic response
DBS0350473	cln3-	cln3	aberrant aggregation \| increased protein secretion \| aberrant cell separation during cytokinesis \| decreased hypotonic response \| aberrant cellular process \| increased pinocytosis \| delayed aggregation \| aberrant cell adhesion \| aberrant slug migration \| aberrant hyperosmotic response \| precocious development \| increased growth rate \| decreased chemotaxis to cAMP \| decreased protein secretion
DBS0350474	cln3-/ [act15]: GFP: cln3	cln3	wild type
DBS0351175	cln5-	cln5	decreased cell-cell adhesion \| aberrant lipid storage \| decreased cell-substrate adhesion \| decreased chemotaxis to cAMP
DBS0235609	cluA-	cluA	decreased mitochondrial fusion \| decreased mitochondrial fission \| aberrant cytokinesis \| aberrant intracellular distribution of mitochondria \| aberrant mitochondrion organization
DBS0349875	cluA-/ [act15]: cluA	cluA	wild type
DBS0235612	cmfB-	cmfB	decreased gene expression \| abolished aggregation
DBS0235613	cnrB-	cnrB	wild type
DBS0350308	cnrF-	cnrF	aberrant contractile vacuole organization \| abolished hypotonic response \| decreased contractile vacuole size \| aberrant regulation of GTPase activity
DBS0350309	cnrF-/ [act15]: cnrF: RFP	cnrF	wild type
DBS0350311	cnrF-/ cnrF(E623Q/ D659Q)	cnrF	aberrant contractile vacuole organization \| abolished hypotonic response \| decreased contractile vacuole size \| aberrant regulation of GTPase activity
DBS0350310	cnrF-/ cnrF(R270A)	cnrF	aberrant contractile vacuole organization \| abolished hypotonic response \| decreased contractile vacuole size \| aberrant regulation of GTPase activity
DBS0302655	cnrN-	cnrN	increased oscillatory cAMP signaling \| increased number of mounds \| decreased spore germination \| increased actin filament polymerization \| aberrant cytokinesis \| aberrant stream morphology \| increased growth rate \| abolished positive regulation of chemorepellant activity \| decreased sporulation
DBS0302656	cnrN-/ [act15]: cnrN	cnrN	wild type
HG1770	cnxA-	cnxA	decreased calcium ion import \| aberrant calcium-mediated signaling
DBS0235615	cofB-	cofB	wild type
DBS0235616	cofC-	cofC-1	wild type
DBS0350522	comA-	comA	aberrant defense response to bacterium \| aberrant phagocytosis \| aberrant hyperosmotic response
DG1016	comB-	comB	abolished culmination
DBS0235618	comC-	comC	aberrant aggregation \| aberrant stream morphology
DBS0235619	comD-	comD	abolished culmination
DBS0235620	comE-	comE	aberrant fruiting body morphogenesis \| aberrant sorus color
DBS0235621	comF-	comF-1 \| comF-2	abolished aggregation
DBS0235622	comG-	comG	increased number of tip-organizers \| development arrests at mound stage
DBS0235623	comH-	comH	development arrests at mound stage
HG1570	corA-	corA	increased myosin II assembly \| aberrant cytokinesis \| decreased growth rate \| decreased cell motility \| aberrant cell morphology
HG1571	corA-	corA	increased myosin II assembly \| aberrant cytokinesis \| decreased growth rate \| decreased cell motility \| aberrant cell morphology
DBS0351402	corA-	corA	aberrant actin cytoskeleton organization \| aberrant cytokinesis
HG1569	corA-	corA	decreased defense response to Gram-negative bacterium \| increased myosin II assembly \| aberrant cytokinesis \| decreased growth rate \| decreased phagocytosis \| increased actin filament polymerization \| decreased cell motility \| aberrant cell morphology \| decreased defense response to Gram-positive bacterium
DBS0350370	corA-	corA	decreased defense response to Gram-negative bacterium \| decreased gene expression \| aberrant chemotaxis to cAMP \| aberrant response to cAMP \| decreased phagocytosis \| aberrant cellular response to extracellular stimulus \| decreased establishment of cell polarity \| abolished aggregation
DBS0351521	corA-/ [act15]: FLAG: corA(1-432)	corA	abolished aggregation
DBS0350345	corA-/ [act15]: GFP: mhkA	corA \| mhkA	wild type
DBS0350346	corA-/ [act15]: GFP: mhkB	corA \| mhkB	wild type
DBS0350344	corA-/ [act15]: GFP: mhkC	corA \| mhkC	decreased catalytic activity \| wild type
DBS0350343	corA-/ [act15]: GFP: pakA(797-1197)	corA \| pakA	wild type
DBS0350371	corA-/ [act15]: corA	corA	wild type
DBS0350341	corA-/ [act15]: corA(I118A/ S119A/ P121A): GFP	corA	wild type \| aberrant binding \| increased myosin II assembly
DBS0350851	corA-/ aip1-	aip1 \| corA	aberrant endocytosis \| aberrant cytokinesis \| increased actin filament polymerization \| development arrests at mound stage \| decreased growth rate \| aberrant nucleus morphology \| increased vegetative cell size \| increased protein level \| decreased chemotaxis to cAMP
DBS0351412	corA-/ mhcA-	corA \| mhcA	aberrant cytokinesis
DBS0351413	corA-/ piaA-	corA \| piaA	aberrant cytokinesis
DBS0305825	corB-	corB	increased lateral pseudopodium formation \| aberrant phagocytosis \| decreased growth rate \| increased cell-substrate adhesion
DBS0349942	cosA-	cosA	decreased cell motility \| decreased fruiting body size \| decreased chemotaxis to cAMP \| aberrant actin filament organization \| increased pseudopodium formation
TL55	cotA-	cotA	decreased spore germination \| aberrant spore coat morphology \| abolished cellulose binding
TL53	cotA-/ cotB-	cotA \| cotB	aberrant spore coat morphology
TL56	cotA-/ cotB-/ cotC-	cotA \| cotB \| cotC	decreased spore germination \| aberrant spore coat morphology \| abolished cellulose binding
TL57	cotA-/ cotB-/ cotC-	cotA \| cotB \| cotC	aberrant spore coat morphology
TL26	cotB-	cotB	decreased spore germination \| aberrant spore coat morphology \| abolished cellulose binding
TL54	cotB-/ cotC-	cotB \| cotC	aberrant spore coat morphology
TL52	cotC-	cotC	aberrant spore coat morphology
HW07	cotE(1-235)	cotE	aberrant spore coat morphology
DBS0351045	cox3-	cox3	decreased defense response to Gram-negative bacterium \| decreased gene expression \| decreased growth rate \| aberrant fruiting body morphogenesis \| aberrant phototaxis
DBS0351538	cpnA-/ AX4	cpnA	increased contractile vacuole size
DBS0238297	cpnA-/ NC4A2	cpnA	delayed hypotonic response \| increased migratory slug size \| decreased post-lysosomal vacuole size \| increased mound size \| aberrant thermotaxis \| increased contractile vacuole size \| increased exocytosis \| decreased growth rate \| aberrant cytokinesis \| aberrant stalk cell differentiation \| development arrests at slug stage \| decreased number of post-lysosomal vacuoles \| aberrant fruiting body morphogenesis \| delayed development \| abolished phototaxis
DBS0238320	cpnA-/ [act15]: GFP: cpnA	cpnA	delayed hypotonic response \| decreased culmination \| delayed development
DBS0350869	crlA-/ AX2	crlA	wild type
DBS0235627	crlA-/ KAX3	crlA	delayed development of tipped mound \| abolished polyketide metabolic process \| increased mound size \| decreased spore germination \| decreased spore cell differentiation \| decreased cell migration to prestalk region \| increased growth rate
DBS0235628	crlA-/ [crlA]: crlA	crlA	increased mound size
DBS0235629	crlB-	crlB	wild type
DBS0235630	crlC-	crlC	wild type
HG1768	crtA-	crtA	decreased calcium ion import \| aberrant calcium-mediated signaling
HG1772	crtA-/ cnxA-	cnxA \| crtA	decreased calcium ion import \| decreased growth rate \| delayed response to cAMP \| decreased phagocytosis \| aberrant calcium-mediated signaling
DBS0235633	crtf-	crtf	abolished sporulation \| decreased gene expression \| abolished aggregation
DBS0351557	cryS-	cryS	decreased pinocytosis \| decreased culmination \| decreased phagocytosis \| aberrant cytokinesis \| decreased growth rate
AX2-T10	csaA-	csaA	decreased cell-cell adhesion \| decreased culmination \| abolished protein localization to cell-cell contact zone \| delayed aggregation \| increased cell-substrate adhesion \| decreased sporulation
TL73	csaA-/ csbA-/ csbC-/ csbC-	csaA \| csbA \| csbB \| csbC	increased stalk width \| aberrant late culminant morphology
TL122	csaA-/ tgrC1-	csaA \| tgrC1	abolished calcium-independent cell-cell adhesion
TL72	csbA-/ csbB-/ csbC-	csbA \| csbB \| csbC	increased resistance to cisplatin \| aberrant cytokinesis \| aberrant late culminant morphology
WTC127	cshA-	cshA	development arrests at loose mound stage \| decreased phagocytosis \| decreased growth rate \| delayed aggregation
DBS0235634	csn5-KD	csn5	decreased growth rate
DBS0235624	ctnA-	ctnA	increased cGMP-mediated signaling \| aberrant cellular metabolic process \| increased glucose level \| decreased protein level \| increased mound size \| decreased catalytic activity \| increased guanylyl cyclase activity \| decreased actin filament polymerization \| decreased oscillatory cAMP signaling \| increased cell-cell adhesion \| increased protein level \| increased cell motility \| decreased myosin II assembly
DBS0235636	ctnB-	ctnB	increased number of mounds \| decreased gene expression \| decreased fruiting body size
DBS0304927	ctnnA-	ctnnA	wild type
DBS0304928	ctnnA-/ mhcA-	ctnnA \| mhcA	aberrant cytokinesis
DG1071	ctr9-	ctr9	aberrant fruiting body morphogenesis
DG1058	ctrA-	ctrA	decreased fruiting body size
DBS0350915	ctsD-	ctsD	aberrant protein modification
DBS0235598	ctxA-	ctxA	aberrant cytokinesis \| decreased cell motility \| aberrant cell morphology
HS1151	ctxA-	ctxA	aberrant cytokinesis \| decreased growth rate \| aberrant stream morphology \| aberrant cellular response to stress
DBS0237568	ctxA-/ [RNAi]enlA	ctxA \| enlA	wild type
DBS0349922	ctxA-/ [act15]: GFP-mhcA	ctxA	aberrant protein localization to basolateral plasma membrane \| aberrant stalk morphogenesis \| aberrant development of tipped mound
DBS0237536	ctxA-/ [act15]: enlA(92-497)	ctxA \| enlA	wild type
DBS0235599	ctxA-/ ctxB-	ctxA \| ctxB	abolished stream development \| aberrant cellular response to fluid shear stress \| abolished adenylate cyclase activity \| increased lateral pseudopodium formation \| aberrant cytokinesis \| development arrests at mound stage \| aberrant chemotaxis to cAMP \| decreased cell motility \| aberrant regulation of GTPase activity \| aberrant cell morphology \| abolished aggregation \| aberrant regulation of protein kinase activity \| increased bleb assembly
DBS0350293	ctxA-/ ctxB-/ [act15]: GFP: arcA	arcA \| ctxA \| ctxB	aberrant protein localization to cell cortex
DBS0349972	ctxA-/ ctxB-/ [act15]: acaA: YFP	acaA \| ctxA \| ctxB	aberrant fruiting body morphogenesis
DBS0349973	ctxA-/ ctxB-/ [act15]: carA: YFP	carA-1 \| carA-2 \| ctxA \| ctxB	abolished stream development \| abolished adenylate cyclase activity \| development arrests at tight mound stage
DBS0235600	ctxB-	ctxB	aberrant cytokinesis \| aberrant stream morphology \| aberrant cell morphology
DBS0350404	ctxC-	ctxC	increased pinocytosis \| decreased oscillatory cAMP signaling \| aberrant stream morphology \| decreased chemotaxis to cAMP \| increased growth rate \| increased phagocytosis
DBS0235639	cudA-	cudA	abolished sporulation \| decreased gene expression \| development arrests at slug stage \| decreased prespore gene expression \| abolished stalk cell differentiation
DBS0238017	cudA-	cudA	abolished gene expression
DBS0235640	culA-	culA	increased number of tip-organizers \| development arrests at tipped mound stage
DBS0235641	culA-/ [cotC]: culA	culA	increased sorus size \| decreased stalk length \| decreased sporulation
DBS0235642	culA-/ [ecmA]: culA	culA	increased sorus size \| decreased stalk length
DBS0235643	culA-/ [pkaC]pkaC	culA \| pkaC	wild type
DBS0266745	culB-	culB	increased number of mound tips \| precocious prestalk gene expression \| aberrant slug development \| decreased fruiting body size \| decreased sporulation
DBS0266761	culB-/ [act15]: pkaC	culB \| pkaC	abolished sporulation \| precocious prestalk gene expression \| abolished aggregation \| abolished prespore gene expression
DBS0266760	culB-/ pkaR-	culB \| pkaR	abolished sporulation \| precocious prestalk gene expression \| abolished aggregation \| abolished prespore gene expression
DBS0235651	cybA-	cybA	abolished sporulation \| aberrant sorocarp development
DBS0350641	cynA-	cynA	aberrant cell motility \| decreased actin filament polymerization \| aberrant chemotaxis to cAMP \| delayed aggregation \| aberrant cell morphology
DBS0351047	cytB-	cytB	decreased defense response to Gram-negative bacterium \| decreased gene expression \| development arrests at mound stage \| decreased growth rate \| aberrant phototaxis
AK108	dagA-	dagA	abolished gene expression \| decreased gene expression \| abolished activation of adenylate cyclase activity \| abolished aggregation \| decreased chemotaxis to cAMP
BW4	dagA-	dagA	abolished positive regulation of chemorepellant activity
DBS0235652	dagA-/ [act15]: dagA	dagA	wild type
DBS0235560	dagA-/ acaA(L394S)	acaA \| dagA	wild type
DBS0235653	darA-	darA	decreased mound size \| abolished aggregation
DBS0350531	dclre1-	dclre1	decreased resistance to bleomycin \| decreased double-strand break repair via nonhomologous end joining \| aberrant double-strand break repair via homologous recombination
DBS0236307	dcsA-	dcsA	abolished cellulose biosynthesis
DG1099	dcsA-	dcsA	abolished stalk development \| abolished sporulation \| aberrant spore coat morphology \| abolished cellulose biosynthesis \| abolished stalk cell differentiation
DG1128	dcsA-	dcsA	abolished stalk development \| abolished sporulation \| aberrant spore coat morphology \| abolished cellulose biosynthesis
TL127	dcsA-	dcsA	abolished stalk development \| abolished sporulation \| aberrant spore coat morphology \| abolished cellulose biosynthesis \| abolished stalk cell differentiation \| aberrant stalk development
TL128	dcsA-/ [act15]: dcsA	dcsA	wild type
DBS0351195	dct-	dct	aberrant chemotaxis to cAMP \| increased activation of GTPase activity
DBS0349967	dcx-/ lis1(D327H)	dcx \| lis1	abolished aggregation
DBS0349804	detA-	detA	increased mound size \| decreased growth rate \| delayed development
DBS0349807	detA-/ [act6]: GFP: detA	detA	wild type
DBS0349816	detA-/ [act6]: GFP: detA/ [act6]: 3xHA: culD	culD \| detA	increased gene expression
DBS0349817	detA-/ [act6]: GFP: detA/ [act6]: 3xHA: repE	detA \| repE	increased gene expression
DBS0349813	detA-/ [cotB]: GFP	detA	decreased prespore cell differentiation
DBS0349811	detA-/ [ecm0]: lacZ	detA	aberrant prestalk O cell differentiation
DBS0349812	detA-/ [ecmA0]: GFP	detA	increased prestalk cell differentiation
DBS0349808	detA-/ [ecmA0]: lacZ	detA	increased prestalk cell differentiation
DBS0349809	detA-/ [ecmA]: lacZ	detA	increased prestalk A cell differentiation
DBS0349810	detA-/ [ecmB]: lacZ	detA	delayed development
DBS0350392	dgat1-	dgat1	aberrant cellular metabolic process \| abolished lipid droplet formation \| increased sporulation
DBS0350393	dgat1-/ dgat2-	dgat1 \| dgat2	abolished lipid droplet formation \| decreased growth rate \| increased sporulation \| aberrant endoplasmic reticulum membrane organization
DBS0350394	dgat1-/ dgat2-/ [act15]: GFP: dgat2	dgat1 \| dgat2	wild type
DBS0349911	dgcA-	dgcA	decreased gene expression \| development arrests at slug stage \| abolished stalk cell differentiation
DBS0349917	dgcA-/ [act15]: dgcA(1-124): YFP	dgcA	development arrests at slug stage
DBS0349918	dgcA-/ [act15]: dgcA(1-273): YFP	dgcA	development arrests at slug stage
DBS0349914	dgcA-/ [act15]: dgcA(125-521): YFP	dgcA	wild type
DBS0349915	dgcA-/ [act15]: dgcA(274-521): YFP	dgcA	wild type
DBS0349916	dgcA-/ [act15]: dgcA(350-521): YFP	dgcA	development arrests at slug stage
DBS0349913	dgcA-/ [act15]: dgcA-Ppal: YFP	dgcA	wild type
DBS0349912	dgcA-/ [act15]: dgcA: YFP	dgcA	wild type
DBS0235695	dgkA-	dgkA	decreased spore germination \| increased myosin II assembly \| aberrant sorocarp development \| decreased chemotaxis rate
DBS0351179	dgkA-	dgkA	aberrant cellular metabolic process \| increased resistance to valproic acid \| aberrant response to lithium
AK299	dhkA-	dhkA	aberrant stalk morphogenesis \| increased prestalk gene expression \| aberrant gene expression \| aberrant fruiting body morphogenesis \| increased sporulation \| abolished response to biotic stimulus \| decreased sporulation
DBS0350665	dhkA-/ [act15]: dhkA(D2076N)	dhkA	decreased sporulation
DBS0350664	dhkA-/ [act15]: dhkA(H1396Q)	dhkA	decreased sporulation
DBS0350666	dhkA-/ [act15]: dhkA(H2396Q)/ [act15]: dhkA(D2076N)	dhkA	wild type
DBS0235703	dhkA-/ [pkaC]: pkaC	dhkA \| pkaC	aberrant stalk morphogenesis
TL134	dhkA-/ dhkB-	dhkA \| dhkB	abolished sporulation \| increased stalk length \| decreased stalk width
HR49	dhkA-/ fbxA-	dhkA \| fbxA	aberrant fruiting body morphogenesis \| decreased sporulation \| decreased cAMP level
HR51	dhkA-/ fbxA-	dhkA \| fbxA	aberrant fruiting body morphogenesis \| decreased sporulation
HR50	dhkA-/ fbxA-	dhkA \| fbxA	abolished culmination \| decreased sporulation
DBS0350663	dhkA-/ pkaR-	dhkA \| pkaR	decreased sporulation
DBS0350662	dhkA-/ regA-	dhkA \| regA	decreased sporulation
DBS0235704	dhkB-	dhkB	precocious spore germination \| decreased cAMP level \| aberrant sorus color
TL135	dhkC-	dhkC	precocious culmination \| decreased spore germination \| precocious aggregation \| precocious development \| precocious gene expression
DBS0350855	dhkC-	dhkC	aberrant chemotaxis to cAMP
DBS0350379	dhkD-	dhkD	abolished stream development \| aberrant slug development \| aberrant sorocarp development \| precocious gene expression \| aberrant late culminant morphology
DBS0350381	dhkD-/ [ecmAO]: lacZ	dhkD	aberrant prestalk cell differentiation
DBS0350382	dhkD-/ [ecmB]: lacZ	dhkD	aberrant prestalk cell differentiation
DBS0350383	dhkD-/ [pspA]: lacZ	dhkD	aberrant prespore cell differentiation
LAS99	dhkE-	dhkE	decreased socially cooperative development
DBS0351297	dhkI-	dhkI-1 \| dhkI-2	aberrant chemotaxis to cAMP \| delayed aggregation
DBS0235710	dhkK-	dhkK	aberrant slug migration \| delayed culmination \| delayed gene expression
DBS0235712	dhkK-/ [act15]: dhkK(D1125N)	dhkK	aberrant fruiting body morphogenesis
DBS0235714	dhkK-/ regA-	dhkK \| regA	precocious development
DBS0348046	dhkM-	dhkM	abolished autophagosome organization \| aberrant autophagic cell death
DBS0348047	dhkM-	dhkM	abolished autophagosome organization \| abolished actin filament depolymerization \| abolished cellulose biosynthesis \| abolished autophagic cell death
DBS0350173	dhkM-	dhkM	decreased autophagic vacuole organization \| delayed development
DBS0235719	dia1-/ [act6]: trap1	dia1 \| trap1	aberrant aggregation \| decreased fruiting body size
DBS0235895	dimA-	dimA	increased standing slug length \| increased migratory slug size \| abolished prestalk cell differentiation \| decreased standing slug width \| aberrant fruiting body morphogenesis \| increased prespore cell differentiation \| decreased prestalk O cell differentiation
DBS0235899	dimA-/ dimB-	dimA \| dimB	increased migratory slug size \| increased standing slug length \| aberrant chemotaxis to cAMP \| decreased standing slug width
DBS0235901	dimB-	dimB	decreased prestalk B cell differentiation \| abolished response to DIF-1 \| increased gene expression \| aberrant prespore gene expression \| aberrant chemotaxis to cAMP
DBS0235903	dimB-/ [act15]: dimA: GFP	dimA \| dimB	abolished protein localization to nucleus
DBS0235904	dimB-/ [act15]: dimB: GFP	dimB	wild type
DBS0349992	dimB-/ [btg]: lacZ	btg \| dimB	increased gene expression
DBS0235902	dimB-/ [cotB]: lacZ	dimB	increased prespore cell differentiation
DBS0350573	dimB-/ [dimB]: dimB(S590A)	dimB	wild type
DBS0235906	dimB-/ [ecmAO]: lacZ	dimB	decreased prestalk O cell differentiation
DBS0349974	dimB-/ [ecmB]: lacZ	dimB	abolished prestalk gene expression
DBS0235907	dimB-/ [ecmO]: lacZ	dimB	aberrant prestalk cell differentiation
DBS0350495	dio3-	dio3	decreased cell-cell adhesion \| aberrant aggregation \| decreased gene expression \| decreased growth rate \| decreased prespore cell differentiation \| decreased chemotaxis to folate \| increased prestalk cell differentiation \| decreased cAMP level \| decreased phototaxis
DBS0350496	dio3-/ [act15]: GFP: dio3	dio3	wild type
DBS0304919	dlpA-	dlpA	aberrant cell separation during cytokinesis \| aberrant cytokinesis \| decreased growth rate \| increased actin filament depolymerization \| increased vegetative cell size \| decreased protein localization \| abolished protein localization to cleavage furrow \| aberrant actin filament organization
DBS0351395	dlpA-/ dlpB-	dlpA \| dlpB	aberrant cytokinesis
DBS0304920	dlpB-	dlpB	aberrant cell separation during cytokinesis \| aberrant cytokinesis \| decreased growth rate \| increased vegetative cell size \| abolished protein localization to cleavage furrow
DBS0304921	dlpC-	dlpC	aberrant cytokinesis
DBS0235913	dmpA-	dmpA	aberrant stream morphology \| aberrant fruiting body morphogenesis \| delayed development \| decreased stalk cell differentiation \| decreased sporulation \| aberrant sorus color
HM1030	dmtA-	dmtA	delayed development of tipped mound \| abolished DIF-1 biosynthesis \| decreased outer basal disc size \| wild type \| abolished prestalk O cell differentiation \| decreased standing slug width \| decreased lower cup size \| decreased prestalk gene expression \| aberrant vacuole organization \| aberrant fruiting body morphogenesis \| delayed development \| decreased prestalk O cell differentiation \| decreased prestalk cell differentiation
DBS0350410	dmtA-/ [act15]: dmtA	dmtA	wild type
DBS0349975	dmtA-/ [dimB]: dimB	dimB \| dmtA	decreased prestalk B cell differentiation
HM1196	dmtA-/ stlA-	dmtA \| stlB	decreased outer basal disc size \| decreased prestalk O cell differentiation
DBS0235914	dnapkcs-	dnapkcs	decreased resistance to bleomycin \| decreased double-strand break repair via nonhomologous end joining
DBS0266875	dnapkcs-/ GFP: pcna	dnapkcs \| pcna	aberrant response to bleomycin
DBS0350561	dnapkcs-/ adprt2-	adprt2 \| dnapkcs	decreased resistance to phleomycin \| decreased resistance to cisplatin
DBS0351060	dnapkcs-/ exo1-	dnapkcs \| exo1	decreased resistance to phleomycin
DBS0235915	dng1-	dng1	decreased growth rate \| delayed aggregation
DBS0235917	dnmA-	dnmA	decreased DNA methylation on cytosine
DBS0235916	dnmA-	dnmA	decreased DNA methylation on cytosine \| aberrant late culminant morphology \| aberrant sorus color \| decreased sporulation
DBS0350457	docA-	docA	decreased chemotaxis to cAMP
DG2015	docA-	docA	development arrests at mound stage
LAS32	docA-	docA	decreased socially cooperative development
DBS0350458	docD-	docD	decreased cell motility \| decreased chemotaxis to cAMP
DBS0350459	docD-/ docA-	docA \| docD	aberrant fruiting body morphogenesis \| delayed development \| decreased chemotaxis to cAMP
DBS0235920	dokA-	dokA	aberrant hyperosmotic response \| aberrant sorus color \| decreased sporulation
DBS0349789	dotA-	dotA	aberrant response to UV \| decreased growth rate \| decreased spore size \| delayed development \| abolished histone H3-K79 methylation
HAD172	dpoA-	dpoA	increased gene expression \| aberrant sorocarp development
HAD200	dpoA-	dpoA	aberrant sorocarp development
HAD201	dpoA-	dpoA	aberrant sorocarp development
HAD202	dpoA-	dpoA	aberrant sorocarp development
HAD203	dpoA-	dpoA	aberrant sorocarp development
HAD205	dpoA-/ gskA-	dpoA \| gskA	aberrant sorocarp development
HM1467	drcA-	drcA	abolished catalytic activity
DBS0238474	drkC-	drkC	decreased phagocytosis \| decreased phagolysosome formation
DBS0238511	drkC-/ [act15]: drkC(1-497): YFP	drkC	decreased phagocytosis
DBS0238513	drkC-/ [act15]: drkC(K518R): YFP	drkC	decreased phagocytosis
DBS0238475	drkC-/ [act15]: drkC: YFP	drkC	wild type
DBS0235922	drnA-	drnA-1	decreased gene expression
DBS0350174	drnB-	drnB	abolished pre-miRNA processing
DBS0350218	drnB-/ [act15]: pre-miRNA	drnB	abolished pre-miRNA processing
DBS0350210	drnB-/ [act6]: lacZ/ [RNAi]lacZ	drnB	abolished production of siRNA involved in RNA interference \| abolished transitive RNA interference
DBS0235924	dscA-	dscA-1 \| dscA-2	aberrant cell morphology
DBS0350775	dscA-	dcsA	decreased cell motility
DBS0302609	dsgg(1-571: 581-733)	dsgg	aberrant contractile vacuole organization
DBS0302608	dsgg(1-571: 581-733)/ dsgg-	dsgg	aberrant contractile vacuole organization \| aberrant cellular localization
DBS0302597	dsgg-	dsgg	aberrant contractile vacuole organization \| aberrant hypotonic response
DBS0302603	dsgg-/ GFP: dsgg	dsgg	wild type
DBS0302602	dsgg-/ OE]: dsgg(Delta-Fbox)	dsgg	wild type
DBS0302606	dsgg-/ [OE]: GFP: lvsD	dsgg \| lvsD	wild type
DBS0302599	dsgg-/ [OE]: dsgg	dsgg	wild type
DBS0302601	dsgg-/ [OE]: dsgg(Q551A)	dsgg	aberrant contractile vacuole organization
DBS0302600	dsgg-/ [OE]: dsggR515A)	dsgg	aberrant contractile vacuole organization
DBS0302607	dsgg-/ [OE]: lvsA	dsgg \| lvsA	aberrant contractile vacuole organization
DBS0302611	dsgg-/ [OE]: phgA	dsgg \| phgA	aberrant contractile vacuole organization
DBS0302678	dsgg-/ [OE]: rab8A	dsgg \| rab8A	aberrant contractile vacuole organization
DBS0302604	dsgg-/ lvsA-	dsgg \| lvsA	wild type
DBS0302605	dsgg-/ lvsD-	dsgg \| lvsD	aberrant contractile vacuole organization
DBS0351070	dspA-	dspA	delayed aggregation \| increased cell-substrate adhesion \| decreased cell motility \| increased protein kinase activation
DBS0235925	dstA-	dstA	abolished gene expression \| increased gene expression \| aberrant prestalk gene expression \| abolished cell migration to prestalk region \| decreased gene expression \| delayed aggregation \| decreased prestalk gene expression \| decreased cell motility \| abolished stalk cell differentiation \| aberrant fruiting body morphogenesis
DBS0235926	dstA-	dstA	aberrant prestalk gene expression \| abolished cell migration to prestalk region \| delayed aggregation \| decreased cell motility \| abolished stalk cell differentiation \| aberrant fruiting body morphogenesis
DBS0238237	dstA-/ GFP: dstA(237-707): ORF+	dstA	abolished culmination \| decreased stalk length
DBS0238236	dstA-/ GFP: dstA(237-707): ORF+/ [OE]dutA(751-1322)	dstA \| dutA	decreased stalk length
DBS0252824	dstA-/ GFP: dstA(237-707): ORF+/ [act15]: 2C	2C \| dstA	aberrant fruiting body morphogenesis
DBS0252823	dstA-/ GFP: dstA(237-707): ORF+/ [act15]: 7E	7E \| dstA \| hssB	wild type
DBS0252826	dstA-/ GFP: dstA(237-707): ORF+/ [act15]: DDB_G0276165	DDB_G0276165 \| dstA	aberrant fruiting body morphogenesis
DBS0252825	dstA-/ GFP: dstA(237-707): ORF+/ [act15]: DDB_G0282325	DDB_G0282325 \| dstA	aberrant fruiting body morphogenesis
DBS0252816	dstA-/ GFP: dstA(237-707): ORF+/ [act15]: hssA	dstA \| hssA	wild type
DBS0252822	dstA-/ GFP: dstA(237-707): ORF+/ [act15]: hssB	dstA \| hssB	wild type
DBS0235928	dstA-/ [act15]: dstA	dstA	wild type
DBS0235929	dstA-/ [cprB]: dstA	dstA	wild type
DBS0235930	dstA-/ [ecmAO]: dstA	dstA	wild type
DBS0235927	dstA-/ dstB-	dstA \| dstB	wild type
DBS0235931	dstB-	dstB	decreased gene expression \| increased gene expression \| decreased growth rate
DBS0235933	dstB-/ [act15]: dstB	dstB	wild type
DBS0235934	dstB-/ [act15]: dstB(L1025R)	dstB	wild type
DBS0235935	dstB-/ [act15]: dstB(Y1143F)	dstB	wild type
DBS0235932	dstB-/ dstC-	dstB \| dstC	wild type
DBS0238125	dstC-	dstC	abolished gene expression \| aberrant response to cation stress \| aberrant response to osmotic stress
DBS0350425	dstC-	dstC	aberrant protein phosphorylation
DBS0235937	dtfA-	dtfA	delayed development of tipped mound \| decreased cell-cell adhesion \| aberrant cytokinesis \| aberrant cell migration to prestalk region \| aberrant fruiting body morphogenesis
DBS0350500	dupA-	dupA	increased defense response to Gram-negative bacterium \| abolished aggregation
DBS0350502	dupA-	dupA	increased defense response to Gram-negative bacterium
DBS0238234	dutA-	dutA	wild type
DBS0235939	dwwA-	dwwA	aberrant cytokinesis \| aberrant actin filament organization \| aberrant cell morphology
DBS0350411	dydA-	dydA	increased myosin II assembly \| increased actin filament polymerization \| increased protein localization to plasma membrane \| decreased chemotaxis to cAMP
DBS0350414	dydA-/ dydA(1-278: 501-1211)	dydA	decreased protein localization to cell cortex \| increased myosin II assembly \| increased actin filament polymerization \| aberrant chemotaxis to cAMP
DBS0350415	dydA-/ dydA(1-586: 703-1211)	dydA	decreased protein localization to cell cortex \| decreased chemotaxis to cAMP
DBS0350060	dymA-	dymA	decreased protein localization to cleavage furrow \| aberrant cell separation during cytokinesis \| decreased growth rate \| increased vegetative cell size \| aberrant actin filament organization
DBS0347874	dymA-	dymA	decreased pinocytosis \| aberrant cell separation during cytokinesis \| aberrant mitochondrion morphology \| decreased phagolysosome size \| increased basal disc size \| decreased growth rate \| aberrant nucleus morphology \| increased vegetative cell size \| aberrant endosome morphology \| aberrant phagosome maturation \| delayed development \| aberrant stalk development \| aberrant fruiting body morphogenesis \| decreased establishment of cell polarity \| aberrant pseudopodium formation \| abolished phagosome acidification \| increased phagocytosis \| aberrant intracellular distribution of mitochondria
DBS0349839	dymA-/ [dymA]: dymA	dymA	wild type
DBS0350803	dymA-/ ehd-	dymA \| ehd	aberrant phagosome maturation \| decreased protein processing in phagocytic vesicle
DBS0347875	dymB-	dymB	decreased growth rate \| aberrant hypotonic response \| increased cell-cell adhesion \| increased cell-substrate adhesion \| decreased vegetative cell size \| decreased catalase activity \| aberrant actin filament organization \| increased growth rate \| increased phagocytosis
DBS0235940	eb1-	eb1	aberrant mitosis \| aberrant cytokinesis \| aberrant protein localization
HJW117	ecmA-	ecmA	increased standing slug length \| decreased standing slug width \| decreased slime trail
HJW01	ecmB-	ecmB	wild type
HJW03	ecmB-	ecmB	wild type
DBS0235944	ecmF-	ecmF	wild type
DBS0350904	efbA-	efbA	aberrant cytokinesis \| delayed development
DBS0235945	egeA-	egeA	decreased activation of adenylate cyclase activity \| decreased gene expression \| abolished aggregation
DBS0350520	egeA-/ [unk]: YFP: carA	carA-1 \| carA-2 \| egeA	development arrests at mound stage
DBS0350521	egeA-/ [unk]: pkaC	egeA \| pkaC	decreased gene expression \| abolished aggregation
DBS0235946	egeB-	egeB	development arrests at mound stage
DBS0350802	ehd-	ehd	aberrant endosome morphology \| aberrant phagosome maturation \| decreased protein processing in phagocytic vesicle
DBS0350804	ehd-/ [act15]: dymA: GFP	dymA \| ehd	aberrant phagosome maturation \| decreased protein processing in phagocytic vesicle
DBS0351166	ei24-	ei24	aberrant aggregation \| decreased spore germination \| increased gene expression \| decreased gene expression \| decreased growth rate \| aberrant cell cycle \| delayed development \| decreased chemotaxis to cAMP \| decreased fruiting body size \| decreased cAMP level \| decreased sporulation
DBS0302590	elmoA-	elmoA	increased protein localization to pseudopodium \| decreased culmination \| abolished establishment of cell polarity \| increased actin filament polymerization \| decreased cell motility \| delayed development \| increased pseudopodium formation \| increased phagocytosis
DBS0302598	elmoA-/ [act15]: elmoA(1-903/ 959-977): GFP	elmoA	decreased cell motility \| increased phagocytosis
DBS0302591	elmoA-/ [act15]: elmoA: GFP	elmoA	wild type
DBS0350065	elmoE-	elmoE	decreased culmination \| decreased actin filament polymerization at leading edge \| decreased chemotaxis to cAMP
DBS0351604	elp3-	elp3	decreased protein level
DBS0302448	epnA-	epnA	aberrant spore morphology \| decreased spore germination \| abolished protein localization to cell cortex \| aberrant cytokinesis \| abolished protein localization to plasma membrane \| aberrant actin cytoskeleton organization \| abolished protein phosphorylation
DBS0302457	epnA-/ [act15]: GFP: epnA(253-677)	epnA	aberrant spore morphology \| abolished protein localization to plasma membrane \| abolished protein localization to clathrin-coated pit
DBS0302456	epnA-/ [act15]: epnA(1-133): GFP	epnA	aberrant localization to coated pits
DBS0302474	epnA-/ [act15]: epnA(R65A/ K78A): GFP	epnA	aberrant spore morphology \| abolished protein localization to plasma membrane \| abolished phosphatidylinositol-4,5-bisphosphate binding \| abolished protein localization to clathrin-coated pit \| abolished protein phosphorylation
DBS0302475	epnA-/ [act15]: epnA(T107A): GFP	epnA	aberrant spore morphology \| abolished protein localization to plasma membrane
DBS0302454	epnA-/ [act15]: epnA: GFP	epnA	wild type
DBS0235947	eppA-	eppA	decreased growth rate \| delayed development \| decreased chemotaxis to folate \| decreased chemotaxis to cAMP \| decreased cAMP level
DBS0235948	eppA-/ [act6]: myc: eppA	eppA	wild type
DBS0350028	erkA-	erkA	decreased mound size \| decreased chemotaxis to cAMP
DBS0350622	erkA-	erkA	aberrant development of tipped mound \| aberrant stream morphology \| abolished protein kinase activation \| aberrant cellular response to extracellular stimulus \| abolished positive regulation of chemorepellant activity
DBS0350623	erkA-	erkA	decreased mound size \| precocious development
DBS0350681	erkA-/ [act15]: gpaE	erkA \| gpaE	wild type
DBS0350029	erkA-/ [act15]: mekA: FLAG	erkA \| mekA	increased protein localization to cell cortex
DBS0351474	erkA-/ regA-	erkA \| regA	decreased mound size \| aberrant fruiting body morphogenesis
DBS0351296	erkB-	erkB	abolished chemotaxis to folate \| increased actin filament polymerization \| abolished protein phosphorylation
HS174	erkB-	erkB	decreased catalytic activity \| aberrant phagocytosis \| decreased cell motility \| decreased prespore gene expression \| decreased prestalk gene expression \| aberrant sorocarp development \| decreased chemotaxis to folate \| abolished aggregation \| decreased chemotaxis to cAMP \| aberrant cell morphology \| decreased sporulation
AK240	erkB-	erkB	abolished aggregation \| decreased sporulation
DBS0350606	erkB-	erkB	decreased prespore cell differentiation
DBS0350683	erkB-/ [ecmA]: lacZ	erkB	aberrant cell migration to prestalk region
DBS0350682	erkB-/ [unk]: erkB(P140S)	erkB	abolished sporulation
DBS0235949	erkB-/ regA-	erkB \| regA	increased oscillatory cAMP signaling \| abolished aggregation
DBS0350530	exo1-	exo1	decreased resistance to bleomycin \| decreased double-strand break repair via homologous recombination
DBS0304864	expl7-	expl7	wild type
DBS0235951	fadA-	fadA	increased cellular thermotolerance
DBS0235952	fadB-	fadB	wild type
DBS0350240	fam21-	fam21	abolished exocytosis \| aberrant vegetative growth \| decreased protein localization to post-lysosomal vacuole \| decreased protein processing in phagocytic vesicle \| aberrant autophagic cell death \| aberrant phagosome maturation \| aberrant lysosome organization
DBS0236034	fam45-	fam45	wild type
DBS0236040	fam91-	fam91	wild type
DBS0350717	far1-	far1	aberrant binding \| decreased actin filament polymerization \| aberrant defense response to bacterium \| aberrant macropinocytosis \| decreased growth rate \| aberrant phagocytosis \| aberrant chemotaxis \| decreased engulfment during phagocytosis \| decreased chemotaxis to folate \| decreased protein kinase activation \| decreased folic acid binding \| aberrant signal transduction
DBS0351093	far1-	far1	abolished chemotaxis to folate
DBS0351545	fatA-	fatA	aberrant lipid storage \| decreased phagocytosis
DBS0235953	fbxA-	fbxA	decreased sporulation
HR6	fbxA-	fbxA	decreased socially cooperative development
HR42	fbxA-/ [act15]: myc: fbxA	fbxA	abolished culmination \| decreased sporulation
DBS0235954	fbxA-/ [ecmA]: GFP(S65T)	fbxA	increased prespore cell differentiation
HR46	fbxA-/ regA-	fbxA \| regA	aberrant fruiting body morphogenesis \| decreased sporulation
HR48	fbxA-/ regA-	fbxA \| regA	aberrant fruiting body morphogenesis \| decreased sporulation
DBS0235956	fbxA1-	fbxA	development arrests at slug stage \| aberrant fruiting body morphogenesis \| increased slug migration \| delayed culmination
DBS0235957	fbxA2-	fbxA	development arrests at slug stage \| aberrant fruiting body morphogenesis \| increased slug migration \| delayed culmination
DBS0235958	fbxA3-	fbxA	development arrests at slug stage \| aberrant fruiting body morphogenesis \| increased slug migration \| delayed culmination
DG1148	fcpA-	fcpA	aberrant fruiting body morphogenesis
DBS0235960	fcsA-	fcsA	decreased fatty acid level \| decreased lipid droplet formation \| increased sporulation
DBS0350128	fcsB-	fcsB	decreased catalytic activity \| decreased phagocytosis
DBS0350129	fcsB-/ fcsA-	fcsA \| fcsB	decreased catalytic activity \| decreased growth rate \| delayed development
DBS0350336	febA-	febA	wild type
DBS0350953	fhbA-	fhbA	increased vegetative cell size \| aberrant cellular response to stress
DBS0350955	fhbA-/ fhbB-	fhbA \| fhbB	aberrant cellular response to stress
DBS0350954	fhbB-	fhbB	increased vegetative cell size \| aberrant cellular response to stress
DBS0235961	fimA-	fimA	decreased vegetative cell size
HM1253	fncD2-	fncD2	decreased resistance to cisplatin
HM1351	fncD2-/ rev3-	fncD2 \| rev3	decreased resistance to cisplatin
HM1405	fncD2-/ xpf-	fncD2 \| xpf	decreased resistance to cisplatin
HM1416	fncE-	fncE	decreased resistance to cisplatin
HM1356	fncI-	fncI	decreased resistance to cisplatin
HM1302	fncL-	fncL	decreased resistance to cisplatin
HM1407	fncM-	fncM	decreased resistance to cisplatin
DBS0235966	forA-	forA	wild type
DBS0350667	forA-	forA	aberrant cellular response to fluid shear stress \| decreased cell motility \| increased cell motility
DBS0350669	forA-/ [act15]: GFP: mhcA	forA \| mhcA	aberrant bleb assembly
DBS0235967	forA-/ forB-	forA \| forB	wild type
DBS0235968	forB-	forB	wild type
DBS0235969	forC-	forC	aberrant culmination \| aberrant fruiting body morphogenesis \| development arrests at tipped mound stage
DBS0350280	forC-	forC	delayed aggregation \| aberrant sorocarp development \| decreased chemotaxis to cAMP \| decreased sporulation \| abolished slug development \| delayed gene expression
DBS0304905	forC-/ [act15]: GFP: forC	forC	wild type
DBS0351307	forE-/ forA-/ forH-	forA \| forE \| forH	aberrant cortical actin cytoskeleton organization \| aberrant cytokinesis \| aberrant sorocarp development \| decreased cell motility \| aberrant cell morphology
DBS0350287	forF-	forF	decreased fruiting body size \| aberrant phototaxis \| increased chemotaxis rate
DBS0350835	forG-	forG	decreased growth rate \| decreased phagocytosis \| aberrant actin cytoskeleton organization \| decreased macropinocytosis \| aberrant actin filament organization
DBS0235970	forH-	forH	decreased cell-substrate adhesion \| decreased chemotaxis rate \| increased cell motility \| aberrant pseudopodium formation \| aberrant cell morphology \| decreased filopodium formation
DBS0235971	forH-/ [act15]: GFP: forH	forH	increased filopodium formation \| decreased cell motility \| increased cell-substrate adhesion
HW440	fpaA(P143A)	fpaA	delayed aggregation \| increased response to hypoxia
HW435	fpaB-/ AX2	fpaB-1 \| fpaB-2	decreased response to hypoxia \| increased culmination \| increased stalk length
DBS0302506	frmA-	frmA	delayed aggregation \| decreased cell motility \| decreased mound size \| increased cell-substrate adhesion \| aberrant cell morphology
DBS0304440	frmA-/ [unk]: GFP	frmA	decreased gene expression \| aberrant sorocarp development \| increased cell-cell adhesion \| delayed development \| abolished phototaxis
DBS0302507	frmA-/ [unk]: frmA-HA	frmA	wild type
DBS0350983	frmB-	frmB	aberrant aggregation \| increased mound size \| decreased cell-substrate adhesion \| increased fruiting body size
DBS0350232	fscE-	fscE	aberrant positive regulation of chemorepellant activity \| decreased growth rate \| aberrant cytokinesis
DBS0350228	fslA-	fslA	aberrant cytokinesis
DBS0350230	fslB-	fslB	aberrant positive regulation of chemorepellant activity \| decreased catalytic activity \| aberrant cytokinesis
DBS0350229	fslK-	fslK	decreased catalytic activity \| aberrant vegetative growth \| aberrant cytokinesis
DBS0350252	fspA-	fspA	decreased gene expression \| aberrant chemotaxis to folate \| aberrant vegetative growth
DBS0350253	fspA-/ [unk]: fspA: FLAG	fspA	wild type
DBS0235976	fszA-	fszA	decreased number of mitochondria \| aberrant mitochondrion morphology
DBS0235978	fszA-/ fszB-	fszA \| fszB	aberrant mitochondrion morphology
DBS0235980	fszB-	fszB	aberrant mitochondrion morphology \| decreased number of mitochondria \| decreased growth rate
DG1066	fut1-	fut1	aberrant fruiting body morphogenesis
DBS0305025	gabT-	gabT	precocious development \| decreased sporulation
DBS0305026	gabT-[pkaC]: pkaC	gabT \| pkaC	aberrant protein secretion
DBS0351298	gacG-	gacG	increased chemotaxis to folate \| increased actin filament polymerization at leading edge
DBS0351318	gacG-	gacG	aberrant macropinocytosis \| abolished vegetative growth
DBS0351299	gacH-	gacH	aberrant chemotaxis to cAMP
DG1094	gacT-	gacT	aberrant fruiting body morphogenesis
DBS0235989	gadA-	gadA	decreased spore cell differentiation \| decreased sporulation
DBS0350071	gadA-	gadA	decreased spore germination
DBS0350077	gadA-/ gadB-	gadA \| gadB	delayed aggregation
DBS0350072	gadB-	gadB	delayed aggregation
DBS0350963	gapA-	gapA	aberrant cell separation during cytokinesis
DBS0349924	gapA-	gapA	decreased actin filament bundle assembly
DBS0350399	gapA-	gapA	decreased protein localization to cleavage furrow \| increased myosin II assembly \| increased lateral pseudopodium formation \| aberrant mitotic spindle organization \| increased actin filament polymerization \| decreased chemotaxis to cAMP \| aberrant cellular response to stress
DBS0350403	gapA-/ iqgC-	gapA \| iqgC	decreased protein kinase activation \| decreased chemotaxis to cAMP
TL198	gbfA-	gbfA	abolished gene expression \| development arrests at mound stage
DBS0302689	gbfA-	gbfA	aberrant oscillatory cAMP signaling
DBS0305094	gbfA-	gbfA	abolished autophagosome organization \| abolished autophagic cell death
DBS0235994	gbpC-	gbpC	decreased protein kinase activation \| decreased fruiting body size
DBS0235995	gbpC-	gbpC	aberrant chemotaxis to cAMP \| aberrant myosin II filament organization \| decreased chemotaxis rate \| aberrant cyclic nucleotide binding \| aberrant cell morphology \| decreased establishment of cell polarity \| decreased fruiting body size
DBS0302680	gbpC-	gbpC	abolished protein localization to nucleus \| decreased mound size \| abolished protein phosphorylation
DBS0350881	gbpC-	gbpC	aberrant cyclic nucleotide binding
DBS0304912	gbpC-/ [act15]: gbpC	gbpC	wild type
DBS0304917	gbpC-/ [act15]: gbpC(1-1698: 2005-2631)	gbpC	decreased chemotaxis to cAMP
DBS0349868	gbpC-/ [act15]: gbpC(1-2331: 2470-2631): GFP	gbpC	aberrant stream morphology \| decreased chemotaxis to cAMP
DBS0304918	gbpC-/ [act15]: gbpC(311-2631)	gbpC	decreased chemotaxis to cAMP
DBS0304916	gbpC-/ [act15]: gbpC(F1892A)	gbpC	decreased chemotaxis to cAMP
DBS0304915	gbpC-/ [act15]: gbpC(F2082A/ E2084A/ F2564A/ E2566A)	gbpC	decreased chemotaxis to cAMP
DBS0304913	gbpC-/ [act15]: gbpC(K342N)	gbpC	decreased chemotaxis to cAMP
DBS0304914	gbpC-/ [act15]: gbpC(K905W)	gbpC	decreased chemotaxis to cAMP
DBS0235996	gbpC-/ gbpD-	gbpC \| gbpD	delayed aggregation \| decreased chemotaxis rate \| decreased establishment of cell polarity \| increased bleb assembly
DBS0235997	gbpD-	gbpD	increased establishment of cell polarity \| decreased cell-substrate adhesion \| decreased lateral pseudopodium formation \| increased chemotaxis rate
DBS0235998	gbpD-/ [act15]: gbpD	gbpD	increased lateral pseudopodium formation \| increased cell-substrate adhesion \| decreased chemotaxis rate \| aberrant actin filament organization \| abolished aggregation
DG1120	gbqA-	gbqA	aberrant fruiting body morphogenesis
DBS0350119	gcA-	gcA	decreased guanylyl cyclase activity
DBS0236000	gca-/ sgcA-	gcA \| sgcA	decreased protein kinase activation
DBS0302679	gca-/ sgcA-	gcA \| sgcA	increased lateral pseudopodium formation \| aberrant activation of GTPase activity \| aberrant chemotaxis to cAMP \| aberrant taxis \| aberrant stream morphology \| decreased mound size \| decreased chemotaxis rate \| decreased fruiting body size
DBS0236002	gcsA-	gcsA	abolished sporulation \| aberrant cellular metabolic process \| decreased gene expression \| increased gene expression \| development arrests at mound stage \| abolished vegetative growth \| mitotic G1 phase arrest \| abolished aggregation \| abolished prespore gene expression
DBS0350387	gcsA-/ [act15]: carA	carA-1 \| carA-2 \| gcsA	abolished aggregation
DBS0236003	gcsA-/ [act15]: gcsA	gcsA	decreased spore germination \| development arrests at mound stage
DBS0350388	gcsA-/ [act15]: yakA	gcsA \| yakA	wild type
DBS0236004	gdt1-	gdt1	increased gene expression \| decreased growth rate \| precocious aggregation
DBS0237190	gdt1-/ [act15]: pkaR(G135E/ G261A)	gdt1 \| pkaR	increased gene expression \| abolished aggregation
DBS0236095	gdt1-/ gpaB-	gdt1 \| gpaB	increased gene expression \| abolished aggregation
DBS0236006	gdt2-	gdt2	increased gene expression \| precocious aggregation
DBS0252697	gefA-	gefA	decreased taxis
RI19	gefA-	gefA	decreased actin filament polymerization \| decreased gene expression \| decreased activation of GTPase activity \| abolished activation of adenylate cyclase activity \| decreased cGMP-mediated signaling \| decreased chemotaxis rate \| abolished aggregation \| increased protein kinase activation
JB10	gefA-	gefA	abolished aggregation
DBS0350821	gefA-	gefA	decreased actin filament polymerization \| decreased activation of GTPase activity \| aberrant chemotaxis to cAMP \| decreased protein kinase activation \| abolished aggregation
DBS0350449	gefA-/ [dscB]: rasG(S17N)	gefA \| rasG	decreased actin filament polymerization \| decreased activation of GTPase activity \| aberrant chemotaxis to cAMP \| decreased protein kinase activation
DBS0351451	gefB-/ AX2	gefB	wild type
DBS0236009	gefB-/ AX3	gefB	abolished pinocytosis \| delayed aggregation \| increased actin filament polymerization \| decreased phagocytosis \| decreased growth rate \| decreased mound size \| abolished vegetative growth \| aberrant fruiting body morphogenesis \| aberrant cell morphology \| increased bleb assembly \| aberrant cytoskeleton organization
DBS0236010	gefB-/ rasS-	gefB \| rasS	decreased phagocytosis \| increased cell motility
DBS0236868	gefC-	gefC	wild type
DBS0236869 (DBS0235543)	gefD-	gefD	wild type \| aberrant activation of GTPase activity
DBS0236870	gefE-	gefE	aberrant thermotaxis \| aberrant activation of GTPase activity \| aberrant phototaxis
DBS0350569	gefE-	gefE	decreased activation of GTPase activity \| increased gene expression \| decreased response to DIF-1 \| increased prespore cell differentiation
DBS0351462	gefE-/ uduB-	gefE \| uduB	wild type
DBS0351450	gefF: GFP	gefF	decreased macropinocytosis
DBS0350822	gefH-	gefH	decreased actin filament polymerization \| decreased activation of GTPase activity \| aberrant chemotaxis to cAMP \| delayed development \| decreased protein kinase activation
DBS0350823	gefH-/ gefA-	gefA \| gefH	decreased actin filament polymerization \| aberrant chemotaxis to cAMP \| abolished activation of GTPase activity \| decreased protein kinase activation \| abolished aggregation
DBS0236012	gefK-	gefK	wild type
DBS0351618	gefK-/ gacL-	gacL \| gefK	decreased response to Gram-negative bacterium \| aberrant vegetative growth
DBS0236871	gefL-	gefL	aberrant thermotaxis \| aberrant phototaxis
HSB61	gefM-	gefM	increased cGMP-mediated signaling \| decreased lateral pseudopodium retraction \| aberrant activation of adenylate cyclase activity \| development arrests at mound stage \| decreased chemotaxis rate
DBS0304968	gefQ-	gefQ	decreased positive regulation of GTPase activity \| increased number of mound tips \| increased myosin II assembly \| increased lateral pseudopodium formation \| abolished cell migration to prestalk region \| abolished guanyl-nucleotide exchange factor activity \| decreased growth rate \| decreased fruiting body size \| abolished phototaxis
DBS0304985	gefQ-/ [act15]: GFP: gefQ(172-654)	gefQ	abolished guanyl-nucleotide exchange factor activity \| decreased phototaxis
DBS0304986	gefQ-/ [act15]: GFP: gefQ(910-1298)	gefQ	decreased phototaxis
DBS0236014	gefR-	gefR	wild type \| decreased activation of GTPase activity
DBS0349892	gefS-	gefS	wild type
DBS0349904	gemA-	gemA	decreased ATP level \| decreased growth rate
DBS0350811	gflB-	gflB	decreased culmination \| decreased protein localization to cell cortex \| aberrant G protein-coupled receptor signaling \| delayed aggregation \| decreased mound size \| decreased chemotaxis to cAMP \| aberrant protein localization to plasma membrane \| increased actin filament polymerization at leading edge \| decreased myosin II assembly
HA201	gflB-	gflB	decreased phagocytosis \| aberrant mitotic actomyosin contractile ring contraction \| increased actin filament polymerization \| decreased macropinocytosis \| increased substrate adhesion-dependent cell spreading
DBS0350814	gflB-/ [act15]: GFP: gflB(380-1601,T1180E)	gflB	decreased chemotaxis to cAMP
DG1109	ggtA-	ggtA	aberrant fruiting body morphogenesis
DBS0351210	gip1-	gip1	decreased protein localization to plasma membrane \| aberrant chemotaxis to cAMP
DBS0266723	glcS-/ DH1	glcS	aberrant stalk morphogenesis \| decreased glycogen level \| decreased spore size \| decreased fruiting body size
DBS0266765	glcS-/ HMX	glcS	abolished cellulose biosynthesis \| decreased autophagic vacuole organization \| aberrant cell morphology
DBS0350514	glk-	glk	decreased defense response to Gram-negative bacterium
DBS0351101	glkA-	glkA	aberrant aggregation \| decreased protein localization to cell cortex \| decreased protein level \| decreased chemotaxis to cAMP \| decreased myosin II assembly \| increased activation of GTPase activity \| increased protein kinase activation
DBS0236078	glpD-	glpD	aberrant glycogen metabolism \| aberrant regulation of catalytic activity
HL250	gmd(G108D)	gmd	decreased spore germination \| decreased growth rate
DBS0236079	gmsA-	gmsA	decreased sexual fusion
DBS0236080	gmsA-	gmsA	decreased sexual fusion
HW503	gnt1(1-253/ H104D)	gnt1	aberrant stalk morphogenesis \| development arrests at slug stage \| increased response to hypoxia
DBS0238384	gnt14-	gnt14	wild type
DBS0238382	gnt15-	gnt15	decreased gene expression \| decreased growth rate \| increased calcium-independent cell-cell adhesion \| abolished aggregation \| abolished culmination
DBS0238383	gnt15-	gnt15	decreased gene expression \| decreased growth rate \| increased calcium-independent cell-cell adhesion \| abolished aggregation \| abolished culmination
DBS0238390	gnt15-/ [act15]: FLAG: gnt15	gnt15	wild type
DBS0238391	gnt15-/ [act15]: FLAG: gnt15	gnt15	wild type
DBS0236081	gnt2-	gnt2	abolished catalytic activity \| abolished protein modification
DBS0236082	gol-	gol	increased resistance to cisplatin
DBS0235414	gp130-	gp130	decreased response to Gram-positive bacterium \| decreased cell-substrate adhesion \| delayed development \| increased growth rate
DBS0236087	gpaA-	gpaA	aberrant aggregation \| increased stalk length \| aberrant response to cAMP \| decreased stalk width
JH131	gpaA-	gpaA	aberrant cellular homeostasis \| wild type \| increased growth rate
DBS0236091	gpaA-/ [ecmB]: lacZ	gpaA	decreased prestalk gene expression
DBS0236092	gpaA-/ [gpaA]: gpaA(G45V)	gpaA	delayed development
DBS0236093	gpaA-/ [gpaA]: gpaA(Q206L)	gpaA	increased basal disc size
DBS0238605	gpaA-/ rpkA-	gpaA \| rpkA	delayed aggregation \| abolished aggregation
DBS0236575	gpaB-	gpaB	decreased response to cAMP \| abolished activation of GTPase activity \| aberrant phagocytosis \| decreased cGMP-mediated signaling \| decreased protein kinase activation \| abolished aggregation \| abolished chemotaxis to cAMP
JH104	gpaB-	gpaB	decreased gene expression \| decreased activation of GTPase activity \| abolished activation of adenylate cyclase activity \| abolished aggregation \| abolished chemotaxis to cAMP
JM1	gpaB-/ [OE]: carA	carA-1 \| carA-2 \| gpaB	aberrant calcium-mediated signaling
DBS0236096	gpaB-/ [act15]: gpaB	gpaB	abolished aggregation
DBS0266942	gpaB-/ [act15]: gpaB	gpaB	delayed aggregation
DBS0266939	gpaB-/ [act15]: gpaB(1-345): gpaD(337-345)	gpaB \| gpaD	abolished aggregation
DBS0351103	gpaB-/ [act15]: gpaB(C4A)	gpaB	abolished protein localization to plasma membrane \| decreased cGMP-mediated signaling \| abolished aggregation
DBS0237137	gpaB-/ [act15]: gpaB(D154V)	gpaB	aberrant aggregation \| decreased activation of adenylate cyclase activity \| decreased cGMP-mediated signaling \| decreased oscillatory cAMP signaling \| decreased chemotaxis rate
DBS0237138	gpaB-/ [act15]: gpaB(E190G)	gpaB	aberrant aggregation \| decreased activation of adenylate cyclase activity \| decreased cGMP-mediated signaling \| decreased oscillatory cAMP signaling
DBS0351105	gpaB-/ [act15]: gpaB(G207A)	gpaB	abolished protein localization to plasma membrane
DBS0351104	gpaB-/ [act15]: gpaB(G2A)	gpaB	abolished protein localization to plasma membrane
DBS0237139	gpaB-/ [act15]: gpaB(I104S)	gpaB	aberrant aggregation \| decreased activation of adenylate cyclase activity \| decreased cGMP-mediated signaling \| decreased oscillatory cAMP signaling \| decreased chemotaxis rate
DBS0237140	gpaB-/ [act15]: gpaB(L110S)	gpaB	aberrant aggregation \| decreased activation of adenylate cyclase activity \| decreased cGMP-mediated signaling \| decreased oscillatory cAMP signaling \| decreased chemotaxis rate
DBS0237141	gpaB-/ [act15]: gpaB(L76P)	gpaB	abolished aggregation
DBS0237142	gpaB-/ [act15]: gpaB(N74D)	gpaB	decreased activation of adenylate cyclase activity \| decreased cGMP-mediated signaling \| decreased oscillatory cAMP signaling \| decreased chemotaxis rate \| abolished aggregation
DBS0237143	gpaB-/ [act15]: gpaB(R64G)	gpaB	decreased chemotaxis rate \| abolished aggregation
DBS0237144	gpaB-/ [act15]: gpaB(S155P)	gpaB	decreased chemotaxis rate \| abolished aggregation
DBS0351217	gpaB-/ [act15]: gpaI	gpaB \| gpaI	wild type
DBS0351267	gpaB-/ [act15]: gpbA: YFP	gpaB \| gpbA	abolished aggregation
DBS0351214	gpaB-/ [act15]: rasG(S17N)	gpaB \| rasG	abolished activation of GTPase activity
DBS0236097	gpaB-/ [gpaA]: gpaB	gpaB	abolished aggregation
DBS0236099	gpaB-/ [gpaB]: gpaB	gpaB	wild type
DBS0236098	gpaB-/ [gpaB]: gpaB(Q208L)	gpaB	aberrant protein localization to plasma membrane
DBS0350373	gpaB-/ regA-	gpaB \| regA	decreased number of mounds
DBS0235986	gpaC-	gpaC	aberrant activation of adenylate cyclase activity \| decreased gene expression \| increased protein kinase activity \| abolished aggregation
JH417	gpaD-	gpaD	decreased gene expression \| aberrant macropinocytosis \| decreased spore cell differentiation \| aberrant fruiting body morphogenesis \| decreased chemotaxis to folate \| decreased protein kinase activation \| abolished protein phosphorylation \| decreased cGMP biosynthesis \| decreased sporulation
DBS0266944	gpaD-/ [act15]: gpaB	gpaB \| gpaD	aberrant fruiting body morphogenesis \| decreased chemotaxis to folate \| decreased cGMP biosynthesis
DBS0266946	gpaD-/ [act15]: gpaB(1-345): gpaD(337-345)	gpaB \| gpaD	aberrant fruiting body morphogenesis \| decreased cGMP biosynthesis
DBS0266943	gpaD-/ [act15]: gpaD	gpaD	wild type
DBS0350608	gpaD-/ [act15]: gpaD(Q200L)	gpaD	development arrests at loose mound stage \| decreased chemotaxis to folate \| decreased protein kinase activation
DBS0350607	gpaD-/ [act15]: gpaD(R107E,R108E)	gpaD	development arrests at slug stage \| aberrant slug development
DBS0266945	gpaD-/ [act15]: gpaE	gpaD \| gpaE	aberrant fruiting body morphogenesis \| decreased chemotaxis to folate \| decreased cGMP biosynthesis
DBS0266947	gpaD-/ [act15]: gpaE(1-339): gpaD(337-345)	gpaD \| gpaE	aberrant fruiting body morphogenesis \| decreased chemotaxis to folate \| decreased cGMP biosynthesis
DBS0351269	gpaD-/ [act6]: AEQ	gpaD	aberrant calcium-mediated signaling
DBS0350374	gpaD-/ regA-	gpaD \| regA	aberrant aggregation \| abolished slug migration \| decreased sporulation
DBS0350378	gpaD-/ regA-/ [ecmB]: lacZ	gpaD \| regA	increased prestalk O cell differentiation
DBS0236101	gpaE(G196T)	gpaE	wild type
DBS0236103	gpaE(Q198L)	gpaE	wild type
JH257	gpaE-	gpaE	delayed development of tipped mound \| increased chemotaxis to folate \| delayed prestalk gene expression \| increased vegetative cell size \| delayed prespore gene expression \| decreased cell migration to prestalk region
DBS0266941	gpaE-/ [act15]: gpaE	gpaE	precocious development of tipped mound
DBS0266948	gpaE-/ [act15]: gpaE(1-339): gpaD(337-345)	gpaD \| gpaE	precocious development of tipped mound
DBS0350678	gpaE-/ [act15]: gpaE(K10E/ K11E)	gpaE	delayed development of tipped mound \| delayed gene expression
DBS0350624	gpaE-/ erkA-	erkA \| gpaE	wild type \| decreased mound size \| precocious development
LW1	gpaG-	gpaG	wild type \| decreased spore cell differentiation \| aberrant GABA signaling pathway
DBS0236107	gpaH-	gpaH	wild type \| increased cell death \| decreased spore germination \| abolished negative chemotaxis \| increased growth rate \| abolished positive regulation of chemorepellant activity \| decreased sporulation
DBS0236108	gpaH-	gpaH	wild type
DBS0350972	gpaH-/ AX2	gpaH	increased growth rate
DBS0350975	gpaH-/ [ecmO]: lacZ	gpaH	aberrant cell differentiation
DBS0236109	gpaI-	gpaI	increased number of mounds \| aberrant cellular homeostasis \| increased establishment of cell polarity \| increased cell death \| aberrant activation of adenylate cyclase activity \| increased chemotaxis to cAMP \| precocious aggregation \| increased actin filament polymerization \| aberrant adaptation of signaling pathway \| decreased mound size \| decreased oscillatory cAMP signaling \| decreased lateral pseudopodium formation \| decreased fruiting body size \| increased growth rate \| aberrant protein localization to plasma membrane \| increased cGMP biosynthesis
DBS0351544	gpat-	gpat	aberrant lipid storage \| decreased lipid droplet formation \| increased sporulation \| increased phagocytosis
LW5	gpbA-	gpbA	aberrant taxis \| increased resistance to N-Phenylthiourea \| abolished aggregation
LW6	gpbA-	gpbA	decreased protein localization to plasma membrane \| aberrant cellular homeostasis \| aberrant extracellular cAMP signaling pathway \| decreased positive regulation of GTPase activity \| increased cell death \| abolished chemotaxis to folate \| aberrant phagocytosis \| aberrant chemotaxis \| abolished activation of adenylate cyclase activity \| decreased cGMP-mediated signaling \| decreased engulfment during phagocytosis \| aberrant sorocarp development \| decreased chemotaxis to folate \| decreased protein kinase activation \| decreased chemotaxis to cAMP \| abolished actin filament polymerization \| increased growth rate \| aberrant protein localization \| aberrant signal transduction
DBS0351277	gpbA-	gpbA	aberrant cytokinesis
DBS0350470	gpbA-/ [act15]: GFP: cap	cap \| gpbA	decreased phagocytosis
LW14	gpbA-/ [act15]: carA	carA-1 \| carA-2 \| gpbA	aberrant calcium-mediated signaling \| decreased protein kinase activation \| abolished aggregation
LW17	gpbA-/ [act15]: carC	carC \| gpbA	abolished aggregation
DBS0351260	gpbA-/ [act15]: gpbA(A99T/ Y271H/ C335M)	gpbA	abolished activation of adenylate cyclase activity \| aberrant fruiting body morphogenesis
DBS0351261	gpbA-/ [act15]: gpbA(M30V/ K85R/ S104P/ Q163H)	gpbA	development arrests at mound stage \| abolished activation of adenylate cyclase activity \| decreased chemotaxis to cAMP
DBS0351263	gpbA-/ [act15]: gpbA(M48T/ I52T/ E310G)	gpbA	wild type \| decreased activation of adenylate cyclase activity \| decreased gene expression \| aberrant slug development
DBS0351259	gpbA-/ [act15]: gpbA(N147D/ H149R/ N237S)	gpbA	development arrests at mound stage \| abolished activation of adenylate cyclase activity \| abolished chemotaxis to cAMP
DBS0351264	gpbA-/ [act15]: gpbA(R13G/ N74S/ S79P/ H149R/ V178A/ V194R/ F293L)	gpbA	decreased activation of adenylate cyclase activity \| decreased gene expression \| development arrests at tipped mound stage
DBS0351262	gpbA-/ [act15]: gpbA(S196G/ V199D/ C211R)	gpbA	decreased activation of adenylate cyclase activity \| aberrant fruiting body morphogenesis
DBS0351258	gpbA-/ [act15]: gpbA(V88A/ F229S/ D235V)	gpbA	abolished activation of adenylate cyclase activity \| aberrant fruiting body morphogenesis \| decreased chemotaxis to cAMP
DBS0351268	gpbA-/ [act6]: AEQ	gpbA	aberrant calcium-mediated signaling
HO547	gpbA-/ [act6]: FRB: [act15]: RFP: gpbA/ [act15]: cnxA: CFP: FKBP/ [act15]: limE(1-145): GFP	gpbA	aberrant cortical actin cytoskeleton organization
HO543	gpbA-/ [act6]: FRB: [act15]: RFP: gpbA/ [act15]: cnxA: YFP: FKBP	gpbA	abolished chemotaxis to folate
DBS0351198	gpbA-/ [act6]: yakA	gpbA \| yakA	abolished vegetative growth
DBS0350832	gpbA-/ [unk]: gpbA(Q208L)	gpbA	aberrant adaptation of signaling pathway
DBS0351278	gpbA-/ mhcA-	gpbA \| mhcA	aberrant cytokinesis
AK1353	gpi-	gpi	decreased response to Gram-positive bacterium
DBS0350477	gpr89-	gpr89	aberrant spore morphology \| aberrant mitochondrion morphology \| abolished cell migration to prestalk region \| decreased gene expression \| aberrant slug development \| abolished vegetative growth \| decreased cell motility \| decreased fruiting body size \| precocious gene expression \| decreased phototaxis \| delayed gene expression
DBS0350479	gpr89-/ [act15]: gpr89: GFP	gpr89	wild type
DBS0304814	grlA-	grlA	delayed prestalk gene expression \| decreased prestalk gene expression \| decreased spore cell differentiation \| decreased sporulation \| delayed culmination
DBS0304815	grlA-/ [act15]: grlA: GFP	grlA	aberrant development of tipped mound
DBS0350074	grlB-	grlB	decreased small molecule binding \| aberrant positive regulation of chemorepellant activity \| delayed aggregation \| aberrant vegetative growth \| delayed gene expression
DBS0350078	grlB-/ grlE-	grlB \| grlE	decreased small molecule binding \| delayed aggregation
DBS0350227	grlD-	grlD	aberrant positive regulation of chemorepellant activity \| decreased growth rate \| aberrant cytokinesis \| abolished small molecule binding \| aberrant cellular response to extracellular stimulus
DBS0236112	grlE-	grlE	decreased spore cell differentiation \| aberrant GABA signaling pathway \| decreased sporulation
DBS0236113	grlE-	grlE	delayed aggregation \| aberrant gene expression \| decreased chemotaxis to cAMP
DBS0350075	grlE-	grlE	decreased spore germination \| delayed aggregation
DBS0350226	grlH-	grlH	aberrant positive regulation of chemorepellant activity \| aberrant protein level \| aberrant vegetative growth \| abolished activation of GTPase activity \| decreased protein binding \| increased growth rate
DBS0351147	grlH-/ [act15]: grlH	grlH	wild type
DBS0238865	grlJ-	grlJ	increased migratory slug size \| aberrant spore morphology \| decreased spore germination \| precocious development \| decreased fruiting body size \| precocious gene expression
DBS0350283	grlJ-	grlJ	aberrant spore morphology \| increased resistance to N-Phenylthiourea
DBS0238866	grlJ-/ [act15]: grlJ: GFP	grlJ	wild type
DBS0350284	grlJ-/ [act15]: grlJ: GFP	grlJ	wild type
DBS0238686	grpA-	grpA	decreased spore germination \| abolished protein secretion
DBS0238687	grpA-/ [act15]: grpA-FLAG	grpA	wild type
ARK200	gskA-	gskA	abolished stream development \| increased gene expression \| decreased gene expression \| increased protein localization to plasma membrane \| decreased chemotaxis to cAMP \| decreased sporulation
DBS0236114	gskA-	gskA	aberrant aggregation \| decreased protein localization to cell cortex \| decreased slug migration \| aberrant sorus morphology \| aberrant extracellular cAMP signaling pathway \| decreased gene expression \| abolished protein localization to plasma membrane \| abolished protein phosphorylation \| decreased chemotaxis to folate \| decreased stalk length \| abolished chemotaxis to cAMP
HM338	gskA-	gskA	precocious aggregation \| decreased prespore cell differentiation \| aberrant mitotic spindle elongation \| aberrant fruiting body morphogenesis \| increased prestalk cell differentiation \| decreased sporulation
DBS0349930	gskA-/ [act15]: GFP: tacA	gskA \| tacA	increased protein localization to nucleus
DBS0349881	gskA-/ [act15]: gskA(Y214F)	gskA	abolished stream development
DBS0349800	gskA-/ [ecmA]: LacZ	gskA	aberrant prestalk gene expression
DBS0349801	gskA-/ [ecmB]: LacZ	gskA	aberrant prestalk gene expression
DBS0350260	gskA-/ [unk]: pikA(1-492(S7D/ S11D/ S109D/ S113D/ S177D/ S181D))	gskA \| pikA	wild type
DBS0351102	gskA-/ glkA-	glkA \| gskA	aberrant sorocarp development \| decreased chemotaxis to cAMP \| increased protein kinase activation
DBS0350427	gskA-/ gskA(K85R): GFP	gskA	aberrant aggregation
DBS0350426	gskA-/ gskA: GFP	gskA	wild type
DBS0350988	gst4-	gst4	decreased fruiting body size
DBS0266891	gtaC-	gtaC	decreased mound size \| aberrant stream morphology \| abolished stalk cell differentiation \| aberrant prestalk B cell differentiation
DBS0350347	gtaC-	gtaC	abolished gene expression \| decreased fruiting body size \| abolished aggregation
DBS0350348	gtaC-/ [act15]: GFP: gtaC	gtaC	wild type
DBS0350357	gtaC-/ [act15]: GFP: gtaC(C500,503,522,525S)	gtaC	aberrant gene expression \| abolished aggregation \| decreased fruiting body size
DBS0350358	gtaC-/ [act15]: GFP: gtaC(T376A/ S379,380A/ C500,503,522,525S)	gtaC	aberrant protein localization to nucleus
DBS0350361	gtaC-/ [act15]: gtaC: (468-496): GFP: gtaC	gtaC	development arrests at mound stage \| decreased mound size \| precocious development
DBS0266892	gtaC-KD	gtaC	abolished stalk cell differentiation
DBS0266893	gtaC-KD/ [act15]: GFP: gtaC	gtaC	wild type
DBS0351091	gtaG-	gtaG	decreased gene expression \| development arrests at slug stage \| aberrant slug development \| decreased prestalk A cell differentiation \| decreased sporulation
DBS0236120	gxcA-	gxcA	decreased activation of GTPase activity \| decreased actin filament polymerization \| delayed development
DBS0236121	gxcB-	gxcB	decreased exocytosis \| delayed development \| aberrant cytoskeleton organization
DBS0350256	gxcC-	gxcC	delayed development
DBS0350257	gxcC-/ [act15]: GFP: gxcC	gxcC	wild type
DBS0238825	gxcDD-	gxcDD	aberrant stream morphology \| delayed development
LAS105	gxcKK-	gxcKK	decreased socially cooperative development
DBS0350268	gxcT-	gxcT	aberrant activation of GTPase activity \| increased lateral pseudopodium formation \| aberrant cytokinesis \| decreased growth rate \| delayed aggregation \| decreased establishment of cell polarity \| decreased chemotaxis to cAMP \| decreased fruiting body size \| aberrant protein localization to plasma membrane
DBS0350269	gxcT-/ [act15]: GFP: gxcT	gxcT	wild type
DBS0350656	hatA-/ [hatB]: hatB	hatA \| hatB	aberrant cellular response to stress
DBS0236129	hbx2-	hbx2	wild type
DBS0236130	hbx2-	hbx2	wild type
DBS0236131	hbx2-/ warA-	hbx2 \| warA	increased basal disc size \| development arrests at mound stage \| decreased prespore cell differentiation \| increased prestalk O cell differentiation
DBS0350324	hbx4-/ [ecmAO]: lacZ	hbx4	increased prespore cell differentiation
DBS0350879	hbx9-	hbx9	decreased cell-cell adhesion \| decreased gene expression \| delayed aggregation \| decreased growth rate \| decreased chemotaxis to cAMP
DBS0350880	hbx9-/ [ecmA]: lacZ	hbx9	increased prestalk A cell differentiation
DBS0236153	hcpA-	hcpA	decreased growth rate
DBS0236157	hcpB-	hcpB	wild type
DBS0305109	hdaB-	hdaB	decreased sporulation \| decreased histone deacetylase activity
HM1012	helC-	helC	decreased gene expression \| delayed development \| aberrant fruiting body morphogenesis
HM444	helC-	helC	decreased gene expression \| aberrant fruiting body morphogenesis \| delayed development
DG1059	helE-	helE	increased slug migration
DBS0236163	helF-	helF	increased migratory slug size \| increased stalk cell differentiation \| delayed development \| increased post-transciptional gene silencing by RNA
DBS0350878	hephA-	hephA	increased response to cAMP \| delayed aggregation \| aberrant sorocarp development \| decreased cAMP level
DBS0350362	hfnA-	hfnA	increased phototaxis \| decreased migratory slug size \| increased slug migration
DBS0350363	hfnA-/ [ecmO]: lacZ	hfnA	aberrant slug development \| aberrant prestalk O cell differentiation
DBS0350364	hfnA-/ abpC-	abpC \| hfnA	wild type \| aberrant prestalk O cell differentiation \| decreased phototaxis
DBS0351593	hgrA-	hgrA \| matA	aberrant macrocyst formation
DBS0351590	hgrA-/ KAX3	hgrA	aberrant macrocyst formation
DBS0351594	hgrB-	hgrB \| matA	aberrant macrocyst formation
DBS0351591	hgrB-/ KAX3	hgrB	aberrant macrocyst formation
DBS0238583	hipA-	hipA	decreased spore germination \| aberrant spore morphology \| aberrant cortical actin cytoskeleton organization \| aberrant spore coat morphology \| increased protein localization to plasma membrane
DBS0305951	hipA-/ epnA-	epnA \| hipA	decreased spore germination \| aberrant spore morphology
DBS0351165	hspb1-	hsbp1-1 \| hsbp1-2	decreased exocytosis \| decreased protein level \| aberrant protein localization to lysosomal membrane
DBS0351532	hspc300-/ AX2	hspc300	aberrant macropinocytosis \| aberrant cytokinesis \| decreased cell motility \| decreased filopodium formation \| abolished protein level
DBS0350289	hspc300-/ [act15]: myc: hspc300	hspc300	wild type
DBS0252818	hssA-	hssA	wild type
DBS0351066	htmA-	htmA	decreased gene expression \| aberrant sorocarp development \| increased cell-substrate adhesion \| decreased cell motility
DBS0349776	htt-	htt	aberrant cell separation during cytokinesis \| decreased growth rate \| decreased chemotaxis rate \| delayed development \| delayed gene expression \| decreased myosin II assembly
DBS0349788	htt-	htt	aberrant aggregation \| abolished stream development \| development arrests at loose mound stage \| aberrant cellular response to starvation \| aberrant spore morphology \| decreased spore germination \| abolished cell motility in response to calcium ion \| increased number of mound tips \| aberrant sorocarp development \| aberrant hypotonic response \| aberrant actin filament organization \| abolished culmination \| decreased sporulation \| aberrant prespore cell differentiation \| abolished calcium-independent cell-cell adhesion \| abolished protein level \| abolished chemotaxis to cAMP
DBS0351281	htt-	htt	abolished gene expression \| aberrant sorus morphology \| decreased gene expression \| decreased growth rate \| aberrant slug development \| aberrant sorocarp development \| delayed development \| decreased cAMP level \| aberrant prestalk cell differentiation
DBS0349786	htt-/ [act15]: htt: GFP	htt	wild type \| aberrant protein level
DBS0350438	ibrA-	ibrA	aberrant substrate adhesion-dependent cell spreading \| aberrant contractile vacuole organization \| decreased phagocytosis \| decreased growth rate \| aberrant cytokinesis \| aberrant hypotonic response \| decreased contractile vacuole discharge
DBS0349794	ibrA-	ibrA	aberrant stalk development
DBS0252699	icmA-	icmA-1 \| icmA-2	abolished sporulation \| abolished stream development \| aberrant extracellular cAMP signaling pathway \| abolished establishment of cell polarity \| development arrests at mound stage \| abolished vegetative growth \| aberrant oscillatory cAMP signaling \| aberrant fruiting body morphogenesis \| aberrant protein localization to nucleus \| delayed gene expression \| aberrant protein localization
DBS0252702	icmA-/ [act15]: TAP: YFP: rasG	icmA-1 \| icmA-2 \| rasG	abolished C-terminal protein methylation
DBS0252701	icmA-/ [act15]: hICMT	icmA-1 \| icmA-2	wild type
DBS0252700	icmA-/ [act15]: icmA	icmA-1 \| icmA-2	wild type
DBS0236421	icpA-	icpA	abolished protein localization to mitotic spindle \| aberrant mitosis \| aberrant cytokinesis \| abolished protein localization to cleavage furrow \| abolished protein localization to mitotic spindle midzone \| aberrant protein localization
DBS0238521	icpA-/ [act15]: GFP: icpA(1-1013)	icpA	aberrant protein localization to mitotic spindle
BS153	ifkA-	ifkA	increased mound size \| precocious aggregation \| precocious gene expression \| decreased protein secretion
BS161	ifkA-/ ifkB-	ifkA \| ifkB	increased mound size \| increased number of mound tips \| increased cell-cell adhesion \| increased cell-substrate adhesion \| aberrant fruiting body morphogenesis
BS160	ifkB-	ifkB	increased prestalk gene expression
DBS0236425	ino1-	ino1	increased number of mound tips \| decreased phagocytosis \| abolished vegetative growth \| increased 2,3-bisphosphoglycerate level \| decreased myo-inositol level
DBS0350801	ino1-	ino1	aberrant cellular metabolic process \| increased number of autophagosomes \| decreased cell-substrate adhesion \| aberrant phosphatidylinositol metabolism \| aberrant cytokinesis \| abolished vegetative growth \| aberrant fruiting body morphogenesis \| decreased myo-inositol level
DBS0266326	iplA-	iplA	abolished cellulose biosynthesis \| abolished autophagosome organization \| abolished autophagic cell death \| aberrant autophagic cell death
HM1038	iplA-	iplA	aberrant cell motility \| precocious aggregation \| delayed aggregation \| aberrant chemotaxis \| aberrant calcium-mediated signaling \| increased bleb assembly \| increased chemotaxis to arachidonic acid \| abolished positive regulation of chemorepellant activity
DBS0351539	iplA-/ AX2	iplA	abolished response to DIF-1 \| abolished response to cAMP \| aberrant GABA signaling pathway
DBS0350439	iplA-/ [act15]: GFP: iplA	iplA	wild type
DBS0252878	iptA-	iptA	decreased spore germination \| aberrant sporulation
DBS0350400	iqgC-	iqgC	decreased myosin II assembly
DBS0351225	iqgC-	iqgC	aberrant cytokinesis \| increased macropinocytosis \| increased phagocytosis
DBS0351435	ireA-	ireA	increased number of autophagosomes \| decreased protein level \| aberrant vacuole organization \| aberrant gene expression \| aberrant cellular response to stress \| aberrant endoplasmic reticulum organization \| aberrant protein localization
DBS0351436	ireA-/ [act15]: ireA(K603N): GFP	ireA	decreased protein level \| aberrant endoplasmic reticulum organization \| aberrant cellular response to stress
DBS0351437	ireA-/ [act15]: ireA(N927A): GFP	ireA	decreased protein level \| aberrant endoplasmic reticulum organization \| aberrant cellular response to stress
DBS0236031	kctd9-	kctd9	wild type
DBS0350057	keaA-	keaA	aberrant extracellular cAMP signaling pathway \| decreased gene expression \| delayed aggregation \| decreased growth rate \| decreased cAMP level
DBS0350472	kif1-	kif1	aberrant transport
DBS0350959	kif10-/ [act15]: dhcA(1384-4725)	dhcA \| kif10	wild type
DBS0350038	kif11-	kif11	wild type
DBS0236489	kif12-	kif12	aberrant protein localization to mitotic spindle \| aberrant cell separation during cytokinesis \| aberrant cytokinesis \| aberrant myosin II filament organization \| increased bleb assembly
DBS0236490	kif12-/ [act15]: FLAG: kif12	kif12	wild type
DBS0302534	kif13-	kif13	precocious mitotic spindle elongation \| aberrant mitotic spindle organization
DBS0350039	kif4-	kif4	decreased growth rate
DBS0350042	kif4-/ [act15]: dhcA(1384-4725)	dhcA \| kif4	aberrant mitotic spindle organization
DBS0350021	kif5-	kif5	wild type
DBS0350022	kif5-/ [act15]: FLAG: kif5	kif5	aberrant cytokinesis \| aberrant cell morphology
DBS0350023	kif5-/ [act15]: FLAG: kif5(342-990)	kif5	aberrant cell morphology
DBS0350024	kif5-/ [act15]: GFP: kif5(805-990)	kif5	aberrant cytokinesis
DBS0236494	kif7-	kif7	decreased cell migration to prestalk region
DBS0350040	kif8-	kif8	aberrant microtubule cytoskeleton organization
DBS0350947	kif8-/ [act15]: dhcA(1384-4725)	dhcA \| kif8	wild type
DBS0349964	kif9-	kif9	aberrant mitotic spindle organization \| aberrant mitosis \| decreased growth rate \| aberrant protein localization to nuclear envelope \| aberrant centrosome localization \| aberrant centromere complex assembly \| aberrant centrosome organization
DBS0236491	kil1-	kil1	abolished defense response to Gram-negative bacterium \| increased defense response to fungus
DBS0351457	kil1-/ lrrkA-	drkD \| kil1	aberrant defense response to bacterium
DBS0350043	kil2-	kil2	aberrant response to cation stress \| aberrant defense response to bacterium \| decreased protein processing in phagocytic vesicle \| abolished defense response to Gram-negative bacterium \| increased defense response to fungus
DBS0350874	kil2-	kil2	aberrant defense response to bacterium \| decreased growth rate
DBS0350044	kil2-/ [act15]: kil1	kil1 \| kil2	abolished defense response to bacterium
DBS0351458	kil2-/ lrrkA-	drkD \| kil2	aberrant defense response to bacterium
DBS0350875	kil2-/ vps13F-	kil2 \| vps13F	aberrant defense response to bacterium \| decreased growth rate
DBS0351502	knkA-	knkA	decreased spore germination \| aberrant spore morphology \| decreased number of autophagosomes \| decreased prespore gene expression \| aberrant fruiting body morphogenesis \| aberrant phototaxis \| decreased sporulation
DBS0236492	krsA-	krsA	decreased chemotaxis to cAMP
DBS0238720	krsA-	krsA	abolished stream development \| precocious culmination \| abolished activation of adenylate cyclase activity \| decreased vegetative cell size \| decreased mound size \| aberrant hyperosmotic response \| precocious gene expression \| decreased cAMP level
DBS0236493	krsA-/ [act15]: GFP: krsA	krsA	wild type
DBS0238721	krsA-/ [act15]: GFP: krsA	krsA	wild type
DBS0238722	krsA-/ [act15]: GFP: krsA(K49R)	krsA	aberrant stream morphology
DBS0238723	krsA-/ [act15]: GFP: krsA(T173A)	krsA	abolished stream development
DBS0238725	krsA-/ [act15]: GFP: krsA(deltaC)	krsA	aberrant stream morphology
DBS0238724	krsA-/ [act15]: GFP: krsA(deltaKinase)	krsA	abolished stream development
DBS0238726	krsA-/ [act15]: GFP: krsA(deltaNS)	krsA	abolished stream development
DBS0350598	krsB-	krsB	aberrant stream morphology \| decreased cell motility \| increased cell-substrate adhesion \| delayed development \| decreased chemotaxis to cAMP
DBS0350599	krsB-/ [tet]: krsB(T176A): GFP	krsB	aberrant stream morphology
DBS0350600	krsB-/ krsA-	krsA \| krsB	aberrant stream morphology \| delayed development
DBS0236495	ku80-	ku80	decreased resistance to bleomycin \| decreased double-strand break repair via nonhomologous end joining
DBS0350536	ku80-/ dclre1-	dclre1 \| ku80	wild type
DBS0350537	ku80-/ myc: ku80(1-782)	ku80	decreased double-strand break repair via nonhomologous end joining
DBS0236498	lagD-	tgrD1	aberrant aggregation \| abolished stream development \| aberrant extracellular cAMP signaling pathway
DBS0236499	limB-	limB	decreased cell-substrate adhesion \| abolished cell migration to prestalk region \| development arrests at mound stage \| delayed prestalk gene expression \| aberrant cell-cell adhesion \| decreased prestalk gene expression \| decreased chemotaxis rate \| aberrant actin filament organization \| decreased establishment of cell polarity
DBS0236502	limB-/ [act15]: paxB: GFP	limB \| paxB	development arrests at mound stage
DBS0236500	limB-/ [cotC]: limB	limB	development arrests at mound stage
DBS0236501	limB-/ [ecmAO]: limB	limB	wild type
DBS0236729	limB-/ paxB-	limB \| paxB	development arrests at mound stage
DBS0350563	limC-	limC	delayed aggregation \| decreased growth rate \| aberrant cytokinesis \| aberrant response to osmotic stress
DBS0350564	limD1-	limD1	increased lateral pseudopodium formation \| delayed aggregation \| decreased growth rate \| aberrant cytokinesis \| aberrant response to osmotic stress \| decreased chemotaxis to cAMP \| decreased establishment of cell polarity \| aberrant actin filament organization
DBS0350565	limD1-/ limC-	limC \| limD1	delayed aggregation \| aberrant cytokinesis \| abolished vegetative growth \| aberrant response to osmotic stress \| decreased chemotaxis to cAMP \| aberrant actin filament organization \| decreased establishment of cell polarity
DBS0236503	limE-	limE	aberrant cytokinesis
DBS0236506	limF-	limF	decreased phagocytosis
DBS0236511	lipA-	lipA	wild type
DBS0236512	lipA-	lipA	wild type
DG1006	lipA-	lipA	abolished culmination
DG1056	lipB-	captC	aberrant fruiting body morphogenesis
DBS0236515	lis1(D327H)	lis1	aberrant microtubule cytoskeleton organization \| increased actin phosphorylation \| aberrant Golgi localization
DBS0349950	lmbd2B-	lmbd2B	aberrant chemotaxis \| delayed development \| aberrant cell morphology \| increased pseudopodium formation
DBS0349982	lmnB-	lmnB	aberrant chromatin assembly \| aberrant centrosome localization
DBS0350354	lmpA-	lmpA	decreased lysosomal protein degradation \| decreased pinocytosis \| decreased protein level \| decreased phagocytosis \| decreased growth rate \| decreased cell motility \| decreased protein processing in phagocytic vesicle \| aberrant phagosome maturation \| decreased fruiting body size \| decreased defense response to Gram-positive bacterium \| decreased sporulation
DBS0351481	lmpB-	lmpB	decreased phagocytosis
DBS0351482	lmpC-	lmpC	decreased protein localization to cell surface \| increased protein localization to cell surface
DBS0350452	lpten-	lpten	aberrant cell motility \| decreased lateral pseudopodium retraction
DBS0350453	lpten-/ [act15]: lpten: RFP	lpten	wild type
DBS0236516	lrrA-	lrrA	increased mound size \| decreased spore germination \| decreased cell-substrate adhesion \| abolished establishment of cell polarity \| decreased gene expression \| development arrests at mound stage \| increased actin filament polymerization \| abolished positive chemotaxis \| abolished aggregation \| delayed gene expression
DBS0350407	lrrB-	lrrB	aberrant thermotaxis \| delayed slug development \| aberrant gene expression \| aberrant sorocarp development \| decreased prestalk gene expression \| aberrant phototaxis \| aberrant late culminant morphology
DBS0350478	lrrB-/ [ecmB]: lacZ	lrrB	aberrant prestalk B cell differentiation
DBS0350476	lrrB-/ [ecmO]: lacZ	lrrB	aberrant prestalk O cell differentiation
DBS0351456	lrrkA-	drkD	aberrant defense response to bacterium \| decreased protein processing in phagocytic vesicle \| abolished vegetative growth
DBS0236517	lst8-	lst8	aberrant activation of adenylate cyclase activity \| decreased actin filament polymerization \| decreased chemotaxis rate \| abolished aggregation \| decreased myosin II assembly \| abolished positive regulation of chemorepellant activity
DBS0350106	lst8-	lst8	increased phagocytosis
DBS0350114	lst8-/ [act15]: GFP: rheb(Q64L)	lst8 \| rheb	increased phagocytosis
DBS0309063	lvsA-	lvsA	increased bleb assembly
AD60	lvsA-	lvsA	abolished cytokinesis \| decreased pinocytosis \| aberrant contractile vacuole organization \| decreased phagocytosis \| aberrant hypotonic response \| increased cell-substrate adhesion
AD63	lvsA-	lvsA	abolished cytokinesis \| abolished contractile vacuole dissociation from plasma membrane \| aberrant calcium-mediated signaling
DBS0237207	lvsA-/ [act6]: GFP: lvsA(1828- 3619)	lvsA	abolished cytokinesis
DBS0236521	lvsB-	lvsB	increased secretion of lysosomal enzymes \| increased lysosome size \| increased exocytosis \| increased pinocytosis \| aberrant protein localization to post-lysosomal vacuole \| aberrant phagosome maturation \| increased endosome size \| aberrant post-lysosomal vacuole exocytosis \| increased endosomal vesicle fusion \| aberrant lysosome organization
DBS0350567	lvsB-/ [act15]: FLAG: Rab14(N121I)	lvsB \| rab14	wild type
DBS0238218	lvsB-[act6]: TAP: GFP: lvsB	lvsB	wild type
DBS0236522	lvsC-	lvsC	wild type
DBS0236523	lvsD-	lvsD	wild type
DBS0236524	lvsE-	lvsE	wild type
DBS0236525	lvsF-	lvsF	wild type
DBS0351162	lyC2-	lyC2	decreased growth rate
DBS0349933	macA-	macA	aberrant macrocyst formation \| decreased sexual fusion
DBS0236536	malA-	malA	wild type
DBS0351251	matA-	matA	abolished mating type determination
HM1524	matA-	matA	abolished mating type determination
DBS0350211	mef2A-	mef2A	decreased growth rate \| aberrant sorocarp development \| aberrant stream morphology \| decreased sporulation
DBS0350212	mef2A-	mef2A	decreased growth rate \| aberrant stream morphology \| aberrant sorocarp development \| aberrant gene expression \| decreased sporulation
DBS0350213	mef2A-/ [ecmA]: lacZ	mef2A	aberrant prestalk A cell differentiation
DBS0350214	mef2A-/ [ecmB]: lacZ	mef2A	aberrant prestalk B cell differentiation
DBS0350215	mef2A-/ [pspA]: lacZ	mef2A	decreased prespore cell differentiation
DBS0236543	mekA-	mekA	decreased mound size \| precocious development \| abolished chemotaxis to cAMP
DBS0350030	mekA-/ [act15]: Myc: erkA	erkA \| mekA	abolished protein localization to cell cortex
DBS0350036	mekA-/ [act15]: mekA(299-360)	mekA	decreased mound size
DBS0350035	mekA-/ [act15]: mekA(K321A)	mekA	decreased mound size
DBS0350032	mekA-/ [act15]: mekA(S444A/ T448A)	mekA	decreased mound size
DBS0350031	mekA-/ [act15]: mekA(S444E/ T448E)	mekA	development arrests at mound stage
DBS0238098	mekA-/ ppp4C-	mekA \| ppp4c	decreased mound size
DBS0238109	mekA-/ ppp4C-/ [act15]: FLAG: pppC	ppp4c	decreased mound size \| precocious development
DBS0236542	mekA-/ smkA-	mekA \| smkA	decreased mound size
DBS0236544	mfeA-	mfeA	aberrant cellular metabolic process \| decreased protein level \| aberrant extracellular cAMP signaling pathway \| development arrests at mound stage
DBS0351543	mfsd8-	mfsd8	increased protein secretion
DBS0266843	mgp1-	mgp1	increased phototaxis \| abolished stream development \| increased filopodium formation \| aberrant contractile vacuole organization \| decreased cell motility \| decreased fruiting body size \| decreased stalk width \| decreased stalk length
DBS0266846	mgp1-/ mgp2-	mgp1 \| mgp2	increased filopodium formation \| aberrant contractile vacuole organization \| aberrant culmination \| decreased cell motility \| decreased phototaxis \| decreased stalk length
DBS0266844	mgp2-	mgp2	increased migratory slug size \| increased mound size
HS1	mhcA-	mhcA	development arrests at mound stage \| aberrant cytokinesis \| decreased growth rate \| increased actin filament polymerization \| aberrant hypotonic response \| aberrant regulation of GTPase activity \| abolished bleb assembly \| aberrant regulation of protein kinase activity \| aberrant cellular response to stress
HS2205	mhcA-	mhcA	abolished cell motility \| decreased cell motility
HS2207	mhcA-	mhcA	abolished cytokinesis \| development arrests at mound stage
DBS0350064	mhcA-	mhcA	decreased cell motility \| decreased establishment of cell polarity
HS2206	mhcA-	mhcA	aberrant cellular response to fluid shear stress \| abolished bleb assembly
HK321	mhcA-	mhcA	aberrant cortical actin cytoskeleton organization \| aberrant chemotaxis to folate \| aberrant cell morphology
HK323	mhcA-	mhcA	decreased cell motility \| aberrant stream morphology
DBS0266674	mhcA-/ [act15]: GFP: abpC(9-148)	abpC \| mhcA	decreased uropod retraction \| decreased pseudopodium retraction
DBS0237564	mhcA-/ [act15]: GFP: ctxA/ [RNAi]enlA	ctxA \| enlA \| mhcA	aberrant mitotic actomyosin contractile ring contraction
DBS0266675	mhcA-/ [act15]: GFP: mhcA(E476K)	mhcA	decreased pseudopodium retraction
DBS0350489	mhcA-/ [act15]: GFP: mhcA/ [RNAi]rmd1	mhcA \| rmd1	abolished protein localization to cleavage furrow
DBS0236548	mhcA-/ [act15]: GFP: pats1(2087-2351)	mhcA \| pats1	aberrant cytokinesis
DBS0350291	mhcA-/ [act15]: gppA: GFP	gppA \| mhcA	aberrant contractile vacuole morphology \| decreased contractile vacuole discharge
DBS0236549	mhcA-/ [act15]: limE(1-145): GFP	limE \| mhcA	increased actin filament polymerization
DBS0350808	mhcA-/ [act15]: mhcA(1-933: 1455-2116]	mhcA	wild type \| aberrant cytokinesis \| aberrant fruiting body morphogenesis
DBS0238158	mhcA-/ [act15]: mhcA(81-2116)	mhcA	decreased growth rate \| development arrests at tipped mound stage
CW0401	mhcA-/ [act15]: mhcA(T1823A/ T1833A/ T2029A)	mhcA	increased myosin II assembly \| decreased growth rate \| aberrant chemotaxis
DBS0236550	mhcA-/ [act15]: mhcA(T1823A/ T1833A/ T2029A)	mhcA	decreased filopodium formation
DBS0236551	mhcA-/ [act15]: mhcA(T1823D/ T1833D/ T2029D)	mhcA	increased filopodium formation
DBS0238399	mhcA-/ [act15]: rapA(G12V)	mhcA \| rapA	increased establishment of cell polarity \| increased actin filament polymerization \| aberrant myosin II filament organization
DBS0236552	mhcA-/ [mhcA]: mhcA(1-1224)	mhcA	aberrant cytokinesis \| development arrests at mound stage
DBS0350948	mhcA-/ [mhcA]: mhcA(1-1224)/ [act15]: mhcA(E683K)	mhcA	aberrant catalytic activity
DBS0350949	mhcA-/ [mhcA]: mhcA(1-1224)/ [act15]: mhcA(R686C)	mhcA	aberrant catalytic activity
DBS0238157	mhcA-/ [mhcA]: mhcA(1-1224)/ [act15]: mhcA(R689H)	mhcA	decreased actin filament sliding
DBS0236547	mhcA-/ [unk]: GFP: icpA	icpA \| mhcA	decreased protein localization to cleavage furrow
DBS0350668	mhcA-/ forA-	forA \| mhcA	abolished cell motility \| decreased cell motility
DBS0351411	mhcA-/ piaA-	mhcA \| piaA	aberrant cytokinesis
CW0371	mhkA-	mhkA	increased myosin II assembly \| aberrant chemotaxis \| decreased cell motility \| aberrant protein localization to pseudopodium
DBS0236557	mhkA-/ [act15]: mhkA	mhkA	decreased growth rate \| development arrests at mound stage \| aberrant cytokinesis \| decreased myosin II assembly
CW0431	mhkA-/ mhkB-/ mhkC-	mhkA \| mhkB \| mhkC	increased myosin II assembly \| decreased growth rate \| aberrant cytokinesis \| aberrant chemotaxis \| decreased cell motility
DBS0236556	mhkA-/ mhkC-	mhkA \| mhkC	increased myosin II assembly \| decreased growth rate \| aberrant cytokinesis
CW0394	mhkA/ mhkB	mhkA \| mhkB	increased myosin II assembly \| decreased growth rate \| aberrant cytokinesis
CW0166	mhkB-	mhkB	increased myosin II assembly \| decreased cell motility
CW0403	mhkC-	mhkC	increased myosin II assembly \| aberrant cytokinesis \| aberrant chemotaxis
DG1069	mhkC-	mhkC	aberrant fruiting body morphogenesis
CW0435	mhkD-	mhkD	increased myosin II assembly \| decreased cell motility
DBS0236559	midA-	midA	decreased pinocytosis \| aberrant cellular homeostasis \| aberrant spore morphology \| decreased glycogen level \| increased ammonia level \| decreased thermotaxis \| increased autophagy \| decreased mitochondrial fission \| decreased growth rate \| decreased phagocytosis \| decreased vegetative cell size \| increased slug migration \| increased glutamate level \| decreased phototaxis
DBS0350123	midA-/ [act15]: GFP: atg18	atg18 \| midA	increased number of autophagosomes
DBS0350136	midA-/ [act15]: GFP: tkt	midA \| tkt-1 \| tkt-2	increased autophagy
DBS0351180	midA/ [act15]: midA(E200A)	midA	aberrant cellular homeostasis \| decreased growth rate \| decreased phototaxis
DBS0351182	midA/ [act15]: midA(G170V/ G172V)	midA	aberrant cellular homeostasis \| decreased growth rate \| decreased phototaxis
DBS0351181	midA/ [act15]: midA(N205A)	midA	aberrant cellular homeostasis \| decreased growth rate \| decreased phototaxis
DG1020	migA-	migA	abolished slug migration \| decreased mound size \| aberrant fruiting body morphogenesis \| decreased fruiting body size
DBS0350958	migA-	migA	decreased gene expression \| aberrant chemotaxis to cAMP
DBS0350025	mip1-	mip1-1 \| mip1-2	increased mound size \| decreased chemotaxis to cAMP
DBS0350027	mip1-/ [act15]: mekA: FLAG	mekA \| mip1-1 \| mip1-2	aberrant protein localization to cytoplasm
DBS0266620	mipp1-	mipp1	aberrant inositol phosphate metabolic process \| increased response to lithium
DBS0309109	mipp1-/ dpoA-	dpoA \| mipp1	aberrant inositol phosphate metabolic process \| increased response to lithium
DBS0236560	mkcA-	mkcA	decreased prestalk gene expression
DBS0236561	mkcA-/ tagB-	mkcA \| tagB	decreased sporulation
DBS0236562	mkcA-/ tagC-	mkcA \| tagC	decreased sporulation
DG1101	mkcB-	mkcB	decreased fruiting body size
DBS0236564	mkkA-	mkkA	precocious culmination \| decreased sorus size \| increased stalk length
DG1121	mkpA-	mkpA	abolished aggregation
DBS0236566	mlcE-	mlcE	aberrant cytokinesis \| decreased growth rate \| delayed aggregation \| aberrant taxis \| aberrant sorocarp development \| decreased cell motility \| aberrant gene expression
DBS0238058	mlcE-/ [act15]: myc: mlcE	mlcE	wild type
DBS0236567	mlcR-	mlcR	aberrant cytokinesis \| development arrests at mound stage \| aberrant myosin II filament organization
DBS0351550	mlcR-/ [ecmAO]: GFP	mlcR	aberrant development of tipped mound
HS183	mlkA-	mlkA	aberrant cytokinesis
DBS0349919	mlkA-/ [act15]: GFP-mhcA	mlkA	aberrant stalk morphogenesis
DG1033	modA-	modA	decreased response to Gram-negative bacterium \| abolished catalytic activity \| aberrant fruiting body morphogenesis
DBS0266903	mpl1-	mpl1	abolished stream development \| decreased cell motility \| decreased chemotaxis to cAMP \| abolished aggregation
DBS0266904	mpl1-/ [act15]: flag: mpl1	mpl1	wild type
DBS0349986	mrfA-	mrfA	aberrant slug migration \| delayed development
DBS0350391	mrfA-/ [act15]: myc: mrfA(K772A): FLAG	mrfA	aberrant protein modification
DBS0350390	mrfA-/ [act15]: myc: mrfA(S767A): FLAG	mrfA	aberrant protein modification \| delayed development
DBS0350389	mrfA-/ [act15]: myc: mrfA: FLAG	mrfA	wild type
DBS0349987	mrfA-/ [emcA]: lacZ	mrfA	decreased prestalk A cell differentiation
DBS0349988	mrfA-/ dimB-/ [emcA]: lacZ	dimB \| mrfA	decreased prestalk A cell differentiation
DBS0350960	mroh1-	mroh1	aberrant exocytosis \| decreased lysosome size
DBS0236569	mrps4-	mrps4	delayed aggregation \| aberrant fruiting body morphogenesis
DBS0304881	mrps4-	mrps4	delayed aggregation
DBS0351541	mscS-/ mclN-/ pkd2-	mcln \| mscS \| pkd2	aberrant calcium-mediated signaling
DBS0304882	mtDNA-	DidioMp05 \| DidioMp21 \| DidioMp26 \| DidioMp27 \| DidioMp30 \| DidioMp35 \| DidioMp36 \| ai2a \| ai2b \| ai3 \| ai4 \| atp1 \| atp4 \| atp6 \| atp8 \| atp9 \| cox1/ 2 \| cox3 \| cytB \| mrpl11 \| mrpl14 \| mrpl16 \| mrpl2 \| mrpl6 \| mrps12 \| mrps13 \| mrps14 \| mrps19 \| mrps2 \| mrps4 \| mrps7 \| mrps8 \| nad1 \| nad11 \| nad2 \| nad3 \| nad4 \| nad4L \| nad5 \| nad6 \| nad7 \| nad9 \| rnlA	abolished vegetative growth \| abolished aggregation
DBS0350868	mtpn-	mtpn	decreased actin filament polymerization \| decreased growth rate \| decreased cell motility \| aberrant stream morphology \| decreased macropinocytosis
HM1464	mus81-	mus81	wild type
DBS0350866	mvpA-	mvpA	aberrant cell morphology
DBS0351489	mvpA-/ mvpB-	mvpA \| mvpB	decreased growth rate \| aberrant cellular component organization
DBS0236570	mybB-	mybB	decreased gene expression \| decreased activation of adenylate cyclase activity \| decreased cGMP-mediated signaling \| abolished aggregation
DBS0236571	mybB-	mybB	abolished aggregation
HM388	mybC-	mybC	decreased gene expression \| development arrests at slug stage \| decreased prespore gene expression \| abolished culmination
DBS0236572	mybE-	mybE	increased migratory slug size \| increased gene expression \| abolished outer basal disc formation
DBS0349993	mybE-/ [btg]: lacZ	btg \| mybE	increased gene expression
DBS0237709	mybE-/ [mrrA]: lacZ	mrrA \| mybE	aberrant prestalk cell differentiation
DBS0236573	mybE-/ mybE: GFP	mybE	wild type \| aberrant prestalk cell differentiation
HDT1	myoA-	myoA	aberrant aggregation \| decreased lateral pseudopodium retraction \| delayed aggregation \| decreased cell motility \| decreased chemotaxis rate \| aberrant pseudopodium formation \| decreased chemotaxis to cAMP
HDT2	myoA-	myoA	increased secretion of lysosomal enzymes \| delayed aggregation
HDT5	myoA-/ myoB-	myoA \| myoB	decreased pinocytosis \| increased secretion of lysosomal enzymes \| increased filopodium formation \| aberrant aggregation \| aberrant endosomal transport \| decreased defense response to Gram-negative bacterium \| aberrant cortical actin cytoskeleton organization \| increased lateral pseudopodium formation \| decreased growth rate \| delayed aggregation \| decreased cell motility \| decreased fruiting body size \| aberrant actin filament organization \| decreased chemotaxis to cAMP \| aberrant cytoskeleton organization
DBS0350990	myoA-/ myoB-/ [act15]: myoB	myoA \| myoB	delayed aggregation
DBS0350991	myoA-/ myoB-/ [act15]: myoB(1-1057)	myoA \| myoB	decreased pinocytosis \| decreased growth rate \| aberrant actin filament organization
DBS0350992	myoA-/ myoB-/ [act15]: myoB(S332)	myoA \| myoB	decreased pinocytosis \| decreased growth rate \| aberrant actin filament organization
DBS0351038	myoA-/ myoF-	myoA \| myoF	decreased lateral pseudopodium retraction \| decreased cell motility \| decreased chemotaxis to cAMP \| aberrant cell morphology \| abolished aggregation
DBS0236579	myoB-	myoB	increased secretion of lysosomal enzymes \| aberrant aggregation \| decreased lateral pseudopodium retraction \| decreased cell motility \| decreased chemotaxis to cAMP
DBS0236580	myoB-	myoB	increased lateral pseudopodium formation \| decreased phagocytosis \| delayed aggregation \| decreased cell motility
DBS0349853	myoB-	myoB	decreased phagolysosome size \| delayed phagosome reneutralization \| aberrant phagosome maturation
DBS0236583	myoB-/ [AS]myoD	myoB \| myoD	decreased pinocytosis \| aberrant aggregation \| decreased growth rate \| decreased phagocytosis \| decreased mound size \| decreased cell motility
DBS0236584	myoB-/ [AS]myoD/ [KD]myoC	myoB \| myoC \| myoD	decreased pinocytosis \| aberrant aggregation \| decreased pinosome size \| decreased growth rate \| decreased phagocytosis \| decreased mound size \| decreased cell motility \| increased number of pinosomes
DBS0351378	myoB-/ [act15]: GFP: myoB(1-720)	myoB	abolished protein localization to plasma membrane
DBS0351379	myoB-/ [act15]: GFP: myoB(1-800,813-1111)	myoB	abolished protein localization to actin wave \| abolished protein localization to plasma membrane
DBS0351380	myoB-/ [act15]: GFP: myoB(713-1111)	myoB	abolished protein localization to leading edge
DBS0351367	myoB-/ [act15]: myoB(S332A)	myoB	abolished protein phosphorylation
HDT6	myoB-/ myoC-	myoB \| myoC	increased secretion of lysosomal enzymes \| decreased pinocytosis \| increased filopodium formation \| decreased growth rate \| decreased cell motility \| decreased fruiting body size \| aberrant actin filament organization \| aberrant cytoskeleton organization
DBS0236585	myoC-	myoC	decreased phagocytosis
HDT4	myoC-	myoC	decreased pinocytosis \| decreased phagocytosis
DBS0236587	myoD-	myoD	wild type
DBS0351031	myoD-/ myoE-	myoD \| myoE	decreased fruiting body size
DBS0351034	myoD-/ myoE-/ myoF-	myoD \| myoE \| myoF	decreased actin filament polymerization \| aberrant engulfment during phagocytosis \| decreased chemotaxis to cAMP \| decreased fruiting body size
DBS0351033	myoD-/ myoF-	myoD \| myoF	decreased fruiting body size
DBS0351032	myoE-/ myoF-	myoE \| myoF	decreased fruiting body size
HDT8	myoF-	myoF	aberrant aggregation \| wild type \| increased lateral pseudopodium formation \| decreased cell motility \| decreased chemotaxis to cAMP \| aberrant cell morphology
DBS0350251	myoG-	myoG	decreased protein localization to plasma membrane \| decreased actin filament polymerization \| abolished establishment of cell polarity \| aberrant chemotaxis to cAMP \| abolished aggregation
DBS0236589	myoI-	myoI	decreased spore germination
DBS0236592	myoI-	myoI	decreased cell-substrate adhesion \| aberrant cytokinesis \| decreased phagocytosis \| aberrant cell morphology
HDT15	myoI-	myoI	decreased phagocytosis
HDT17	myoI-	myoI	decreased cell-cell adhesion \| decreased protein level \| decreased cell-substrate adhesion \| decreased phagocytosis \| decreased filopodium formation
DBS0266889	myoI-/ [act15]: GFP: myoI	myoI	wild type
DBS0351400	myoI-/ [act15]: GFP: myoI(1-1020)	myoI	abolished protein localization to pseudopodium \| decreased filopodium formation
DBS0351398	myoI-/ [act15]: GFP: myoI(2057-2357)	myoI	increased filopodium formation
DBS0266890	myoI-/ [act15]: GFP: myoI(809-1154)	myoI	decreased phagocytosis
DBS0351399	myoI-/ [act15]: GFP: myoI(K23333A,K2336A)	myoI	increased filopodium formation
DBS0237617	myoI-/ [act15]: gbpD	gbpD \| myoI	increased cell-substrate adhesion \| aberrant cell morphology \| increased pseudopodium formation
HTD7	myoJ-	myoJ	wild type
DBS0350931	myoJ-	myoJ	decreased hypotonic response \| aberrant contractile vacuole discharge \| aberrant contractile vacuole localization
DBS0349844	myoK-	myoK	aberrant cortical actin cytoskeleton organization \| delayed aggregation \| decreased phagocytosis \| aberrant engulfment during phagocytosis \| aberrant phagosome maturation \| decreased chemotaxis rate \| aberrant cell morphology \| delayed phagosome acidification
DBS0349846	myoK-/ [act15]: YFP: myoK(1-121: 262-858)	myoK	decreased phagocytosis
DBS0349850	myoK-/ [act15]: myoK	myoK	increased phagocytosis
DBS0349854	myoK-/ [act15]: pakB(1-337: 563-852)	myoK \| pakB	wild type
DBS0236595	myoM-	myoM	wild type
DBS0351046	nad2-	nad2	decreased defense response to Gram-negative bacterium \| decreased gene expression \| decreased growth rate \| aberrant fruiting body morphogenesis \| aberrant phototaxis
DBS0351048	nad5-	nad5	decreased defense response to Gram-negative bacterium \| decreased gene expression \| decreased growth rate \| aberrant phototaxis
AK1372	nagB1-	nagB1	decreased response to Gram-positive bacterium
DBS0236596	napA-	napA	aberrant cellular response to extracellular stimulus
SB12	napA-	napA	decreased cell-cell adhesion \| decreased cell-substrate adhesion \| decreased actin filament polymerization \| decreased cell motility \| decreased vegetative cell size \| decreased establishment of cell polarity \| decreased phototaxis
DBS0351534	napA-/ AX2	napA	decreased protein level \| increased membrane ruffling \| aberrant cytokinesis \| increased vegetative cell size \| decreased cell motility
SB14	napA-/ pirA-	napA \| pirA	decreased actin filament polymerization
HC476	ncsA-	ncsA	increased cAMP level \| precocious gene expression \| precocious development
HC477	ncsA-	ncsA	increased cAMP level \| precocious gene expression \| precocious development
DBS0350297	ncstn-	ncstn	aberrant culmination \| abolished catalytic activity \| decreased prespore cell differentiation
DBS0350307	ncstn-	ncstn	wild type \| aberrant sorocarp development \| decreased macropinocytosis
DBS0350301	ncstn-/ psenA-	ncstn \| psenA	aberrant culmination \| decreased prespore cell differentiation
DBS0349947	ndm-	ndm	aberrant chemotaxis \| increased pinocytosis \| decreased fruiting body size \| aberrant pseudopodium formation
DBS0349895	ndrA-	ndrA	decreased engulfment during phagocytosis
DBS0349896	ndrA-/ [unk]: GFP: ndrA	ndrA	wild type
DBS0350446	ndrC-	ndrC	increased positive regulation of GTPase activity \| increased number of centrosomes \| aberrant cell separation during cytokinesis
DBS0350121	ndufaf5-	ndufaf5	aberrant spore morphology \| decreased growth rate \| delayed development \| aberrant phototaxis \| decreased fruiting body size \| decreased sporulation
DBS0350125	ndufaf5--/ [act15]: ndufaf5(G86V): GFP: TAP	ndufaf5	decreased growth rate
DBS0350126	ndufaf5--/ [act15]: ndufaf5(L165F): GFP: TAP	ndufaf5	decreased growth rate
DBS0350127	ndufaf5--/ [act15]: ndufaf5(L235P): GFP: TAP	ndufaf5	decreased growth rate
DBS0350124	ndufaf5--/ [act15]: ndufaf5: GFP: TAP	ndufaf5	wild type
DBS0350122	ndufaf5-/ [act15]: GFP: atg18	atg18 \| ndufaf5	increased number of autophagosomes
DBS0350134	ndufaf5-/ [act15]: GFP: tkt	ndufaf5 \| tkt-1 \| tkt-2	increased autophagy
DBS0350137	ndufaf5-/ [act15]: [AS]snfA	ndufaf5 \| snfA	aberrant phototaxis
DBS0304633	nfaA-	nfaA	aberrant extracellular cAMP signaling pathway \| aberrant activation of GTPase activity \| increased actin filament polymerization \| delayed aggregation \| decreased cell motility \| aberrant regulation of GTPase activity \| aberrant regulation of protein kinase activity \| aberrant protein localization to plasma membrane \| decreased chemotaxis to cAMP \| increased pseudopodium formation
DBS0304634	nfaA-/ rasG-	nfaA \| rasG	decreased establishment of cell polarity
DBS0351061	ngap-	ngap	aberrant regulation of fruiting body formation \| aberrant extracellular cAMP signaling pathway \| aberrant adaptation of signaling pathway \| increased actin filament polymerization \| aberrant chemotaxis to cAMP \| aberrant regulation of protein kinase activity \| decreased establishment of cell polarity \| increased activation of GTPase activity
DBS0236604	nhe1-	nhe1	abolished cell motility in response to calcium ion \| decreased intracellular pH \| abolished establishment of cell polarity \| decreased actin filament polymerization \| decreased chemotaxis rate \| delayed development \| aberrant actin filament organization \| decreased establishment of cell polarity \| abolished chemotaxis to cAMP
DBS0350003	nhe1-/ [act15]: GFP: aip1	aip1 \| nhe1	decreased establishment of cell polarity \| decreased chemotaxis to cAMP
DBS0350006	nhe1-/ [act15]: GFP: aip1(E125A, E167A, F181A, F193A)	aip1 \| nhe1	abolished aggregation \| abolished chemotaxis to cAMP
DBS0350001	nhe1-/ [act15]: aip1(168-597)	aip1 \| nhe1	delayed development
DBS0350002	nhe1-/ [act15]: aip1(383-597): FLAG	aip1 \| nhe1	decreased actin filament polymerization \| abolished establishment of cell polarity \| abolished chemotaxis to cAMP
DBS0349841	nhe1-/ [act15]: mhcA: GFP	mhcA \| nhe1	abolished protein localization to trailing edge
DBS0236605	nhe1-/ [act15]: nhe1: HA	nhe1	wild type
DBS0350508	nlp-	nlp	wild type
DBS0350509	nlp-/ slp-	nlp \| slp	decreased actin filament polymerization \| aberrant organelle organization \| abolished protein localization to cytoplasmic vesicle \| decreased chemotaxis to cAMP
DBS0351466	nola4(I23T)	nola4	decreased resistance to bleomycin \| decreased growth rate \| increased growth rate \| aberrant response to oxidative stress
DBS0351467	nola4(T33M)	nola4	decreased resistance to bleomycin \| decreased gene expression \| decreased growth rate \| increased growth rate \| aberrant response to oxidative stress
DBS0236606	nosA null (15-S-12)	nosA	development arrests at mound stage
DBS0236607	nosA null (2E4)	nosA	development arrests at mound stage
DBS0235950	nosA-	nosA	development arrests at mound stage \| aberrant protein modification
DBS0236941	nosA-/ sonA-	nosA \| sonA	wild type
DBS0236608	noxA-	noxA	abolished sporulation \| aberrant sorocarp development
DBS0236611	noxA-/ [act15]: noxA: myc2	noxA	aberrant fruiting body morphogenesis
DBS0236610	noxA-/ noxB	noxA \| noxB	abolished sporulation \| aberrant sorocarp development \| decreased superoxide generation
DBS0350768	noxA-/ noxB-/ noxC-	noxA \| noxB \| noxC	aberrant defense response to bacterium
DBS0236612	noxB-	noxB	abolished sporulation \| aberrant sorocarp development \| decreased superoxide generation
DBS0236613	noxC-	noxC	abolished sporulation \| aberrant sorocarp development
DBS0238849	npcA-	npcA	wild type
HSB60	nramp1-	nramp1	decreased defense response to Gram-negative bacterium \| decreased defense response to Gram-positive bacterium \| abolished iron ion transport
DBS0236696	nramp1-/ [act15]: nramp1: GFP	nramp1	increased defense response to Gram-negative bacterium
DBS0236697	nramp1-/ [act15]: nramp1: GFP	nramp1	increased defense response to Gram-negative bacterium
DBS0350092	nrampB-	nrampB	decreased defense response to Gram-negative bacterium \| delayed aggregation
DBS0350093	nrampB-/ nramp1-	nramp1 \| nrampB	increased number of tip-organizers \| decreased defense response to Gram-negative bacterium \| delayed aggregation
HM1060	nsfA(A1847G, A1939T, T1977C, T2005G, A2025T, A2366T)	nsfA	decreased rate of endocytosis \| decreased phagocytosis \| abolished cell motility \| decreased actin filament polymerization at leading edge
HM1067	nsfA(A1854T, T1984A, C2131A, A2398T, T2574A)	nsfA	decreased rate of endocytosis \| abolished cell motility \| decreased cell motility \| aberrant hypotonic response \| decreased actin filament polymerization at leading edge \| increased phagocytosis
DBS0236955	nxnA-	nxnA	decreased lysosomal protein degradation \| decreased culmination \| decreased growth rate \| delayed development \| decreased chemotaxis to cAMP
DBS0351164	nxnA-	nxnA	aberrant cellular response to stress
DBS0236702	nxnA-/ [act15]: GFP: nxnB	nxnA \| nxnB	development arrests at mound stage
DBS0350857	odc-	odc	aberrant cellular metabolic process \| aberrant cell cycle \| abolished vegetative growth
DBS0236704	osbA-	osbA	increased slug migration \| precocious development
DBS0238357	p2xA-	p2xA	aberrant hypotonic response
DBS0304487	p2xA-	p2xA	wild type
DBS0350312	p2xA-	p2xA	aberrant contractile vacuole organization \| abolished hypotonic response \| decreased contractile vacuole size \| aberrant regulation of GTPase activity
DBS0350484	p2xA-/ AX2	p2xA	wild type \| aberrant contractile vacuole discharge
DBS0350485	p2xA-/ AX4	p2xA	aberrant contractile vacuole discharge \| aberrant hypotonic response
DBS0238362	p2xA-/ [act15]: p2xA: GFP	p2xA	wild type
DBS0350315	p2xA-/ p2xA(K67A/ K289A)	p2xA	abolished hypotonic response
DBS0350314	p2xA-/ p2xA(R285K)	p2xA	decreased hypotonic response
DBS0350313	p2xA-/ p2xA(R63A)	p2xA	precocious hypotonic response
DBS0306169	p2xA-/ p2xB-/ p2xC-/ p2xD-/ p2xE-	p2xA \| p2xB \| p2xC \| p2xD \| p2xE	delayed hypotonic response \| decreased growth rate
DBS0306166	p2xB-	p2xB	wild type
DBS0306167	p2xC-	p2xC	wild type
DBS0306168	p2xD-	p2xD	wild type
DBS0304486	p2xE-	p2xE	wild type
DBS0304465	padA(1-276)	padA	aberrant aggregation \| decreased cell-cell adhesion \| decreased gene expression \| development arrests at slug stage \| delayed aggregation \| aberrant stalk cell differentiation \| aberrant chemotaxis to cAMP \| aberrant stream morphology \| aberrant fruiting body morphogenesis \| delayed development
DBS0350013	pah-	pah	abolished catalytic activity \| abolished vegetative growth
DBS0350014	pah-/ [act15]: 6xHis: pah	pah	wild type
DBS0350016	pah-/ [act15]: 6xHis: pah(92-415)	pah	abolished vegetative growth
DBS0350015	pah-/ [act15]: 6xHis: pah(92-441)	pah	wild type
DBS0236705	pakA-	pakA	aberrant cytokinesis \| delayed development \| decreased myosin II assembly
DBS0236706	pakA-	pakA	wild type
DBS0349885	pakA-	pakA	delayed development \| decreased chemotaxis to cAMP \| increased bleb assembly
DBS0236707	pakA-/ [act15]: pakA	pakA	wild type
DBS0350810	pakA-/ [act15]: pakA(T579A)	pakA	decreased chemotaxis to cAMP
DBS0349889	pakA-/ [act15]: pakA: GFP	pakA	wild type
DBS0236709	pakB-	pakB	decreased growth rate \| decreased bleb assembly
DBS0236708	pakB-	pakB	abolished establishment of cell polarity \| decreased lateral pseudopodium retraction
DBS0236712	pakB-/ [act15]: GFP-pak(1-600)	pakB	abolished cytokinesis
DBS0236710	pakB-/ [act15]: GFP-pakB(1-337: 563-851)	pakB	abolished cytokinesis \| increased pinocytosis \| increased phagocytosis
DBS0350428	pakB-/ [act15]: RFP: abpE	abpE-1 \| abpE-2 \| pakB	decreased chemotaxis to cAMP \| aberrant establishment or maintenance of cell polarity \| abolished aggregation \| abolished protein localization to leading edge
DBS0350430	pakB-/ [act15]: RFP: abpE/ [act15]: GFP: pak(1-180)	abpE-1 \| abpE-2 \| pakB	wild type
DBS0236715	pakB-/ pakC-	pakB \| pakC	decreased chemotaxis rate
DBS0236717	pakC(K121H/ E124L)	pakC	abolished protein binding
DBS0236719	pakC(R34C)	pakC	decreased lateral pseudopodium retraction \| decreased chemotaxis rate
DBS0236720	pakC(S466A/ P470A)	pakC	decreased lateral pseudopodium retraction \| decreased chemotaxis rate
DBS0236716	pakC-	pakC	decreased lateral pseudopodium retraction \| decreased bleb assembly \| decreased chemotaxis rate
DBS0350281	pakD-	pakD	aberrant cellular homeostasis \| aberrant filopodium formation \| aberrant actin cytoskeleton organization \| abolished negative regulation of vegetative growth \| abolished aggregation \| aberrant actin filament polymerization \| aberrant establishment or maintenance of cell polarity \| decreased chemotaxis to cAMP \| increased growth rate \| aberrant cellular response to extracellular stimulus \| abolished positive regulation of chemorepellant activity
DBS0350282	pakD-/ [act15]: pakD	pakD	development arrests at mound stage
DBS0350395	pakD-/ [act15]: pakD: GFP	pakD	wild type
HC392	patB-	patB	abolished vegetative growth
DBS0236726	pats1-	pats1	aberrant cytokinesis
DBS0350097	pats1-	pats1	aberrant cytokinesis
LAS45	pats1-	pats1	decreased socially cooperative development
DBS0236727	pats1-/ [act15]: GFP: pats1(2087-2351)	pats1	aberrant cytokinesis
DBS0236728	paxB-	paxB	decreased exocytosis \| decreased cell-substrate adhesion \| abolished slug migration \| increased chemotaxis to cAMP \| development arrests at mound stage \| decreased prespore gene expression \| aberrant fruiting body morphogenesis \| decreased cell migration to prestalk region \| increased phagocytosis
DBS0304926	paxB-	paxB	aberrant cell separation during cytokinesis \| decreased cell-substrate adhesion \| aberrant cytokinesis \| decreased cell motility
DBS0304930	paxB-/ [act15]: GFP: paxB	paxB	wild type
DBS0350973	paxB-/ [act15]: gpaH	gpaH \| paxB	aberrant cytokinesis
DBS0350094	paxB-/ [act15]: pldB	paxB \| pldB	wild type \| increased phagocytosis
DBS0236730	paxB-/ [ecmA]: paxB: GFP	paxB	decreased cell migration to prestalk region
DBS0236732	paxB-/ [pspA]: paxB: GFP	paxB	decreased cell migration to prestalk region
DBS0304929	paxB-/ mhcA-	mhcA \| paxB	aberrant cytokinesis
DBS0236733	pcp-	pcp	wild type \| aberrant hypotonic response
DBS0236734	pde4-	pde4	decreased culmination \| abolished stream development \| delayed slug development \| increased number of early culminant tips \| increased protein level \| delayed culmination
DBS0236735	pde4-/ [act15]: pde4: GFP	pde4	wild type
DBS0235991	pdeD-	pdeD	decreased 3',5'-cyclic-GMP phosphodiesterase activity
DBS0236736	pdeD-	pdeD	aberrant calcium-mediated signaling
DBS0350517	pdeD-	pdeD	decreased 3',5'-cyclic-GMP phosphodiesterase activity \| increased fruiting body size \| aberrant stream morphology
DBS0351194	pdeD-	pdeD	decreased protein localization to cell cortex \| abolished protein localization to cell cortex \| aberrant chemotaxis to cAMP \| aberrant actin filament polymerization \| decreased myosin II assembly \| increased activation of GTPase activity
DBS0350518	pdeD-/ [act15]: pdeD: YFP	pdeD	wild type
DBS0235992	pdeD-/ pdeE-	pdeD \| pdeE	decreased protein localization to cell cortex \| decreased 3',5'-cyclic-GMP phosphodiesterase activity \| decreased 3',5'-cyclic-AMP phosphodiesterase activity \| decreased lateral pseudopodium formation \| increased protein kinase activation
DBS0350893	pdeD-/ pdeE-/ [unk]: pdeE	pdeD \| pdeE	delayed aggregation
DBS0350900	pdeE-	pdeE	increased oscillatory cAMP signaling \| abolished 3',5'-cyclic-AMP phosphodiesterase activity
DBS0235993	pdeE-	pdeE	decreased 3',5'-cyclic-AMP phosphodiesterase activity \| aberrant chemotaxis to cAMP
DBS0236740	pdiA-	pdiA	decreased mound size \| aberrant oscillatory cAMP signaling \| decreased fruiting body size
DBS0350797	pdkA-	pdkA	aberrant macropinocytosis \| decreased protein kinase activation
DBS0350817	pdkA-	pdkA	decreased mound size \| decreased protein kinase activation
DBS0350799	pdkA-/ pdkB-	pdkA \| pdkB	aberrant chemotaxis to cAMP \| development arrests at mound stage \| decreased protein kinase activation \| decreased establishment of cell polarity
DBS0350819	pdkA-/ pdkB-	pdkA \| pdkB	aberrant sorocarp development
DBS0350798	pdkB-	pdkB	increased macropinocytosis
DBS0350818	pdkB-	pdkB	decreased mound size
DBS0237029	pdsA-	pdsA	aberrant chemotaxis to cAMP \| aberrant stream morphology
UK7	pdsA-	pdsA	decreased 3',5'-cyclic-AMP phosphodiesterase activity \| decreased gene expression \| aberrant sorocarp development \| abolished aggregation
HPX235	pdsA-	pdsA	abolished catalytic activity \| abolished aggregation
DBS0236741	pefA-	pefA	wild type
DBS0236742	pefA-/ pefB-	pefA \| pefB	wild type
DBS0236744	pefB-	pefB	wild type
DBS0236745	pefB-/ cybA-	cybA \| pefB	wild type
DBS0236746	pefB-/ noxA-	noxA \| pefB	wild type
DBS0236747	pefB-/ noxA-/ [act15]: pefB	noxA \| pefB	aberrant sorocarp development
DBS0236748	pefB-/ noxB-	noxB \| pefB	wild type
DBS0236749	pefB-/ noxC-	noxC \| pefB	abolished sporulation \| aberrant sorocarp development
HW260	pgtA-	pgtA	increased vegetative cell size
DBS0305022	pgtB-	pgtB	aberrant cellular metabolic process \| aberrant spore coat morphology \| aberrant hyperosmotic response
DBS0305024	pgtB-/ pgtC-	pgtB \| pgtC	aberrant cellular metabolic process \| aberrant spore coat morphology \| aberrant hyperosmotic response
DBS0305023	pgtC-	pgtC	aberrant cellular metabolic process \| aberrant hyperosmotic response
DBS0236752	phdA-	phdA	decreased actin filament polymerization \| decreased mound size \| decreased chemotaxis rate \| decreased fruiting body size
DBS0236753	phdA-/ [act15]: phdA	phdA	wild type
DBS0236754	phdA-/ [act15]: phdA: GFP	phdA	wild type
DBS0350865	phdG-	phdG	decreased chemotaxis to cAMP
DBS0236755	phg1A-	phg1A	increased secretion of lysosomal enzymes \| decreased lysosomal protein degradation \| decreased protein level \| decreased cell-substrate adhesion \| decreased gene expression \| aberrant defense response to bacterium \| aberrant cytokinesis \| decreased phagocytosis \| abolished defense response to bacterium \| decreased growth rate \| development arrests at slug stage \| decreased protein localization to cell surface \| aberrant phagocytosis \| increased lysosomal pH \| decreased protein stabilization
DBS0351549	phg1A-	phg1A	decreased cell-substrate adhesion \| decreased phagocytosis
DBS0236757	phg1A-/ [act15]: kil1	kil1 \| phg1A	decreased lysosomal protein degradation \| increased secretion of lysosomal enzymes \| wild type \| increased lysosomal pH \| decreased protein stabilization
DBS0304869	phg1A-/ [act15]: phg1A(1-276): phg1B221-587)	phg1A \| phg1B	decreased phagocytosis
DBS0304868	phg1A-/ [act15]: phg1B	phg1A \| phg1B	increased secretion of lysosomal enzymes \| wild type \| decreased cell-substrate adhesion \| aberrant protein level \| decreased phagocytosis
DBS0304870	phg1A-/ [act15]: phg1B(1-220): phg1a(277-642)	phg1A \| phg1B	decreased phagocytosis
DBS0304872	phg1A-/ phg1B-	phg1A \| phg1B	increased secretion of lysosomal enzymes \| decreased cell-substrate adhesion \| decreased phagocytosis \| decreased growth rate \| development arrests at tipped mound stage \| abolished culmination
DBS0304866	phg1B-	phg1B	increased secretion of lysosomal enzymes \| decreased protein level \| decreased phagocytosis \| decreased growth rate \| abolished culmination
DBS0236758	phg2-	phg2	decreased cell-substrate adhesion \| decreased phagocytosis \| aberrant cytokinesis \| decreased cell motility \| aberrant cell morphology \| aberrant actin filament organization \| precocious development \| precocious gene expression \| aberrant response to nutrient
DBS0238400	phg2-	phg2	increased filopodium formation \| increased actin filament polymerization \| increased cell-substrate adhesion \| decreased chemotaxis to cAMP \| aberrant cell morphology \| increased phagocytosis
DBS0350578	phg2-	phg2	abolished gene expression \| decreased protein phosphorylation \| aberrant protein localization to nucleus
DBS0236760	phg2-/ [act15]: GFP: phg2(199-1389)	phg2	decreased phagocytosis
DBS0237615	phg2-/ [act15]: gbpD	gbpD \| phg2	aberrant cell morphology \| abolished chemotaxis to cAMP \| increased pseudopodium formation
DBS0350580	phg2-/ [act15]: myc: ptpC	phg2 \| ptpC	abolished protein phosphorylation
HG1648	phgA-	phgA	increased contractile vacuole size \| aberrant contractile vacuole organization \| aberrant hypotonic response \| aberrant pore formation during contractile vacuole discharge
DBS0302610	phgA-/ [OE]: dsgg	dsgg \| phgA	aberrant contractile vacuole organization
DBS0236761	phgA-/ lvsA-/ [act6]: GFP: lvsA	lvsA \| phgA	aberrant protein localization to contractile vacuole
DBS0236762	phlp1-	phlp1	decreased response to cAMP \| aberrant regulation of protein modification \| abolished chemotaxis to folate \| decreased growth rate \| abolished protein localization to plasma membrane \| decreased cGMP-mediated signaling \| abolished aggregation \| abolished chemotaxis to cAMP
DBS0236763	phlp1-/ [OE]: phpl1	phlp1	wild type
DBS0236764	phlp3-	phlp3	wild type
DBS0350824	phr-	phr	aberrant chemotaxis to cAMP \| delayed development
HW288	phyA-	phyA	abolished sporulation \| abolished stalk development \| abolished peptidyl-proline hydroxylation \| abolished culmination \| increased response to hypoxia
DBS0266771	phyA-/ [ecmA]: phyA(D132N): myc	phyA	decreased peptidyl-proline hydroxylation
DBS0266770	phyA-/ [ecmA]: phyA(R276A): myc	phyA	abolished peptidyl-proline hydroxylation \| abolished culmination
	piaA(G917D)	piaA
DBS0236769	piaA(G917D)/ [act15]: piaA	piaA	delayed aggregation
DBS0351455	piaA(G917D)/ [unk]: GFP: piaA(G963E)	piaA	abolished aggregation
DBS0350882	piaA(G917D)/ acrA-	acrA \| piaA	abolished gene expression \| abolished establishment of cell polarity \| abolished chemotaxis to cAMP
DBS0350877	piaA(G917D)/ hephA-	hephA \| piaA	increased response to cAMP \| wild type \| abolished activation of adenylate cyclase activity \| decreased cAMP level
DBS0236767	piaA-	piaA	aberrant activation of adenylate cyclase activity
DBS0236770	piaA-	piaA	aberrant cytokinesis
DBS0236771	piaA-	piaA	abolished aggregation \| decreased myosin II assembly \| increased phagocytosis
DBS0304637	piaA-	piaA	decreased cell motility \| decreased chemotaxis rate \| decreased establishment of cell polarity \| aberrant protein tyrosine phosphorylation
DBS0351319	piaA-	piaA	decreased taxis
DBS0349879	piaA-	piaA	decreased protein phosphorylation \| decreased protein kinase activity \| abolished protein phosphorylation \| decreased chemotaxis to cAMP \| aberrant protein localization to plasma membrane \| increased activation of GTPase activity \| abolished positive regulation of chemorepellant activity
DBS0351403	piaA-	piaA	aberrant cytokinesis
DBS0236779	pik6-	pik6	decreased gene expression \| abolished aggregation
DBS0236772	pikA-	pikA	wild type
DBS0236766	pikA-/ pikB-	pikA \| pikB	aberrant negative chemotaxis \| decreased response to bacterium \| decreased actin filament polymerization \| decreased activation of GTPase activity \| abolished protein localization to plasma membrane \| aberrant chemotaxis to cAMP \| decreased cell motility \| abolished protein kinase activation \| abolished protein localization to trailing edge \| decreased chemotaxis to folate \| decreased chemotaxis to cAMP \| decreased myosin II assembly
DBS0236773	pikA-/ pikB-	pikA \| pikB	abolished stream development \| decreased pinocytosis \| aberrant aggregation \| decreased exocytosis \| aberrant activation of adenylate cyclase activity \| aberrant macropinocytosis \| abolished protein localization to plasma membrane \| delayed aggregation \| decreased spore cell differentiation \| increased cAMP level \| abolished vegetative growth \| aberrant sorocarp development \| aberrant phagolysosome formation \| aberrant phagosome maturation \| decreased phosphatidylinositol biosynthesis \| aberrant fruiting body morphogenesis \| aberrant actin filament organization \| aberrant cell morphology
HM1141	pikA-/ pikB-	pikA \| pikB	decreased pinocytosis \| decreased growth rate \| decreased cell motility \| decreased taxis
DBS0350471	pikA-/ pikB-/ [act15]: GFP: cap	cap \| pikA \| pikB	wild type
DBS0252703	pikA-/ pikB-/ pikC-	pikA \| pikB \| pikC	decreased protein localization to leading edge \| increased cell motility
HM1200	pikA-/ pikB-/ pikC-/ pikF-/ pikG-	pikA \| pikB \| pikC \| pikF \| pikG	aberrant aggregation \| decreased pinocytosis \| decreased protein tyrosine phosphorylation \| increased chemotaxis to folate \| aberrant macropinocytosis \| decreased growth rate \| decreased phagocytosis \| decreased cell motility \| increased bleb assembly \| decreased chemotaxis to cAMP \| aberrant protein localization to plasma membrane \| aberrant signal transduction
HM1284	pikA-/ pikB-/ pikC-/ pikF-/ pikG-/ pikH-	pikA \| pikB \| pikC \| pikF \| pikG \| pikH	decreased defense response to Gram-negative bacterium \| decreased cell motility
HM1295	pikA-/ pikB-/ pikC-/ pikF-/ pikG-/ pten-	pikA \| pikB \| pikC \| pikF \| pikG \| pten	aberrant aggregation \| decreased defense response to Gram-negative bacterium \| decreased growth rate \| decreased cell motility \| increased resistance to N-Phenylthiourea
DBS0238073	pikA-/ pikB-/ plaA-	pikA \| pikB \| plaA	decreased actin filament polymerization \| delayed aggregation \| aberrant chemotaxis to cAMP \| abolished positive chemotaxis
DBS0236774	pikB-	pikB	wild type
DBS0236776	pikC-	pikC	wild type
DBS0236777	pikD1	pikD	abolished slug migration \| delayed aggregation \| decreased mound size \| aberrant fruiting body morphogenesis \| decreased sporulation
DBS0236778	pikE-	pikE	wild type
HM1241	pikF-	pikF	decreased pinocytosis \| decreased growth rate \| aberrant pinosome maturation
LAS31	pikG-	pikG	aberrant socially cooperative development
HM1513	pikI-	pikI	decreased catalytic activity \| decreased actin filament polymerization \| decreased growth rate \| aberrant chemotaxis to cAMP \| decreased cGMP-mediated signaling \| aberrant calcium-mediated signaling \| decreased protein kinase activation \| increased bleb assembly
DBS0350828	pinA-/ [ecmAO]: lacZ	pinA	aberrant prestalk cell differentiation
DBS0350827	pinA-/ [pspA]: lacZ	pinA	aberrant prespore cell differentiation
DBS0351429	pip5k3-/ AX2	pip5k3	decreased defense response to Gram-negative bacterium \| aberrant defense response to bacterium \| aberrant phagosome maturation \| decreased protein processing in phagocytic vesicle \| decreased protein localization to phagocytic vesicle
DBS0351428	pip5k3-/ AX3	pip5k3	aberrant macropinocytosis \| decreased growth rate
SB16	pirA-	pirA	decreased vegetative cell size \| increased cell motility
SB3	pirA-	pirA	increased actin filament polymerization \| increased vegetative cell size \| decreased cell motility \| aberrant cellular response to stress \| increased pseudopodium formation
DBS0351205	pirA-	pirA	decreased cell motility \| aberrant pseudopodium formation \| abolished protein level
DBS0351533	pirA-/ AX2	pirA	decreased protein level \| aberrant macropinocytosis \| aberrant cytokinesis \| increased vegetative cell size \| decreased cell motility \| decreased pseudopodium formation \| increased bleb assembly \| decreased filopodium formation
DBS0351206	pirA-/ pirA(K193D/ R194D): EGFP	pirA	abolished protein localization to cell periphery \| decreased protein phosphorylation
DBS0349901	pisA-	pisA	increased gene expression \| precocious development \| decreased fruiting body size \| aberrant prestalk cell differentiation
DBS0236783	pkaC-	pkaC	abolished gene expression \| increased protein phosphorylation \| aberrant response to abiotic stimulus \| decreased protein level \| decreased gene expression \| decreased activation of GTPase activity \| abolished catalytic activity \| aberrant response to cAMP \| increased cellular thermotolerance \| aberrant myosin II filament organization \| decreased protein kinase activation \| abolished aggregation \| aberrant actin filament organization \| aberrant protein localization to plasma membrane \| aberrant protein localization to cell cortex \| abolished chemotaxis to cAMP \| increased protein kinase activation \| increased activation of GTPase activity \| abolished positive regulation of chemorepellant activity
DBS0350694	pkaC-/ [act15]: pkaC	pkaC	abolished culmination
DBS0350708	pkaC-/ [act6]: pkaC(303-648)	pkaC	wild type
DBS0350707	pkaC-/ [act6]: pkaC(330-648)	pkaC	abolished aggregation
DBS0350710	pkaC-/ [dscC]: LUC	pkaC	decreased gene expression \| increased macropinocytosis
DBS0236782	pkaC-/ gdt1-	gdt1 \| pkaC	increased gene expression \| abolished aggregation
HTY217	pkaR(A31T)	pkaR	abolished protein kinase activation \| precocious development
DBS0235411	pkaR-	pkaR	abolished stream development \| increased resistance to valproic acid \| decreased spore germination \| aberrant extracellular cAMP signaling pathway \| aberrant response to lithium \| increased gene expression \| precocious sporulation \| increased lateral pseudopodium formation \| aberrant chemotaxis to cAMP \| decreased cell motility \| decreased fruiting body size \| aberrant cell morphology
DBS0351315	pkbA-	pkbA	decreased macropinocytosis
DBS0236784	pkbA-	pkbA	decreased pinocytosis \| decreased protein phosphorylation \| aberrant macropinocytosis \| decreased bleb assembly \| abolished protein kinase activation \| abolished protein localization \| abolished protein localization to trailing edge \| aberrant phagosome maturation \| increased phagocytosis \| decreased myosin II assembly
DBS0349876	pkbA-	pkbA	aberrant cellular response to extracellular stimulus \| increased protein kinase activation
DBS0350113	pkbA-/ [act15]: GFP: rheb(Q64L)	pkbA \| rheb	decreased phagocytosis
DBS0236785	pkbA-/ pkgB-	pkbA \| pkgB	aberrant chemotaxis to cAMP \| abolished vegetative growth \| decreased chemotaxis rate \| abolished protein phosphorylation \| abolished aggregation \| aberrant cellular response to extracellular stimulus \| increased activation of GTPase activity \| increased protein kinase activation
DBS0304640	pkbA-/ pkgB-	pkbA \| pkgB	aberrant cell motility \| abolished vegetative growth
DBS0351317	pkbA-/ pkgB-	pkbA \| pkgB	aberrant macropinocytosis \| abolished vegetative growth \| abolished macropinocytosis
DBS0350916	pkcA-	pkcA	decreased cell-cell adhesion \| decreased protein level \| increased chemotaxis to cAMP \| decreased gene expression \| increased number of mound tips \| increased actin filament polymerization \| aberrant oscillatory cAMP signaling \| decreased fruiting body size \| abolished positive regulation of chemorepellant activity
DBS0350918	pkcA-	pkcA	aberrant aggregation \| decreased catalytic activity \| aberrant cytokinesis \| aberrant sorocarp development
DBS0350919	pkcA-/ [act15]: pldB	pkcA \| pldB	aberrant aggregation \| decreased sporulation
DBS0350917	pkcA-/ [ecmA]: GFP	pkcA	aberrant prestalk gene expression
DBS0350475	pkd2-	pkd2	increased resistance to naringenin \| decreased growth rate
DBS0350367	pkd2-	pkd2	aberrant cellular response to fluid shear stress \| aberrant exocytosis
DBS0351540	pkd2-/ AX2	pkd2	aberrant calcium-mediated signaling
DBS0351542	pkd2-/ iplA-	iplA \| pkd2	aberrant calcium-mediated signaling
DBS0236786	pkgB-	pkgB	decreased protein phosphorylation \| development arrests at mound stage \| abolished spore cell differentiation
DBS0350328	pkgB-	pkgB	aberrant sorocarp development
DBS0351316	pkgB-	pkgB	decreased macropinocytosis
DBS0304638	pkgB-	pkgB	decreased cell-substrate adhesion \| development arrests at mound stage \| decreased chemotaxis rate \| decreased taxis \| increased cell motility \| increased bleb assembly
DBS0236787	pkgB-/ [act15]: pkbA	pkbA \| pkgB	wild type
DBS0236789	pkgB-/ [act15]: pkgB(K182M)	pkgB	development arrests at mound stage
DBS0350329	pkgB-/ [emcB]: lacZ	pkgB	abolished prestalk gene expression
DBS0236790	pkgB-/ [gbfA]: pkbA	pkbA \| pkgB	wild type
DBS0236791	pkgB-/ [gbfA]: pkgB	pkgB	wild type
DBS0350319	pks17-	pks17	decreased fatty acid level \| increased gene expression \| delayed development \| decreased fruiting body size
LAS44	pks2-	pks2	decreased socially cooperative development
LAS19	pks26-	pks26	aberrant socially cooperative development
DBS0238068	plaA-	plaA	aberrant chemotaxis to cAMP \| abolished aggregation \| abolished positive regulation of chemorepellant activity
DBS0238067	plaA-	plaA	abolished aggregation
DBS0306196	plaA-	plaA	aberrant chemotaxis to cAMP \| decreased bleb assembly \| decreased necrotic cell death
DBS0350831	plaA-/ piaA-	piaA \| plaA	decreased taxis \| decreased chemotaxis to cAMP \| aberrant actin filament organization
DBS0350486	plaA-/ sgcA-	plaA \| sgcA	aberrant chemotaxis to cAMP
DBS0350487	plaA-/ sgcA-/ pkgB-	pkgB \| plaA \| sgcA	aberrant chemotaxis to cAMP
DG1067	plbG-	plbG	decreased stalk width \| decreased stalk length
HAD236	plc-	plc	decreased protein localization to plasma membrane \| aberrant chemotaxis to cAMP \| decreased protein localization to cytoplasm \| decreased protein kinase activation \| abolished aggregation
HD1.19	plc-	plc	aberrant negative chemotaxis
HD10	plc-	plc	aberrant cellular homeostasis \| wild type \| aberrant spore germination
DBS0267125	plc-/ [OE]: dagA(PH): GFP/ [OE]: plc	dagA \| plc	increased protein localization to plasma membrane \| decreased chemotaxis to cAMP
DBS0350047	plc-/ [act15]: pten: GFP	plc \| pten	wild type \| aberrant protein localization to cytoplasm
DBS0236796	pldB-	pldB	decreased catalytic activity \| precocious aggregation
DBS0236797	pldB-/ [act15]: pldB: GFP	pldB	abolished aggregation
DBS0350604	pldB-/ [unk]: GFP	pldB	increased cell migration to prestalk region
DBS0350605	pldB-/ [unk]: lacZ	pldB	increased cell migration to prestalk region
DBS0236799	plip-	plip	delayed aggregation
DBS0351187	plnA-	plnA	aberrant defense response to bacterium
DBS0350007	png-	png	delayed aggregation \| decreased mound size \| aberrant fruiting body morphogenesis
DBS0350492	png-/ [ecmAO]: lacZ	png	aberrant prestalk cell differentiation
DBS0350491	png-/ [ecmA]: lacZ	png	aberrant prestalk A cell differentiation
DBS0350493	png-/ [pspA]: lacZ	png	decreased prespore cell differentiation
DBS0236820	ponA-	ponA	precocious aggregation \| decreased actin nucleation \| aberrant sorocarp development \| aberrant pseudopodium formation
DBS0236821	ponA-	ponA	precocious aggregation \| decreased actin nucleation \| aberrant sorocarp development \| aberrant pseudopodium formation
DG1057	potA-	potA	aberrant fruiting body morphogenesis
DBS0351064	poxA-	poxA	aberrant defense response to bacterium
DBS0236824	ppk1-	ppk1	decreased growth rate \| decreased phagocytosis \| decreased fruiting body size \| delayed culmination \| decreased sporulation
ASH01	ppk1-	ppk1	aberrant cellular homeostasis \| decreased ATP level \| decreased growth rate \| aberrant spore germination \| aberrant macromolecule biosynthesis \| decreased fruiting body size \| increased growth rate
DBS0351356	ppk1-/ [act15]: GFP: hsp48	hsp48 \| ppk1	decreased protein level
DBS0236825	ppk1-/ [act15]: ppk1	ppk1	wild type
DBS0238099	ppp4C-	ppp4c	development arrests at mound stage \| delayed development
DBS0238110	ppp4C-/ [act15]: smkA	ppp4c \| smkA	development arrests at mound stage \| delayed development
DBS0238033	proC-	proC	increased lateral pseudopodium formation \| decreased chemotaxis rate \| decreased establishment of cell polarity
DBS0238034	proC-/ [unk]: FLAG: proC	proC	wild type
DBS0266716	pscA-	pscA	wild type
DBS0266803	psenA-	psenA	aberrant culmination \| decreased prespore cell differentiation
DBS0350302	psenA-	psenA	decreased prespore cell differentiation \| aberrant calcium-mediated signaling
DBS0350304	psenA-/ psenB-	psenA \| psenB	increased gene expression \| abolished prespore cell differentiation \| development arrests at mound stage \| increased protein modification \| decreased phagocytosis \| aberrant calcium-mediated signaling \| increased cAMP level \| aberrant sorocarp development \| decreased macropinocytosis \| aberrant phagosome maturation \| decreased protein processing in phagocytic vesicle \| decreased prestalk gene expression \| decreased stalk cell differentiation
DBS0350305	psenA-/ psenB-/ [act15]: GFP: psenB	psenA \| psenB	wild type
DBS0350306	psenA-/ psenB-/ [act15]: psenB(D348A/ D394A)	psenA \| psenB	wild type
DBS0350295	psenB-	psenB	decreased phagocytosis \| abolished catalytic activity
DBS0350303	psenB-	psenB	decreased prespore cell differentiation \| aberrant calcium-mediated signaling
DBS0351095	psenB-	psenB	aberrant response to chemical
DBS0350298	psenB-/ psenA-	psenA \| psenB	aberrant culmination \| decreased phagocytosis \| abolished catalytic activity \| decreased prespore cell differentiation
HOK2	psiA-	psiA	abolished prespore cell division
DBS0351581	psiA-/ [ecmB]: lacZ	psiA	precocious prestalk gene expression
DBS0351578	psiA-/ [rnrB]: lacZ	psiA	aberrant prespore gene expression
DBS0236021	psiM-	psiM	wild type
DBS0236022	psiM-	psiM	wild type
DBS0236828	pslA-	pslA	abolished sporulation \| increased mound size \| decreased sorus size \| aberrant prestalk gene expression \| increased stalk length \| abolished stalk cell differentiation \| abolished prespore gene expression
DBS0236829	psmC1-	psmC1	increased resistance to spectinomycin \| aberrant standing slug morphology \| abolished slug migration \| increased vegetative cell size
HW70	pspB-	pspB	aberrant spore coat morphology \| precocious spore germination
DBS0302352	psrA-	psrA	decreased culmination \| increased protein phosphorylation \| decreased activation of GTPase activity \| delayed prestalk gene expression \| decreased cell motility \| delayed development \| increased protein kinase activation
DBS0351094	psrA-	psrA	aberrant response to chemical
DBS0302356	psrA-/ [act15]: FLAG: gskA	gskA \| psrA	increased protein kinase activation
DBS0302353	psrA-/ [act15]: ecmA: lacZ	psrA	aberrant prestalk gene expression
DBS0302354	psrA-/ [act15]: ecmB: lacZ	psrA	aberrant prestalk gene expression
DBS0302357	psrA-/ [act15]: gskA(K84M/ K85M)	gskA \| psrA	decreased culmination \| decreased prespore gene expression \| delayed development \| increased protein kinase activation
DBS0302355	psrA-/ [act15]: psrA	psrA	wild type
DBS0350829	psrA-/ [unk]: FLAG: rasD(G12T)	psrA \| rasD	increased protein kinase activation
HM1289	pten-	pten	aberrant cell motility \| decreased lateral pseudopodium retraction \| decreased cell motility \| decreased macropinocytosis \| abolished aggregation \| decreased chemotaxis to cAMP
DBS0236830	pten-	pten	decreased response to Gram-negative bacterium \| decreased positive regulation of GTPase activity \| decreased actin filament polymerization \| decreased lateral pseudopodium retraction \| abolished protein localization to plasma membrane \| decreased growth rate \| increased actin filament polymerization \| decreased phagocytosis \| decreased bleb assembly \| decreased cell motility \| increased protein localization to plasma membrane \| decreased chemotaxis to cAMP \| abolished aggregation \| aberrant pseudopodium formation \| increased pseudopodium formation \| aberrant signal transduction \| abolished positive regulation of chemorepellant activity
DBS0349884	pten-	pten	aberrant cytokinesis \| increased protein kinase activity \| decreased chemotaxis to cAMP \| decreased establishment of cell polarity
DBS0350660	pten-	pten	decreased uropod retraction \| decreased protein localization to cleavage furrow \| decreased growth rate \| aberrant cytokinesis \| decreased protein localization to pseudopodium
DBS0350454	pten-/ [act15]: lpten: RFP	lpten \| pten	wild type
DBS0349890	pten-/ [act15]: pakA: GFP	pakA \| pten	aberrant cytokinesis
DBS0350754	pten-/ [act15]: pten(186-515): GFP	pten	aberrant sorocarp development \| decreased chemotaxis to cAMP
DBS0350755	pten-/ [act15]: pten(C124S): GFP	pten	aberrant sorocarp development \| decreased chemotaxis to cAMP
DBS0351587	pten-/ [act15]: pten(G129E)	pten	increased lateral pseudopodium formation \| aberrant localization
DBS0236831	pten-/ [act15]: pten: GFP	pten	wild type
DBS0349888	pten-/ gefS-	gefS \| pten	aberrant cytokinesis \| decreased chemotaxis to cAMP
DBS0349891	pten-/ pakA-	pakA \| pten	decreased chemotaxis to cAMP
DBS0349893	pten-/ pakA-/ [act15]: pakA(T585A): GFP	pakA \| pten	decreased chemotaxis to cAMP
DBS0349900	pten-/ pakA-/ [act15]: pakA(T585E): GFP	pakA \| pten	aberrant cytokinesis \| decreased chemotaxis to cAMP
DBS0349899	pten-/ pakA-/ [act15]: pakA: GFP	pakA \| pten	aberrant cytokinesis
DBS0349887	pten-/ piaA-	piaA \| pten	decreased protein kinase activity \| decreased chemotaxis to cAMP
DBS0349880	pten-/ pkbA-	pkbA \| pten	decreased chemotaxis to cAMP
DBS0349886	pten-/ pkgB-	pkgB \| pten	aberrant cytokinesis \| increased protein kinase activation
DBS0236832	ptpA1-	ptpA1-1 \| ptpA1-2	decreased prespore cell differentiation \| precocious development \| increased prestalk O cell differentiation
DBS0236833	ptpB-	ptpB	increased migratory slug size
DBS0350675	ptpB-/ [act15]: 6xHis: erkA	erkA \| ptpB	aberrant stream morphology
DBS0236834	ptpC+/ -	ptpC	aberrant cytokinesis \| decreased growth rate
DBS0236835	pufA-	pufA	increased protein kinase activity \| aberrant fruiting body morphogenesis \| increased protein level \| precocious development
DBS0304391	pyk3-	pyk3	increased prespore gene expression \| decreased prestalk gene expression \| increased prespore cell differentiation \| delayed culmination
DBS0350577	pyk3-	pyk3	decreased protein phosphorylation \| decreased gene expression \| aberrant protein localization to nucleus
DBS0350581	pyk3-	pyk3	decreased protein phosphorylation \| decreased gene expression
DBS0304393	pyk3-/ [act15]: T7: pyk3	pyk3	wild type
DBS0350579	pyk3-/ phg2-	phg2 \| pyk3	abolished gene expression \| decreased protein phosphorylation \| aberrant protein localization to nucleus
DBS0236836	pykA-	pykA	decreased growth rate \| abolished aggregation
DBS0236837	pyr56-	pyr56	increased resistance to 5-Fluoroorotic acid \| abolished uracil biosynthetic process
DBS0236838	pyr56-	pyr56	increased resistance to 5-Fluoroorotic acid \| abolished uracil biosynthetic process
DBS0351499	pzoA-	pzoA	aberrant cellular response to fluid shear stress \| aberrant chemotaxis to cAMP
DBS0350017	qdpr-	qdpr	decreased spore germination \| decreased growth rate \| abolished catalytic activity \| aberrant response to oxidative stress
DBS0350018	qdpr-/ [act15]: pah	pah \| qdpr	decreased growth rate
DBS0236839	qkgA-	qkgA-1 \| qkgA-2	increased mound size \| delayed aggregation \| aberrant vegetative growth \| aberrant nucleus organization \| increased growth rate \| abolished negative chemotaxis
DBS0351552	qkgA-	qkgA-1 \| qkgA-2	aberrant aggregation \| decreased actin filament polymerization \| aberrant cytokinesis \| decreased cell motility \| decreased chemotaxis to cAMP
DBS0350011	qkgA-/ [act15]: bzpN: GFP	bzpN \| qkgA-1 \| qkgA-2	abolished negative regulation of vegetative growth
DBS0351560	qtrt1-	qtrt1	aberrant response to stimulus
DBS0350263	rab7A-	rab7A	decreased growth rate
DBS0236841	racB-	racB	decreased actin filament polymerization \| delayed aggregation \| aberrant fruiting body morphogenesis \| decreased chemotaxis rate \| decreased myosin II assembly
DBS0236842	racC-	racC	decreased protein localization to plasma membrane \| decreased actin filament polymerization \| aberrant cytokinesis \| aberrant stream morphology \| decreased chemotaxis rate \| aberrant cell morphology \| aberrant protein localization
DBS0350272	racC-	racC	aberrant cytokinesis \| decreased growth rate \| abolished positive regulation of chemorepellant activity
DBS0237191	racC-/ [act15]: CFP: racC	racC	increased actin filament polymerization
DBS0235413	racE-	racE	abolished cytokinesis \| aberrant cortical actin cytoskeleton organization \| abolished protein localization to cell cortex
DBS0350271	racE-	racE	decreased protein phosphorylation \| increased lateral pseudopodium formation \| aberrant cytokinesis \| delayed aggregation \| decreased growth rate \| aberrant regulation of GTPase activity \| aberrant protein localization to plasma membrane \| decreased establishment of cell polarity \| decreased chemotaxis to cAMP
DBS0351308	racE-	racE	aberrant cortical actin cytoskeleton organization \| abolished protein localization to cell cortex \| aberrant cytokinesis \| decreased cell motility \| aberrant cell morphology
DBS0351348	racE-/ [act15]: GFP: racE(G20V)	racE	decreased protein phosphorylation \| decreased chemotaxis to cAMP
DBS0351349	racE-/ [act15]: GFP: racE(G23V)	racE	increased protein phosphorylation
DBS0351350	racE-/ [act15]: GFP: racE(S192D)	racE	increased protein phosphorylation \| wild type
DBS0351347	racE-/ [act15]: GFP: racE(T25N)	racE	wild type
DBS0351614	racE-/ [act15]: GFP: racE(T25N/ S192D)	racE	wild type
DBS0351351	racE-/ [act15]: GFP: rasC(Q62L)	racE \| rasC	decreased protein phosphorylation
DBS0349949	racE-/ [act15]: fttB	fttB \| racE	decreased growth rate
DBS0349946	racE-/ [act15]: fttB: GFP	fttB \| racE	abolished protein localization to cell cortex
DBS0350956	racE-/ [act15]racE(G20V)	racE	wild type
DBS0350957	racE-/ [act15]racE(T25N)	racE	abolished cytokinesis
DBS0351505	racF1-	racF1	wild type
DBS0236844	racF2(G12V)	racF2	decreased cell-cell adhesion
DBS0236845	racF2(N17T)	racF2	increased cell-cell adhesion \| decreased sexual fusion
DBS0236843	racF2-	racF2	increased mound size \| increased cell-cell adhesion \| decreased sexual fusion
DBS0236849	racG-	racG	decreased cell motility \| decreased protein localization to phagocytic vesicle
DBS0236850	racH-	racH	decreased exocytosis \| aberrant protein localization to cytoplasmic vesicle \| decreased pinocytosis \| decreased defense response to Gram-negative bacterium \| aberrant defense response to bacterium \| decreased defense response to bacterium
DBS0351149	rapC-	rapC	increased number of mound tips \| aberrant cytokinesis \| increased cell-substrate adhesion \| decreased cell motility \| aberrant cell morphology
DBS0266936	rapgap1-	rapgap1	decreased positive regulation of GTPase activity \| increased actin filament polymerization \| increased cell-substrate adhesion \| decreased cell motility \| decreased myosin II assembly \| increased protein kinase activation
DBS0266937	rapgap1-/ [act15]: GFP: rapgap1	rapgap1	increased positive regulation of GTPase activity \| increased lateral pseudopodium formation \| decreased cell-substrate adhesion \| increased myosin II assembly \| increased actin filament polymerization \| increased cell motility
DBS0351487	rapgap3-	rapgap3	increased cell motility \| increased activation of GTPase activity
DBS0350864	rapgap3-/ AX2	rapgap3	delayed aggregation \| decreased chemotaxis to cAMP \| decreased fruiting body size
DBS0350863	rapgap3-/ KAX3	rapgap3	delayed development of tipped mound \| increased calcium-dependent cell-cell adhesion \| decreased cell motility \| aberrant cell migration to prestalk region \| aberrant regulation of GTPase activity
DBS0350316	rapgap9-	rapgap9	increased filopodium formation \| increased actin filament polymerization \| aberrant cytokinesis \| decreased spore size \| increased cell-substrate adhesion \| decreased chemotaxis to cAMP
DBS0350317	rapgap9-/ [act15]: GFP: rapgap9	rapgap9	wild type
DBS0350628	rapgapB-	rapgapB	aberrant aggregation \| increased cell-substrate adhesion \| aberrant regulation of GTPase activity \| aberrant actin filament organization
DBS0350630	rapgapB-/ [ecmAO]: RFP	ecmA \| rapgapB	aberrant cell-cell adhesion
DBS0350631	rapgapB-/ [ecmA]: lacZ	rapgapB	aberrant cell migration to prestalk region
DBS0350632	rapgapB-/ [ecmO]: lacZ	rapgapB	aberrant cell migration to prestalk region
DBS0350629	rapgapB-/ [pspA]: RFP	pspA \| rapgapB	aberrant cell-cell adhesion
DBS0236852	rasB-	rasB	decreased growth rate
DBS0350836	rasB-	rasB	decreased phagocytosis \| decreased macropinocytosis \| aberrant actin filament organization
DBS0236853	rasC-/ AX2	rasC	increased rate of endocytosis \| aberrant response to cAMP \| decreased cell motility \| increased vegetative cell size \| abolished protein kinase activation \| decreased protein kinase activation \| decreased taxis \| abolished aggregation \| aberrant pseudopodium formation \| aberrant actin filament organization \| aberrant protein localization to cell cortex \| aberrant cellular response to extracellular stimulus
DBS0236854	rasC-/ JH10	rasC	wild type \| aberrant gene expression \| decreased protein kinase activation \| abolished aggregation \| abolished chemotaxis to cAMP
DBS0237614	rasC-/ [act15]: gbpD	gbpD \| rasC	increased cell-substrate adhesion \| aberrant cell morphology
DBS0350740	rasC-/ [rasC]: rasG	rasC \| rasG	abolished activation of adenylate cyclase activity \| abolished aggregation
DBS0350742	rasC-/ [rasC]: rasG(1-77(D30A)): rasC(79-189)	rasC \| rasG	wild type
DBS0350741	rasC-/ [rasC]: rasG(D30A)	rasC \| rasG	aberrant aggregation \| decreased activation of adenylate cyclase activity
DBS0236855	rasC-/ dmpA-	dmpA \| rasC	abolished stream development
DBS0236856	rasC-/ pikD1	pikD \| rasC	increased establishment of cell polarity \| increased chemotaxis to cAMP \| aberrant gene expression \| aberrant fruiting body morphogenesis \| decreased protein kinase activation \| abolished aggregation
DBS0236857	rasC-/ rasD-	rasC \| rasD	abolished aggregation
DBS0236858	rasC-/ rasG-	rasC \| rasG	aberrant cell separation during cytokinesis \| wild type \| aberrant cell motility \| decreased activation of adenylate cyclase activity \| decreased gene expression \| abolished guanylyl cyclase activity \| abolished chemotaxis to folate \| decreased growth rate \| aberrant chemotaxis to folate \| abolished protein kinase activation \| abolished vegetative growth \| decreased cell motility \| increased protein level \| abolished aggregation \| delayed gene expression \| abolished chemotaxis to cAMP \| abolished positive regulation of chemorepellant activity
DBS0266697	rasC-/ rasG-/ [act15]: carA	carA-1 \| carA-2 \| rasC \| rasG	decreased activation of adenylate cyclase activity \| abolished activation of GTPase activity \| decreased growth rate \| abolished vegetative growth \| abolished protein kinase activation \| abolished cGMP-mediated signaling \| abolished chemotaxis to cAMP
DBS0350480	rasC-/ rasG-/ [rasG]: rasD	rasC \| rasD \| rasG	decreased chemotaxis to folate
DBS0350482	rasC-/ rasG-/ [rasG]: rasD(1-104): rasG(103-189)	rasC \| rasD \| rasG	decreased chemotaxis to folate
DBS0350481	rasC-/ rasG-/ [rasG]: rasG	rasC \| rasG	wild type
DBS0350483	rasC-/ rasG-/ [rasG]: rasG(1-104): rasD(103-187)	rasC \| rasD \| rasG	wild type
DBS0351062	rasC-/ rasG-/ [unk]: carA	carA-1 \| carA-2 \| rasC \| rasG	decreased protein localization to plasma membrane
DBS0351449	rasC-/ rasS-	rasC \| rasS	increased macropinocytosis
DBS0351213	rasC-[act15]: rasG(S17N)	rasC \| rasG	abolished activation of GTPase activity \| decreased chemotaxis to cAMP
DBS0236860	rasD-	rasD	aberrant thermotaxis \| aberrant phototaxis
DBS0351459	rasD-/ AX3	rasD	increased gene expression \| increased prespore cell differentiation
DBS0236862	rasG-/ AX2	rasG	decreased pinocytosis \| decreased gene expression \| delayed aggregation \| aberrant taxis \| decreased cGMP-mediated signaling \| decreased protein kinase activation \| delayed gene expression
IR15	rasG-/ AX2	rasG	aberrant cell separation during cytokinesis \| aberrant filopodium formation \| decreased actin filament polymerization \| decreased growth rate \| increased vegetative cell size \| decreased macropinocytosis \| decreased cell motility \| decreased protein kinase activation \| decreased establishment of cell polarity \| aberrant actin filament organization
IR17	rasG-/ AX3	rasG	aberrant cytokinesis \| decreased cell motility \| increased vegetative cell size
DBS0351460	rasG-/ AX3	rasG	increased prestalk cell differentiation
DBS0236863	rasG-/ JH10	rasG	aberrant cell separation during cytokinesis \| wild type \| decreased gene expression \| delayed aggregation \| abolished activation of GTPase activity \| aberrant chemotaxis to folate \| decreased growth rate \| decreased cGMP-mediated signaling \| decreased protein kinase activation \| delayed gene expression
DBS0236864	rasG-/ [OE]: rasB	rasB \| rasG	decreased growth rate
DBS0350572	rasG-/ [act15]: FLAG: rasG(K169R,K173R,K176R,K178R)	rasG	aberrant cytokinesis
DBS0350571	rasG-/ [act15]: FLAG: rasG(K169R,K173R,K176R,K178R,K179R,K180R,K184R)	rasG	decreased protein modification
DBS0350448	rasG-/ [dscB]: rasG(S17N)	rasG	decreased positive regulation of GTPase activity \| decreased actin filament polymerization \| decreased protein kinase activation \| decreased chemotaxis to cAMP
DBS0351447	rasG-/ rasS-	rasG \| rasS	decreased macropinocytosis
DBS0236872	rasS-/ AX2	rasS	decreased macropinocytosis \| decreased cell motility \| aberrant pinosome maturation \| decreased establishment of cell polarity
DBS0351446	rasS-/ AX2	rasS	aberrant macropinocytosis
DBS0236873	rasS-/ DH1	rasS	decreased rate of endocytosis \| decreased growth rate \| increased actin filament polymerization \| abolished vegetative growth \| increased cell motility \| aberrant cytoskeleton organization
DBS0351314	rasS-/ DdB	rasS	decreased macropinocytosis \| increased cell motility
DBS0236874	rasZ-	rasZ	wild type
DBS0351598	rbdB-	rbdB	abolished pre-miRNA processing
DBS0350261	rbg3-	rbg3	precocious development \| increased growth rate
DBS0236877	rblA-	rblA	increased cell migration to prestalk region \| decreased spore germination \| decreased gene expression \| increased gene expression \| abolished negative regulation of vegetative growth \| decreased growth rate \| aberrant vegetative growth \| decreased vegetative cell size \| precocious development \| increased prestalk cell differentiation
DBS0349999	rblA-/ [act15]: GFP	rblA	increased cell migration to prestalk region
DBS0349996	rblA-/ [act15]: GFP/ [act15]: myc: btg	btg \| rblA	increased cell migration to prestalk region
DBS0349994	rblA-/ [btg]: lacZ	btg \| rblA	decreased gene expression
DBS0236878	rbrA-	rbrA	increased gene expression \| decreased gene expression \| development arrests at slug stage \| aberrant prespore gene expression \| decreased cell migration to prestalk region \| decreased phototaxis \| decreased sporulation
DBS0236879	rbrA-/ [unk]: rbrA	rbrA	wild type
DBS0305613	rccA-	rccA	increased resistance to cheating during development
DBS0236880	rckA-	rckA	increased mound size \| precocious aggregation \| delayed slug development \| delayed prestalk gene expression \| delayed prespore gene expression \| increased chemotaxis rate
DBS0236885	rckA-/ [act15]: myc: rckA	rckA	delayed development \| decreased chemotaxis rate
DBS0236881	rckA-/ [act15]: myc: rckA(C551A)	rckA	delayed slug development \| decreased chemotaxis rate
DBS0236882	rckA-/ [act15]: myc: rckA(E510G)	rckA	wild type \| decreased chemotaxis rate
DBS0236883	rckA-/ [act15]: myc: rckA(E510G/ N511A)	rckA	delayed slug development \| decreased chemotaxis rate
DBS0236884	rckA-/ [act15]: myc: rckA(K867A)	rckA	development arrests at mound stage \| decreased chemotaxis rate
FR17	rdeA-	rdeA	precocious aggregation \| decreased mound size \| aberrant fruiting body morphogenesis \| precocious development \| precocious gene expression
HH201	rdeA-	rdeA	aberrant chemotaxis to cAMP \| increased cAMP level
WTC10	rdeA-	rdeA	aberrant chemotaxis to cAMP \| increased cAMP level \| decreased macropinocytosis
FR17	rdeA-	rdeA	precocious aggregation \| decreased mound size \| aberrant fruiting body morphogenesis \| precocious development \| precocious gene expression
DBS0236886	rdeA-/ [act15]: rdeA	rdeA	wild type
DBS0350688	rdeA-/ acaA-	acaA \| rdeA	increased cAMP level \| decreased sporulation
DBS0350468	rdiA-	rdiA	decreased pinocytosis \| decreased protein localization to cell cortex \| decreased protein level \| decreased actin filament polymerization \| aberrant contractile vacuole morphology \| decreased growth rate \| aberrant cytokinesis
DBS0351504	rdiA-	rdiA	aberrant cytokinesis
DBS0236887	recA-	recA	decreased resistance to hydrogen peroxide \| aberrant response to UV \| decreased resistance to mitomycin C
DBS0266664	redA-	redA	development arrests at mound stage \| aberrant mound color
DBS0350511	redA-	redA	decreased defense response to Gram-negative bacterium
DG1047	redA-	redA	development arrests at mound stage \| aberrant mound color
DBS0236889	regA-	regA	increased resistance to cisplatin \| aberrant chemotaxis to cAMP \| increased cAMP level \| aberrant fruiting body morphogenesis
DBS0236958	regA-	regA	decreased spore germination \| precocious sporulation \| abolished protein localization to cell cortex \| increased lateral pseudopodium formation \| aberrant chemotaxis to cAMP
HM332	regA-	regA	decreased lateral pseudopodium retraction
HR45	regA-	regA	aberrant fruiting body morphogenesis
HM1015	regA-	regA	increased cAMP level \| decreased macropinocytosis \| aberrant oscillatory cAMP signaling
DBS0350372	regA-/ KAX3	regA	precocious sporulation \| increased sporulation
DBS0235706	regA-/ [act15]: dhkK(D1125N)	dhkK \| regA	aberrant fruiting body morphogenesis \| precocious development
DBS0235708	regA-/ [act15]: dhkK(H825Q)	dhkK \| regA	aberrant fruiting body morphogenesis \| precocious development
DBS0351475	regA-/ [act15]: erkA	erkA \| regA	delayed slug development
DBS0351472	regA-/ [act15]: regA(R588A,R589A,L594A,I595A,L596A)	regA	delayed development
DBS0351284	regA-/ [act15]: regA(S142A)	regA	aberrant fruiting body morphogenesis \| precocious development
DBS0351283	regA-/ [act15]: regA(S142E)	regA	delayed development
DBS0351285	regA-/ [act15]: regA(S413A)	regA	increased mound size \| delayed development
DBS0351286	regA-/ [act15]: regA(S413E)	regA	increased mound size \| delayed development
DBS0351287	regA-/ [act15]: regA(T676A)	regA	delayed sporulation
DBS0351288	regA-/ [act15]: regA(T676E)	regA	aberrant fruiting body morphogenesis \| precocious development
DBS0350689	regA-/ [regA]: regA	regA	wild type
DBS0350670	regA-/ [regA]: regA(D212N)	regA	precocious sporulation
DBS0350380	regA-/ dhkD-	dhkD \| regA	aberrant fruiting body morphogenesis
DBS0351473	regA-/ regA(R588A,R589A,L594A,I595A,L596)	regA	precocious sporulation \| decreased mound size \| increased protein binding \| aberrant fruiting body morphogenesis
DBS0236891	regA-/ tagB-	regA \| tagB	decreased sporulation
DBS0236892	regA-/ tagC-	regA \| tagC	decreased sporulation
DBS0266818	repB(1-754)	repB	aberrant response to UV
HM1351	rev3-	rev3	aberrant vegetative growth \| decreased resistance to cisplatin
HM1451	rev3-/ xpf-	rev3 \| xpf	decreased resistance to cisplatin
DBS0236893	rgaA-	rgaA	abolished cell migration to prestalk region \| aberrant cytokinesis \| abolished stalk cell differentiation \| decreased protein kinase activation \| abolished culmination \| decreased sporulation
DBS0349935	rgaA-	rgaA	aberrant stalk morphogenesis \| increased number of tip-organizers \| aberrant cellular response to fluid shear stress \| increased actin filament polymerization \| increased growth rate \| increased cell motility \| aberrant actin filament organization
DBS0350398	rgaA-	rgaA	increased lateral pseudopodium formation \| decreased myosin II assembly \| increased chemotaxis rate
DBS0349921	rgaA-/ [act15]: GFP-mhcA	rgaA	aberrant stalk morphogenesis \| aberrant development of tipped mound \| abolished protein localization to apical plasma membrane
DBS0349937	rgaA-/ ctxA-	ctxA \| rgaA	aberrant cytokinesis \| abolished protein localization to cleavage furrow
DBS0349936	rgaA-/ gapA-	gapA \| rgaA	aberrant cellular response to fluid shear stress \| aberrant cytokinesis \| abolished protein localization to cleavage furrow \| increased cell motility
DBS0350401	rgaA-/ gapA-	gapA \| rgaA	decreased protein localization to cleavage furrow \| increased myosin II assembly \| aberrant mitotic spindle organization \| increased actin filament polymerization \| decreased chemotaxis to cAMP \| increased protein kinase activation
DBS0350406	rgaA-/ gapA-/ [unk]: myc: gapA(R308E/ K317E)	gapA \| rgaA	increased protein kinase activation
DBS0350402	rgaA-/ iqgC-	iqgC \| rgaA	decreased myosin II assembly \| increased protein kinase activation
DBS0351526	rgbA-/ AX2	rgbA	aberrant macropinocytosis \| aberrant activation of GTPase activity \| decreased macropinocytosis \| aberrant engulfment during phagocytosis \| decreased chemotaxis to folate
DBS0351527	rgbA-/ DdB	rgbA	aberrant macropinocytosis \| increased activation of GTPase activity
DBS0350019	rgfA-	rgfA	wild type
DBS0350020	rgfA-/ [act15]: rgfA	rgfA	decreased chemotaxis to folate \| delayed development
DBS0350108	rheb-	rheb	increased phagocytosis
DBS0236894	rhgA-	rhgA	wild type
DBS0350192	ric8-	ric8	abolished gene expression \| abolished chemotaxis to folate \| decreased chemotaxis to cAMP \| abolished aggregation \| aberrant signal transduction
DBS0350193	ric8-/ [act15]: GFP: ric8	ric8	wild type
DBS0236900	ripA-	ripA	decreased guanylyl cyclase activity \| abolished activation of adenylate cyclase activity \| decreased chemotaxis rate \| decreased taxis \| abolished aggregation \| decreased establishment of cell polarity \| aberrant regulation of protein kinase activity \| decreased myosin II assembly \| increased phagocytosis
DBS0350770	ripA-/ [act15]: GFP: rapA(G12V)	rapA \| ripA	decreased protein kinase activation
DBS0350115	ripA-/ [act15]: GFP: rheb(Q64L)	rheb \| ripA	increased phagocytosis
DBS0236902	ripA-/ [unk]: ripA(K680E/ R681E)	ripA	aberrant sorocarp development \| decreased chemotaxis rate
DBS0236901	ripA-/ [unk]ripA	ripA	wild type
DBS0351068	rnf113-	rnf113	delayed aggregation \| increased cell-substrate adhesion \| decreased cell motility
DBS0351042	rnlA-	rnlA	decreased thermotaxis \| decreased growth rate \| decreased defense response to bacterium \| decreased phototaxis
DBS0236903	rnpA-	rnpA	increased gene expression
DBS0350096	roco11-	roco11	increased stalk length
DBS0350095	roco4-	roco4	delayed slug development \| aberrant stalk development \| delayed culmination
DBS0350100	roco4-/ [unk]: roco4(1018-1292(G1179S))	roco4	increased catalytic activity
DBS0350098	roco4-/ [unk]: roco4(1018-1292(S1187A))	roco4	abolished catalytic activity
DBS0350099	roco4-/ [unk]: roco4(1018-1292(S1189A))	roco4	decreased catalytic activity
DBS0238225	rpkA-	rpkA	development arrests at loose mound stage \| decreased defense response to Gram-negative bacterium \| aberrant cellular response to nitrogen starvation \| decreased phagocytosis \| decreased cell motility \| decreased establishment of cell polarity \| abolished aggregation \| aberrant cellular response to extracellular stimulus
DBS0236906	rrpA-	rrpA	abolished post-transciptional gene silencing by RNA
DBS0350178	rrpA-/ rrpB-/ rrpC-	rrpA \| rrpB \| rrpC	increased gene expression \| decreased gene expression
DBS0350189	rrpA-/ rrpB-/ rrpC-/ [act6]: lacZ/ [RNAi]lacZ	rrpA \| rrpB \| rrpC	abolished transitive RNA interference
DBS0350176	rrpA-/ rrpC-	rrpA \| rrpC	increased gene expression \| decreased gene expression
DBS0350187	rrpA-/ rrpC-/ [act6]: lacZ/ [AS]lacZ	rrpA \| rrpC	aberrant production of siRNA involved in RNA interference
DBS0350182	rrpA-/ rrpC-/ [act6]: lacZ/ [RNAi]lacZ	rrpA \| rrpC	abolished transitive RNA interference
DBS0350177	rrpB-/ rrpC-	rrpB \| rrpC	increased gene expression \| decreased gene expression
DBS0350185	rrpB-/ rrpC-/ [act6]: lacZ/ [AS]lacZ	rrpB \| rrpC	aberrant production of siRNA involved in RNA interference
DBS0350184	rrpB-/ rrpC-/ [act6]: lacZ/ [RNAi]lacZ	rrpB \| rrpC	abolished transitive RNA interference
DBS0350209	rrpC-	rrpC	decreased gene expression \| increased gene expression
DBS0350219	rrpC-/ [act15]: pre-miRNA	rrpC	increased pre-miRNA processing
DBS0350216	rrpC-/ [act6]: LacZ/ [RNAi]lacZ	rrpC	abolished transitive RNA interference
DBS0350217	rrpC-/ [act6]: lacZ/ [AS]lacZ	rrpC	aberrant production of siRNA involved in RNA interference
DBS0236875	rtoA-	rtoA	decreased rate of endocytosis \| increased defense response to Gram-negative bacterium \| increased prestalk cell differentiation \| delayed culmination
DBS0236911	rtoA-	rtoA	delayed development
DBS0236914	rzpA-	rzpA	aberrant aggregation \| decreased slug migration \| increased mound size \| increased prespore gene expression \| decreased prestalk gene expression \| delayed development
DBS0309040	sadA-	sadA	abolished protein localization to cell surface \| decreased phagocytosis \| decreased protein stabilization
DBS0236921	sadA-	sadA	abolished cell-substrate adhesion \| decreased phagocytosis \| aberrant cytokinesis \| increased growth rate \| aberrant actin filament organization \| aberrant cell morphology
DBS0350974	sadA-/ [act15]: gpaH	gpaH \| sadA	aberrant cytokinesis
DBS0349790	sadA-/ [act15]: sadA(1-923): GFP	sadA	decreased cell-substrate adhesion
DBS0349792	sadA-/ [act15]: sadA(S924A/ S925A): GFP	sadA	wild type
DBS0349791	sadA-/ [act15]: sadA(S924E/ S925E): GFP	sadA	decreased cell-substrate adhesion
DBS0236922	sadA-/ [act15]: sadA: GFP	sadA	wild type
DBS0351564	sbdS(1-30,TS18,31-274)	sbds	development arrests at loose mound stage \| aberrant cellular process \| abolished vegetative growth
DBS0351566	sbdS(1-30,TS18,31-274)/ [act15]: eIF(T56K)	eIF6 \| sbds	wild type
DG1105	scaA-	scaA	abolished aggregation
DBS0350825	scaA-	scaA	decreased actin filament polymerization \| aberrant chemotaxis to cAMP \| abolished activation of GTPase activity \| decreased protein kinase activation \| abolished aggregation
DBS0236924	scrA-	scrA	increased number of tip-organizers \| abolished protein localization to endolysosome \| decreased exocytosis \| decreased pinocytosis \| decreased actin filament polymerization \| increased lateral pseudopodium formation \| decreased phagocytosis \| decreased vegetative cell size \| decreased fruiting body size \| precocious development
IR46	scrA-	scrA	aberrant mitotic spindle organization \| aberrant cytokinesis \| abolished activation of GTPase activity \| decreased vegetative cell size \| decreased cell motility \| aberrant cellular response to stress \| aberrant pseudopodium formation \| increased bleb assembly \| abolished positive regulation of chemorepellant activity
IR48	scrA-	scrA	decreased growth rate \| aberrant cytokinesis \| decreased bleb assembly \| decreased phototaxis
DBS0236925	scrA-	scrA	increased filopodium formation \| decreased protein level \| aberrant macropinocytosis \| aberrant cytokinesis \| decreased macropinocytosis \| decreased cell motility \| aberrant actin filament organization \| aberrant pseudopodium formation
DBS0351524	scrA-/ [act15]: scrA(R177A,R179A,K180A,R183A,R184A,R187A,K190A,K191A,K194A)	scrA	decreased bleb assembly \| increased cellular localization \| aberrant pseudopodium formation
DBS0351611	scrA-/ [act15]: scrA(S287,290,301,335,339,384,388,389,430,432,433,437,440A)	scrA	aberrant pseudopodium formation
DBS0351522	scrA-/ [act15]: scrA(S430A,S432A,S433A,S437A,S440A)	scrA	decreased bleb assembly \| increased cellular localization \| aberrant pseudopodium formation
DBS0351523	scrA-/ [act15]: scrA(S430D,S432D,S433D,S437D,S440D)	scrA	decreased pseudopodium size
DBS0349927	scrA-/ [act15]: wasA: GFP/ [ act8]: RFP: arcD	scrA	decreased establishment of cell polarity \| decreased pseudopodium formation
DBS0350063	scrA-/ [tet]: scrA/ mhcA-	mhcA \| scrA	aberrant cytokinesis
DBS0351610	scrA-/ [tet]: scrA/ wasA-	scrA \| wasA	aberrant cell motility \| abolished vegetative growth \| abolished bleb assembly \| aberrant pseudopodium formation
DBS0238440	scrA-/ [unk]: scrA(97-443): GFP	scrA	aberrant cytokinesis \| increased vegetative cell size \| decreased chemotaxis to cAMP \| aberrant cytoskeleton organization
DBS0238446	scrA-/ [unk]: scrA: GFP	scrA	wild type
SB18	scrA-/ napA-	napA \| scrA	decreased actin filament polymerization \| decreased cell motility
SB7	scrA-/ pirA-	pirA \| scrA	decreased vegetative cell size
HM1163	sec1-/ sec1(M213K/ E258G/ M427V/ K527I/ T541N/ F558S/ N581D)	sec1	abolished cell motility
HM1325	sec1-/ sec1(M250L/ A296V/ M427L/ S435R/ K505N/ V552D/ H570Q)	sec1	abolished cytokinesis \| aberrant hypotonic response \| abolished cell motility \| aberrant plasma membrane organization \| aberrant cell morphology
DBS0350286	sec1-/ sec1(M250L/ A296V/ M427L/ S435R/ K505N/ V552D/ H570Q)/ gppA: GFP	gppA \| sec1	abolished contractile vacuole discharge
DBS0350101	sec7-	sec7	aberrant cell motility \| decreased phagocytosis \| decreased growth rate \| aberrant phototaxis \| decreased protein secretion
DBS0306234	secG-	secG	decreased cell-substrate adhesion \| decreased chemotaxis rate
DBS0351035	seiP-	seiP	aberrant lipid droplet formation
DBS0350264	sepA-	sepA	aberrant cytokinesis \| delayed aggregation \| decreased growth rate \| decreased fruiting body size
DBS0351077	sepA-	sepA	aberrant gene expression \| increased cell-substrate adhesion \| decreased cell motility
DBS0350906	sepA-	sepA	decreased protein phosphorylation \| aberrant pseudopodium formation
DBS0351252	sesn-	sesn	increased mound size \| aberrant standing slug morphology \| decreased gene expression \| decreased autophagy \| aberrant response to oxidative stress
DBS0236928	set1-	set1	precocious aggregation \| abolished histone H3-K4 methylation \| precocious gene expression
HG1132	sevA-	sevA	wild type
DG1008	sfbA-	sfbA	decreased fruiting body size
DBS0350889	sgcA-/ AX2	sgcA	aberrant aggregation \| decreased guanylyl cyclase activity \| aberrant chemotaxis to cAMP
DBS0350888	sgcA-/ AX3	sgcA	aberrant aggregation \| decreased guanylyl cyclase activity \| aberrant chemotaxis to cAMP
SA576	sgkA-	sgkA	decreased resistance to carboplatin \| decreased growth rate \| decreased resistance to cisplatin
HM1093	sgkA-/ sgkB-	sgkA \| sgkB	decreased resistance to carboplatin \| decreased growth rate \| decreased resistance to cisplatin
HM1091	sgkB-	sgkB	decreased resistance to carboplatin \| decreased growth rate \| decreased resistance to cisplatin
SA555	sglA-	sglA	increased stalk width \| increased resistance to cisplatin \| increased mound size \| decreased lateral pseudopodium retraction \| decreased gene expression \| abolished slug migration \| decreased cell motility \| decreased chemotaxis rate \| decreased fruiting body size \| aberrant cytoskeleton organization \| decreased sporulation \| increased resistance to carboplatin
SA554	sglA-	sglA	delayed aggregation \| decreased mound size
DBS0236934	shkA-	shkA	aberrant aggregation \| decreased phagocytosis \| aberrant cytokinesis \| decreased chemotaxis rate \| decreased fruiting body size \| decreased establishment of cell polarity \| aberrant actin filament organization
DBS0236935	sibA-	sibA	decreased cell-substrate adhesion \| decreased phagocytosis
DBS0302653	sibC-	sibC	decreased phagocytosis
DBS0236936	sigB-	sigB	wild type
DBS0236937	sigD-	sigD	wild type
DBS0266513	sigN(group1)-	sigN1 \| sigN105-1 \| sigN2 \| sigN25 \| sigN3 \| sigN4 \| sigN5	wild type
DBS0266514	sigN(group2)-	DDB_G0271820 \| sigN10 \| sigN11 \| sigN12 \| sigN14 \| sigN6 \| sigN7 \| sigN8 \| sigN9	wild type
DBS0351170	sir2A-	sir2A	abolished slug migration \| increased number of mound tips \| increased gene expression \| decreased gene expression \| decreased growth rate \| aberrant sorocarp development \| decreased autophagy \| decreased chemotaxis to cAMP \| decreased cAMP level
DBS0350859	sir2D-	sir2D	decreased gene expression \| increased gene expression \| increased number of mound tips \| delayed aggregation \| decreased growth rate \| decreased autophagy \| decreased mound size \| decreased stalk length
DBS0350860	sir2D-/ [ecmAO]: lacZ	sir2D	decreased prestalk cell differentiation
DBS0350861	sir2D-/ [pspA]: lacZ	sir2D	aberrant prespore cell differentiation
DBS0350985	slc4-	slc4	aberrant transport
DBS0349958	sma-	sma	increased chemotaxis to folate \| decreased gene expression \| increased cell-substrate adhesion \| decreased vegetative cell size \| increased cell-cell adhesion
DBS0349957	sma-/ ampA/ [ampA]: ampA	ampA \| sma	decreased chemotaxis to folate
DBS0350327	smdA-/ [pspA]: lacZ	smdA	aberrant gene expression
DBS0236938	smkA-	smkA	aberrant cytokinesis \| delayed development \| decreased chemotaxis rate \| decreased myosin II assembly
HDB7YA	smlA-	smlA	increased oscillatory cAMP signaling \| decreased cell-cell adhesion \| aberrant cellular metabolic process \| decreased response to Gram-negative bacterium \| increased resistance to cisplatin \| decreased protein level \| decreased guanylyl cyclase activity \| increased myosin II assembly \| increased actin filament polymerization \| decreased cGMP-mediated signaling \| decreased mound size \| increased protein level \| decreased secretion of lysosomal enzymes \| increased cell motility \| decreased fruiting body size
DBS0302657	smlA-/ cnrN-	cnrN \| smlA	decreased fruiting body size
DBS0236940	smlA-/ ctnA-	ctnA \| smlA	increased cell-cell adhesion
DBS0304496	smlA-/ sslA1(CR11)	smlA \| sslA1	increased fruiting body size
DBS0350977	snfA-	snfA	decreased pinocytosis \| increased cell death \| decreased autophagic cell death \| decreased phagocytosis \| decreased number of autophagosomes \| aberrant sorocarp development \| decreased prespore cell differentiation \| aberrant gene expression \| aberrant protein modification \| increased growth rate \| aberrant prestalk cell differentiation \| aberrant sporulation
DBS0302523	sodC-	sodC	aberrant cytokinesis
DBS0302524	sodC-	sodC	aberrant aggregation \| decreased positive regulation of GTPase activity \| decreased actin filament polymerization \| increased actin filament polymerization \| aberrant chemotaxis to cAMP \| increased protein localization to plasma membrane \| decreased chemotaxis rate \| aberrant regulation of GTPase activity \| aberrant protein localization to plasma membrane \| aberrant cell morphology \| increased protein kinase activation
DBS0351063	sodC-/ [unk]: rasG(C118A)	rasG \| sodC	aberrant regulation of GTPase activity
DBS0350894	sodD-	sodD	aberrant response to UV
DBS0351196	sogA-	sogA	aberrant chemotaxis to cAMP \| increased activation of GTPase activity
DBS0350966	spaA-	spaA	abolished sporulation
AK1346	spc3-	spc3	decreased response to Gram-negative bacterium
DBS0350891	spdA-	spdA	decreased substrate adhesion-dependent cell spreading \| decreased phagocytosis
DBS0350892	spdA-ins	spdA	decreased growth rate \| increased substrate adhesion-dependent cell spreading \| increased phagocytosis
HL351	spiA-	spiA	decreased spore germination
DBS0236943	spkA-1-/ spkA-2-	spkA-1 \| spkA-2	decreased cell-substrate adhesion \| aberrant cytokinesis \| decreased mound size \| decreased chemotaxis rate \| decreased establishment of cell polarity \| aberrant cell morphology \| decreased fruiting body size
DBS0236944	spkA-1-/ spkA-2-/ [act15]: spkA: FLAG	spkA-1 \| spkA-2	aberrant aggregation \| decreased chemotaxis rate \| aberrant actin filament organization \| decreased establishment of cell polarity
DBS0236945	splA-	splA	abolished sporulation \| aberrant spore morphology \| increased sorus size \| aberrant sorus color \| decreased stalk length
DBS0350131	splB-	splB	abolished protein tyrosine phosphorylation \| abolished protein localization to nucleus \| abolished response to DIF-1 \| decreased gene expression
DBS0350582	splB-/ pyk3-	pyk3 \| splB	abolished gene expression \| abolished protein localization to nucleus \| aberrant sorocarp development \| abolished protein phosphorylation
DBS0236947	spnA-	spnA	abolished prespore cell differentiation \| development arrests at mound stage \| abolished prestalk cell differentiation \| aberrant sorocarp development
DBS0236948	spnA-/ arkA-	arkA \| spnA	decreased gene expression \| increased sorus size \| decreased stalk length \| delayed gene expression
DBS0236949	spr-	spr	decreased spore germination \| decreased pteridine level \| decreased cytochrome C oxidase activity \| decreased growth rate
DBS0350914	spsA-	spsA	decreased stalk length
DBS0351174	srcp1-	srcp1	aberrant protein modification
DBS0236950	srfA(1-8): lacZ	srfA	decreased slug migration \| aberrant fruiting body morphogenesis \| delayed culmination
DBS0236951	srfA-	srfA	aberrant spore morphology \| decreased spore germination \| aberrant spore coat morphology \| decreased gene expression
DBS0266691	srfB-	srfB	abolished stream development \| aberrant extracellular cAMP signaling pathway \| increased lateral pseudopodium formation \| precocious aggregation \| decreased growth rate \| increased pinocytosis \| aberrant cytokinesis \| precocious gene expression
DBS0304409	srsA-	srsA	increased mound size \| decreased gene expression \| increased gene expression \| delayed aggregation
DBS0304497	sslA1-/ sslA1(CR11)	sslA1	increased fruiting body size \| decreased oscillatory cAMP signaling \| decreased cGMP-mediated signaling
DBS0236952	stkA-	stkA	decreased gene expression \| increased prestalk gene expression \| delayed prespore gene expression \| aberrant fruiting body morphogenesis \| increased prestalk cell differentiation
HM1157	stlA-	stlA	aberrant aggregation \| abolished sporulation \| wild type \| increased gene expression \| decreased gene expression \| aberrant stream morphology \| decreased spore cell differentiation \| decreased chemotaxis to cAMP \| aberrant sorus color \| abolished MPBD level \| decreased cAMP level \| aberrant sporulation
DBS0350222	stlA-/ [cotB]: lacZ	stlA	decreased sporulation \| aberrant prespore cell differentiation
DBS0350223	stlA-/ stlB-	stlA \| stlB	decreased gene expression \| increased gene expression \| aberrant gene expression \| decreased stalk width
DBS0350224	stlA-/ stlB-/ [ecmA]: lacZ	stlA \| stlB	decreased prestalk cell differentiation
HM1154	stlB-	stlB	abolished DIF-1 biosynthesis \| abolished prestalk B cell differentiation \| aberrant gene expression \| aberrant fruiting body morphogenesis \| decreased prestalk O cell differentiation \| abolished lower cup formation \| abolished outer basal disc formation \| decreased prestalk cell differentiation
DBS0351220	stlB-	stlB	abolished autophagosome organization \| abolished autophagic cell death
DBS0350409	stlB-/ [act15]: stlB	stlB	wild type
DBS0349941	sunB-	sunB	increased number of tip-organizers \| aberrant cytokinesis
DBS0304547	svkA-	svkA	delayed cell separation during cytokinesis \| aberrant cytokinesis \| aberrant fruiting body morphogenesis
DBS0236055	swip-	swip	aberrant protein localization to cytoplasm \| abolished exocytosis \| abolished phagosome reneutralization \| abolished actin filament polymerization \| aberrant protein localization
AK1321	swp1-	swp1	decreased response to Gram-positive bacterium
AK1200	tagA-	tagA	decreased spore cell differentiation \| aberrant fruiting body morphogenesis
AK859	tagA-	tagA	decreased spore germination \| increased number of mound tips \| decreased spore cell differentiation \| increased prestalk A cell differentiation \| delayed culmination \| decreased sporulation
AK1201	tagA-/ [ecmA]: GFP	tagA	abolished cell migration to prestalk region
AK228	tagB-	tagB	abolished sporulation \| abolished DIF-1 biosynthesis \| development arrests at mound stage \| aberrant prestalk A cell differentiation
DBS0350637	tagB-/ [pkaC]: pkaC	pkaC \| tagB	aberrant response to biotic stimulus \| abolished spore cell differentiation
DBS0350672	tagB-/ pkaR-	pkaR \| tagB	decreased sporulation
DBS0236974	tagB-/ psmA1-	psmA1 \| tagB	abolished sporulation
DBS0236975	tagC-	tagC	abolished sporulation \| development arrests at mound stage
DBS0350698	tagC-/ [pkaC]: pkaC	pkaC \| tagC	development arrests at mound stage \| abolished spore cell differentiation
DBS0236976	talA-	talA	decreased protein level \| decreased cell-substrate adhesion \| aberrant cytokinesis \| decreased phagocytosis \| aberrant cell morphology
HG1666	talA-	talA	decreased cell-cell adhesion \| decreased cell-substrate adhesion \| aberrant cytokinesis \| decreased growth rate \| decreased phagocytosis \| increased cell-substrate adhesion
HG1663	talA-	talA	decreased cell-substrate adhesion
HG1664	talA-	talA	decreased uropod retraction \| decreased growth rate \| decreased phagocytosis \| aberrant mitotic actomyosin contractile ring contraction
HG1665	talA-	talA	decreased cell-cell adhesion \| aberrant cytokinesis
DBS0304585	talA-/ [act15]: FLAG: talB	talA \| talB	decreased cell-substrate adhesion
DBS0237616	talA-/ [act15]: gbpD	gbpD \| talA	increased cell-substrate adhesion \| aberrant cell morphology \| increased pseudopodium formation
DBS0238395	talA-/ [act15]: rapA(G12V)	rapA \| talA	increased cell-substrate adhesion
DBS0350442	talA-/ sibA-	sibA \| talA	wild type
DBS0304581	talA-/ talB-	talA \| talB	development arrests at loose mound stage \| abolished cell-substrate adhesion \| aberrant cytokinesis \| abolished cell motility \| increased bleb assembly
DBS0304582	talA-/ talB-/ [act15]: FLAG: talB	talA \| talB	wild type
DBS0350713	talA-/ talB-/ [act15]: talB(K16A)	talA \| talB	decreased cell-substrate adhesion
HKT104	talB-	talB	decreased slug migration \| aberrant extracellular cAMP signaling pathway \| aberrant cellular process \| decreased cell motility \| development arrests at tipped mound stage \| increased protein level \| aberrant signal transduction
DBS0302472	talB-	talB	abolished autophagosome organization \| abolished autophagic cell death \| aberrant autophagic cell death
DBS0304586	talB-/ [act15]: talA: GFP	talA \| talB	aberrant fruiting body morphogenesis
DBS0350712	talB-/ [act15]: talB(K16A)	talB	development arrests at tipped mound stage
DBS0351501	talB-/ pikB-	pikB \| talB	aberrant cellular process
DBS0351346	tert-	tert	increased gene expression \| decreased gene expression \| aberrant cell adhesion \| aberrant chemotaxis to cAMP \| aberrant sorocarp development \| delayed development \| aberrant oscillatory cAMP signaling \| decreased cAMP level
DBS0351559	tert-	tert	decreased catalytic activity \| increased gene expression
AK1505	tgrB1-	tgrB1	development arrests at loose mound stage \| delayed sporulation \| decreased cell motility \| decreased sporulation
DBS0351148	tgrB1-/ tgrB1(1-827): HA	tgrB1	development arrests at mound stage
AK1540	tgrB1-/ tgrC1-	tgrB1 \| tgrC1	development arrests at loose mound stage \| abolished cell-cell self recognition \| aberrant oscillatory cAMP signaling
AK1549	tgrB1-/ tgrC1-/ QS31\|tgrB1/ tgrC1	tgrB1 \| tgrC1	wild type
AK1552	tgrB1-/ tgrC1-/ QS38\|tgrB1/ tgrC1	tgrB1 \| tgrC1	wild type
AK1555	tgrB1-/ tgrC1-/ QS45\|tgrB1/ tgrC1	tgrB1 \| tgrC1	wild type
AK1546	tgrB1-/ tgrC1-/ QS4\|tgrB1/ tgrC1	tgrB1 \| tgrC1	wild type
AK1664	tgrB1-/ tgrC1-/ alg9(-19ins)	alg9 \| tgrB1 \| tgrC1	decreased sporulation
DBS0351131	tgrB1-/ tgrC1-/ tgrB1(G275D)	tgrB1 \| tgrC1	wild type
DBS0351132	tgrB1-/ tgrC1-/ tgrB1(G307D)	tgrB1 \| tgrC1	wild type
DBS0351133	tgrB1-/ tgrC1-/ tgrB1(L846F)	tgrB1 \| tgrC1	aberrant standing slug morphology \| increased number of mound tips \| decreased fruiting body size
AK127	tgrC1-	tgrC1	development arrests at loose mound stage \| aberrant aggregation \| abolished gene expression \| increased mound size \| decreased gene expression
AK1521	tgrC1-	tgrC1	abolished sporulation \| development arrests at loose mound stage \| decreased cell motility
AK1657	tgrC1-/ (QS38\|tgrC1)/ alg9(-19ins)	alg9 \| tgrC1	delayed development \| decreased fruiting body size \| decreased sporulation
AK1661	tgrC1-/ alg9(-19ins)	alg9 \| tgrC1	delayed development \| decreased fruiting body size \| decreased sporulation
DBS0350743	tgrC1-/ alg9(-19ins)-REMI	alg9 \| tgrC1	decreased sporulation
DBS0350625	tgrC1-/ stcA-	stcA \| tgrC1	decreased mound size \| delayed development \| decreased sporulation
DBS0350626	tgrC1-/ stcB-	stcB \| tgrC1	decreased mound size \| delayed development \| decreased sporulation
DBS0350627	tgrC1-/ stcC-	stcC \| tgrC1	aberrant stream morphology \| delayed development \| decreased fruiting body size \| decreased sporulation
AK244	tipA-	tipA	increased number of tip-organizers \| increased mound size \| development arrests at mound stage \| decreased prestalk gene expression
JS64	tipA-/ tipB-/ [act15]: lacZ	tipA \| tipB	increased mound size \| increased number of mound tips \| development arrests at mound stage
JS98	tipA-/ tipC-/ [ecmA]: lacZ	tipA \| tipC	development arrests at loose mound stage
JS128	tipA-/ tipD-/ [ecmA]: lacZ	tipA \| tipD	development arrests at loose mound stage
DBS0351500	tipB-	tipB	increased number of mound tips
JS56	tipB-	tipB	increased number of tip-organizers \| increased mound size \| increased number of mound tips \| development arrests at mound stage
JS99	tipB-/ tipC-/ [ecmA]: lacZ	tipB \| tipC	increased number of mound tips \| development arrests at tipped mound stage
JS129	tipB-/ tipD-/ [ecmA]: lacZ	tipB \| tipD	increased number of mound tips \| development arrests at tipped mound stage
JS55	tipC-	tipC	increased number of tip-organizers \| increased mound size \| development arrests at mound stage \| decreased number of autophagosomes \| decreased autophagy
DBS0350729	tipC-/ [unk]: tipC(2725-3848): GFP	tipC	decreased fruiting body size
JS130	tipC-/ tipD-/ [ecmA]: lacZ	tipC \| tipD	development arrests at loose mound stage
JS93	tipD-	tipD	increased number of tip-organizers \| increased mound size \| development arrests at mound stage \| aberrant vacuole organization \| decreased autophagy
DBS0350730	tipD-	tipD	decreased pinocytosis \| increased cell death \| decreased spore germination \| decreased catalytic activity \| increased gene expression \| increased number of mound tips \| increased protein modification \| aberrant phagosome maturation \| aberrant slug development \| aberrant fruiting body morphogenesis \| abolished protein localization to autophagosome
DBS0304519	tirA-	tirA	decreased response to Gram-negative bacterium \| decreased defense response to Gram-negative bacterium \| aberrant defense response to bacterium \| decreased growth rate \| aberrant phagocytosis \| aberrant vegetative growth
YLD31A	tlp2-	tlp2	decreased growth rate
DBS0236016	tmcB-/ V12	tmcB	decreased macrocyst size \| aberrant macrocyst formation
DBS0236018	tmcC-/ V12	tmcC	aberrant macrocyst formation
DBS0351084	tnlA/ tnlB-REMI	tnlA \| tnlB	decreased gene expression \| delayed aggregation \| increased cell-substrate adhesion \| decreased cell motility \| increased protein kinase activation
DBS0350285	tom1-	tom1	decreased rate of endocytosis
DBS0237017	torA-	torA	delayed aggregation \| decreased growth rate \| decreased cell motility \| decreased chemotaxis rate
DBS0237018	torA-/ [act15]: torA: GFP	torA	abolished vegetative growth
DBS0351498	tpc2-	tpc2	increased number of autophagosomes \| increased gene expression \| decreased gene expression \| aberrant vegetative growth \| aberrant calcium-mediated signaling \| increased protein kinase activity \| delayed development \| increased lysosomal pH
DBS0350506	tpp1-	tpp1	aberrant response to chemical
DBS0350504	tpp1-	tpp1	increased autophagic cell death \| decreased catalytic activity \| aberrant response to chemical \| aberrant cell morphology \| precocious development \| decreased sporulation
DBS0350505	tpp1-/ [cotB]: tpp1	tpp1	wild type
DBS0350507	tpp1-/ stpA-	stpA \| tpp1	wild type
DBS0351017	tpp1F-	tpp1F	wild type
DBS0351558	tpt1-	tpt1	decreased spore germination \| decreased gene expression \| decreased growth rate \| aberrant cytokinesis \| decreased number of mounds \| decreased macropinocytosis \| delayed development \| aberrant fruiting body morphogenesis \| increased prestalk cell differentiation
DBS0351265	trfA-	trfA	aberrant aggregation \| aberrant vegetative growth \| decreased chemotaxis to cAMP
DBS0237924	triA-	triA	decreased cell-cell adhesion \| increased stalk width \| increased number of mounds \| decreased spore germination \| aberrant upper cup formation \| aberrant cell motility \| aberrant stream morphology \| decreased spore size \| decreased cell fate determination \| aberrant late culminant morphology
DBS0237996	triA-	triA	aberrant late culminant morphology
DBS0237997	triA-	triA	aberrant late culminant morphology
DBS0237998	triA-/ [act15]: GFP	triA	aberrant late culminant morphology
DBS0237999	triA-/ [ecmAO]: lacZ: [ecmAO]: gus	triA	increased prestalk O cell differentiation
DBS0238001	triA-/ [psA]: lacZ: [psA]: gus	triA	increased prespore cell differentiation
DBS0351605	trm9-	trm9	decreased protein level
DBS0350107	tsc2-	tsc2	decreased phagocytosis
DBS0237022	tsg101-	tsg101	decreased fruiting body size
DBS0351612	tsg101-	tsg101	aberrant cellular process \| decreased protein localization \| increased defense response to Gram-positive bacterium
DBS0350816	tspC-	tspC	aberrant response to osmotic stress
HM1725	tstD-	tstD	decreased growth rate \| decreased plasma membrane organization \| increased growth rate
DBS0302370	tsuA-	tsuA	increased oscillatory cAMP signaling \| abolished establishment of cell polarity \| aberrant chemotaxis to folate \| aberrant chemotaxis to cAMP \| delayed aggregation \| decreased mound size \| decreased fruiting body size \| aberrant pseudopodium formation
DBS0302383	tsuA-/ [unk]: tsuA(1-1774): YFP	tsuA	abolished protein localization to microtubules \| abolished protein localization to microtubule organizing center \| decreased mound size \| decreased fruiting body size
DBS0302385	tsuA-/ [unk]: tsuA(1-260): YFP	tsuA	abolished protein localization to microtubules \| abolished protein localization to microtubule organizing center \| decreased mound size \| decreased fruiting body size
DBS0302384	tsuA-/ [unk]: tsuA(1774-2247): YFP	tsuA	abolished protein localization to microtubules \| abolished protein localization to microtubule organizing center \| decreased mound size \| decreased fruiting body size
DBS0302382	tsuA-/ [unk]: tsuA(K34R): YFP	tsuA	decreased mound size \| decreased fruiting body size
DBS0302381	tsuA-/ [unk]: tsuA: YFP	tsuA	wild type
DBS0237024	ubcB-	ubcB	increased number of tip-organizers \| development arrests at mound stage
DBS0306165	ube2t-	ube2t	decreased resistance to cisplatin
DBS0237025	ubpA-	ubpA	decreased gene expression \| decreased chemotaxis rate \| abolished aggregation
DBS0237026	ubpB-	ubpB	aberrant sorus morphology \| increased prestalk gene expression \| decreased prespore gene expression \| precocious development
DBS0351464	uduB-/ AX3	uduB	increased prestalk cell differentiation
DBS0237027	ufc1-	ufc1	wild type
DBS0237028	ugpB-/ DH1	ugpB	abolished sporulation \| decreased glycogen level \| aberrant cell differentiation \| decreased fruiting body size \| delayed culmination
DBS0266763	ugpB-/ DH1	ugpB	decreased stalk length
DBS0266764	ugpB-/ HMX	ugpB	abolished cellulose biosynthesis \| decreased autophagic vacuole organization \| aberrant cell morphology
DBS0350591	uppA-	uppA	decreased catalytic activity
DBS0237031	vacA-	vacA	wild type
DBS0351567	vacA-	vacA	decreased phagocytosis
DBS0351571	vacA-/ vacB-/ vacC-	vacA \| vacB \| vacC	decreased cell-substrate adhesion \| decreased gene expression \| decreased phagocytosis \| aberrant phagosome maturation \| decreased protein localization \| aberrant protein localization
DBS0237032	vacB-	vacB	decreased exocytosis \| increased defense response to bacterium
DBS0351568	vacB-	vacB	decreased phagocytosis
DBS0351570	vacB-/ vacC-	vacB \| vacC	decreased phagocytosis
DBS0351569	vacC-	vacC	decreased phagocytosis
DBS0237034	vasP-	vasP	abolished filopodium formation
DBS0237035	vasP-	vasP	decreased lateral pseudopodium retraction \| decreased cell-substrate adhesion \| decreased vegetative cell size \| decreased cell motility \| decreased chemotaxis rate \| aberrant hyperosmotic response \| aberrant actin filament organization \| decreased chemotaxis to cAMP \| abolished filopodium formation \| decreased filopodium formation
DBS0237033	vasP-/ [act15]: GFP: vasP(1-264/ 285-380)	vasP	abolished filopodium formation
DBS0237836	vasP-/ [act15]: YFP: wipA	vasP \| wipA	decreased filopodium formation
DBS0237842	vasP-/ [act15]: YFP: wipA/ [act15]: vasP: FLAG	vasP \| wipA	increased filopodium formation
DBS0351313	vasP-/ [act15]: abpB(129-295)	abpB \| vasP	aberrant cellular process
DBS0351300	vasP-/ [act15]: eYFP: vasP(S141A)	vasP	decreased protein localization to cell cortex \| wild type \| decreased lateral pseudopodium retraction \| decreased establishment of cell polarity \| aberrant actin filament organization
DBS0351301	vasP-/ [act15]: eYFP: vasP(S141D)	vasP	aberrant hyperosmotic response \| decreased filopodium formation
DBS0237036	vasP-/ [act15]: myr: vasP	vasP	increased filopodium formation \| aberrant cytokinesis \| increased actin filament polymerization
DBS0237040	vasP-/ [act15]: vasP	vasP	decreased filopodium formation
DBS0237840	vasP-/ [act15]: vasP	vasP	increased filopodium formation \| increased actin filament polymerization
DBS0237037	vasP-/ [act15]: vasP(1-110: 231-380)	vasP	aberrant cytokinesis \| increased actin filament polymerization \| decreased filopodium formation
DBS0237038	vasP-/ [act15]: vasP(1-228)	vasP	decreased filopodium formation
DBS0237039	vasP-/ [act15]: vasP(111-380)	vasP	increased filopodium formation \| increased actin filament polymerization
DBS0350466	vasP-/ [unk]: vasP(1-197: 221-380)	vasP	wild type
DBS0350467	vasP-/ [unk]: vasP(1-261: 285-380)	vasP	decreased cell motility \| abolished filopodium formation
DBS0351536	vasP-/ hspc300-	hspc300 \| vasP	development arrests at slug stage \| aberrant sorocarp development
DBS0351537	vasP-/ pirA-	pirA \| vasP	increased number of mound tips
DBS0350602	vilA-	vilA	decreased chemotaxis to cAMP \| decreased phototaxis
DBS0236058	vmp1-	vmp1	aberrant aggregation \| decreased exocytosis \| increased cell death \| aberrant autophagy \| decreased gene expression \| decreased growth rate \| aberrant hypotonic response \| decreased macropinocytosis \| aberrant vacuole organization \| aberrant protein localization to autophagosome \| aberrant protein localization \| aberrant signal transduction
DBS0351250	vmp1-/ [act15]: vmp1(G268L): GFP	vmp1	aberrant aggregation \| aberrant protein localization to autophagosome
DBS0350873	vps13F-	vps13F	aberrant defense response to bacterium \| decreased growth rate
DG1118	vps46-	vps46	increased sorus size
DBS0237046	vwkA-	vwkA	increased myosin II assembly \| decreased growth rate \| aberrant cytokinesis \| aberrant contractile vacuole morphology \| aberrant hypotonic response \| delayed development \| increased protein level \| aberrant fruiting body morphogenesis \| decreased contractile vacuole discharge
DBS0350290	vwkA-/ [act15]: GFP: mhcA	mhcA \| vwkA	aberrant myosin II filament organization
TL61	wacA-	wacA	wild type
TL99	wacA-	wacA	wild type
DBS0237048	warA-	warA	development arrests at slug stage \| increased basal disc size \| decreased prespore cell differentiation \| increased prestalk O cell differentiation
DBS0237049	warA-	warA	development arrests at slug stage \| increased basal disc size \| decreased prespore cell differentiation \| increased prestalk O cell differentiation
DBS0237050	warA-/ hbx2-	hbx2 \| warA	increased basal disc size \| development arrests at mound stage \| decreased prespore cell differentiation \| increased prestalk O cell differentiation
DBS0237051	wasA-	wasA	decreased cell motility \| delayed development \| aberrant actin filament organization
DBS0351506	wasA-	wasA	aberrant protein localization to trailing edge
DBS0351509	wasA-/ [tet]: scrA/ [unk]: GFP: wasA(I173A/ F179A)	scrA \| wasA	aberrant pseudopodium formation
DBS0351508	wasA-/ [unk]: GFP: wasA(I173A/ F179A)	wasA	aberrant protein localization to trailing edge \| decreased establishment of cell polarity
DBS0237052	wasA1-/ [tet]: YFP: wasA2	wasA	decreased actin filament polymerization \| abolished positive chemotaxis \| abolished aggregation \| aberrant actin filament organization
DBS0237812	wasA1-/ [tet]: YFP: wasA2/ [act15]: wasA	wasA	increased actin filament polymerization at leading edge
DBS0237811	wasA1-/ [tet]: YFP: wasA2/ [act15]: wasA(Y33A/ W39A/ F90A/ F91A)	wasA	decreased actin filament polymerization \| decreased actin filament polymerization at leading edge
DBS0237820	wasA1-/ [tet]: YFP: wasA2/ [act15]: wipA	wasA \| wipA	abolished positive chemotaxis
DBS0350254	wasB-	wasB	abolished protein localization to cytoplasmic vesicle \| aberrant chemotaxis to cAMP \| increased actin filament polymerization \| increased protein level \| aberrant pseudopodium formation
DBS0350255	wasB-/ [act15]: YFP: wasB	wasB	wild type
DBS0351525	wasC-	wasC	increased actin filament polymerization \| decreased phagocytosis \| increased cell-substrate adhesion \| decreased chemotaxis rate
DBS0350239	washc5-	washc5	abolished exocytosis \| decreased protein level \| decreased growth rate \| decreased phagocytosis \| aberrant endosome morphology \| decreased vegetative cell size \| abolished phagosome reneutralization \| decreased secretion of lysosomal enzymes \| abolished actin filament polymerization \| aberrant lysosome organization
DBS0351185	washc5-/ [act15]: washc5(N457D): GFP	washc5	abolished exocytosis
DG1053	wimA-	wimA	aberrant fruiting body morphogenesis
DG1064	wimA-	wimA	aberrant fruiting body morphogenesis
DBS0349863	wshA-	wshA	increased protein localization \| abolished exocytosis \| decreased defense response to Gram-negative bacterium \| decreased macroautophagy \| abolished endocytic recycling \| aberrant vegetative growth \| decreased phagocytosis \| decreased protein processing in phagocytic vesicle \| aberrant phagosome maturation \| abolished phagosome reneutralization \| decreased secretion of lysosomal enzymes \| increased defense response to Gram-positive bacterium \| decreased protein localization \| aberrant lysosome organization \| aberrant protein localization
DBS0350872	wshA-/ [act15]: GFP: wshA/ [act15]: vatB: RFP	vatB \| wshA	abolished endocytic recycling
DBS0350451	wshA-/ atg1-	atg1 \| wshA	wild type
DBS0350248	wshA-/ fam21-/ [act15]: GFP: fam21	fam21 \| wshA	abolished actin filament polymerization
DBS0350247	wshA-/ fam21-/ [act15]: GFP: wshA	fam21 \| wshA	aberrant lysosome organization
DBS0350943	xacA-	xacA	decreased hypotonic response \| aberrant contractile vacuole morphology \| aberrant actin filament organization
DBS0350950	xacA-	xacA	increased lateral pseudopodium formation \| decreased chemotaxis to cAMP \| aberrant actin filament organization
DBS0350944	xacA-/ [act15]: xacA(1-320)	xacA	decreased growth rate \| aberrant cytokinesis
DBS0350945	xacA-/ [act15]: xacA(779-1335)	xacA	decreased hypotonic response \| aberrant contractile vacuole morphology
HM1456	xpc-	xpc	wild type \| aberrant vegetative growth
HM1403	xpf-	xpf	aberrant vegetative growth \| decreased resistance to cisplatin
AK235	yakA-	yakA	abolished aggregation
AK800	yakA-	yakA	decreased protein localization to cell cortex \| decreased gene expression \| aberrant cell cycle \| increased cellular thermotolerance \| aberrant gene expression \| decreased protein kinase activation \| abolished aggregation \| aberrant response to oxidative stress \| aberrant cellular response to stress \| decreased cAMP level
DBS0237087	yakA-/ AX3	yakA	decreased growth rate \| abolished aggregation \| abolished actin filament polymerization \| decreased cGMP biosynthesis
DBS0237091	yakA-/ [crlA]: crlA	crlA \| yakA	abolished vegetative growth
DBS0350058	yakA-/ keaA-	keaA \| yakA	wild type
DBS0351199	yakA-/ pkaC-	pkaC \| yakA	aberrant cellular response to stress
AK804	yakA-/ pufA-	pufA \| yakA	increased protein kinase activity \| increased protein level \| aberrant fruiting body morphogenesis \| increased growth rate \| precocious development
DBS0350898	yelA-/ AX2	yelA	precocious prestalk gene expression \| increased basal disc size
DG1014	yelA-/ AX4	yelA	aberrant spore morphology \| precocious sporulation \| development arrests at mound stage \| aberrant mound color \| aberrant sporulation
DBS0349797	zak2-	zak2	decreased prespore gene expression \| decreased protein kinase activation \| aberrant fruiting body morphogenesis \| decreased sporulation
DBS0349883	zak2-/ [act15]: GFP	zak2	decreased sporulation
DBS0349798	zak2-/ [ecmA]: LacZ	zak2	aberrant prestalk gene expression
DBS0349882	zak2-/ [ecmA]: zakA	zak2 \| zakA	precocious prestalk gene expression
ARK100-110	zakA-	zakA	abolished stream development \| decreased protein kinase activity \| increased prestalk gene expression \| decreased prespore gene expression \| aberrant fruiting body morphogenesis \| decreased chemotaxis to cAMP \| delayed culmination \| decreased sporulation
DBS0238142	zakA-	zakA	development arrests at tipped mound stage
DBS0349803	zakA-/ [ecmB]: LacZ	zakA	aberrant prestalk gene expression
DG1050	zipA-	zipA	decreased fruiting body size
DBS0350068	zizB-	zizB	aberrant fruiting body morphogenesis \| delayed development \| decreased chemotaxis to cAMP

Last updated July 28, 2024


		Genomes Dictyostelium discoideum Dictyostelium purpureum Dictyostelium fasciculatum Polysphondylium pallidum Explore Learn About Dicty Teaching Protocols Dictyostelium Genome Resources D. discoideum Genome Statistics Pictures/Videos dictyArt Useful Links Virtual Library Dictyostelium Page Research Techniques Dicty Anatomy Ontology Mutant Phenotypes HTP Phenotyping at Princeton Codon Bias Table Nomenclature Guidelines Axenic Strains History Franke Dictyostelium Reference Library Tools New JBrowse Genome Browser Chromosome 1 Chromosome 2 Chromosome 3 Chromosome 4 Chromosome 5 Chromosome 6 Mitochondrial DNA Ribosomal DNA Legacy Genome Browser Chromosome 1 Chromosome 2 Chromosome 3 Chromosome 4 Chromosome 5 Chromosome 6 Mitochondrial DNA Ribosomal DNA BLAST ID Converter dictyMart Textpresso Biochemical Pathways Third Party Tools Stock Center Dicty Stock Center Home About Stock Center Search Stock Center Order Deposit Strain Catalog Plasmid Catalog Additional Materials Stock Center FAQ Nomenclature Guidelines Other Stock Centers Download Community Submit an Abstract to dictyNews Read the dictyNews ListServ Archive Add or update your colleague profile Dicty Annual Conference Job opportunities History Dicty Labs on the Web Citing dictyBase and the Dictyostelium Genome Project		About Us Contact Help